{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "6df32601eebd9e82e58451b5dfe77f1a",
    "title": "Morgan Stanley | RESEARCH",
    "source_uri": "25.9月 普通个人版/9.1 普通个人版/MS/Biopharma A picture is worth a thousand wordsBiopharma A picture is worth a thousand words_2025-08-29",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-26T12:24:19.192863",
      "extracted_at": "2025-10-26T12:24:19.192876"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 93,
        "successful_pages": 93,
        "date": "2025-08-29",
        "publication": "25.9月 普通个人版/9.1 普通个人版/MS",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 2,
          "removed_paragraphs": 2,
          "reduction_ratio": 0.055447549914622196
        },
        "input_relative_path": "25.9月 普通个人版/9.1 普通个人版/MS"
      }
    }
  },
  "passages": [
    {
      "passage_id": "a3a3524498293839",
      "text": "August 29, 2025 12:27 PM GMT",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "a3bc1a7783112eed",
      "text": "Comprehensive US drug market analysis (IQVIA Rx). The latest weekly Total Prescription YoY growth (wk ending 8/22) was \\(+2.3\\%\\) vs. \\(+2.6\\%\\) last wk and \\(+2.7\\%\\) over the past 12 wks.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "ed694f8a333e4798",
      "text": "For week ended Aug 22, US total market weekly TRx YoY change was \\(+2.3\\%\\) vs. \\(+0.8\\%\\) year ago (Exhibit7). Rolling 4- week TRx YoY was \\(+2.6\\%\\) and rolling 12- week TRx YoY was \\(+2.7\\%\\) . Extended unit (EUTRx) weekly YoY growth was \\(+1.8\\%\\) , below TRx YoY (Exhibit 11). Sequential weekly TRx growth was \\(+0.3\\%\\) compared to \\(+1.1\\%\\) week before. Exhibit16- Exhibit18 depict YoY momentum for key products.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "86a0a5b1aba16a54",
      "text": "BMY's Cobenfy was approved for schizophrenia on 9/26/24. Scripts are \\(\\sim 2,160\\) for the week vs \\(\\sim 2,100\\) last week. For full details on our views on the launch see our note \"Contextualizing Cobenfy launch expectations\", where we discuss that the analogs we are most focused on are the schizophrenia volumes from the Rexulti, Caplyta, and Lybalvi launches. We estimated that to achieve 2025 consensus expectations Cobenfy TRx needs to track at \\(\\sim 2 - 3x\\) the volumes from those launches (see Exhibit 1) based on the implied consensus trend as '25 estimates have declined to \\(\\) 17\\(1mn from\\) \\ \\(196m\\) since our initial note, which implies \\(\\sim 129K\\) TRx are required to reach consensus estimates (assuming a \\(\\sim\\) 1,200 net price, in line with our estimated price in our BMY model). We also show the Cobenfy launch to date and our estimate of the trajectory to achieve consensus relative to recent anti- psychotic launches, with TRx combined across all indications, in Exhibit 2 below for reference as well.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "08a3156d6e2da9d1",
      "text": "VRTX's Journavex was approved for acute pain on 1/30/25. Scripts are \\(\\sim 7,060\\) for the week vs \\(\\sim 6,890\\) last week. VRTX notes that hospital scripts are not captured by IQVIA, which makes up \\(\\sim 35\\%\\) of total scripts, and it further confirms that the average script duration is \\(^{14}\\) days (LINK). We note VA cons estimate for 2025 has increased to \\(\\) 78\\(mn from\\) \\ \\(65mn\\) after 2Q earnings. To achieve \\(\\) 78\\(mn sales, we estimate that \\(\\sim 349\\) total scripts are needed for 14 - day script duration (assuming\\) \\ \\(225\\) net price per script, where we assume \\(50\\%\\) GTN, but note we have limited visibility). Baged on 2Q Journavex sales and scripts, we estimate the GTN to be \\(\\sim 69\\%\\) Using a line method, we project the weekly TRx needed to achieve cons estimate, by flexing the GTN from \\(50\\% - 75\\%\\) for 14- day scripts (Exhibit 3). In addition, we include a line where the actual scripts are grossed up with estimated hospital scripts, such that \\(35\\%\\) of the total scripts come from hospitals.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "1c051f829199e415",
      "text": "GILD's Yeztugo vs. Descovy vs. Apretude launch comparison chart (Exhibit 4). GILD's Yeztugo (lenacapavir) was approved on 6/18/2025 and has started to appear in IQVIA. Latest week TRx were \\(\\sim 390\\) vs \\(\\sim 340\\) previous week. Yeztugo injectable formulation TRx were \\(50.4\\%\\) vs oral at \\(49.6\\%\\) of total TRx. See here for more details on approval, pricing and launch expectations.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "70c442785f326a2a",
      "text": "North America Industry View BIOTECHNOLOGY North America Industry View Attractive",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "72e96b1beffae922",
      "text": "Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "f2cc978fc52fd497",
      "text": "For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "733c064810a905d9",
      "text": "LLY's Mounjaro & Zepbound launch (Exhibit 60). Please see our note \"Mounjaro +Zepbound Script Tracker\" for more details.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "9b474b1e19df66c7",
      "text": "Oral Psoriasis market. We are tracking BMY's SotykTu launch vs. AMGN's Otezla (Exhibit 104).",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "25a5eaa9006d0eb8",
      "text": "Alzheimer's launch. LLY launched its Alzheimer's drug Kisunla in July- 24. See Exhibit 137 to Exhibit 140 for Kisunla and BIIB/Eisai Leqembi sales charts.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "e36fca909661ab6d",
      "text": "Immunology pricing analysis. We updated the charts for 2Q25 for Stelara and Tremfya (Exhibit 76 - Exhibit 81). We have divided the historical quarterly reported sales for Stelara, Tremfya, Skyrizi, Rinvoq, Dupixent and Cosentyx with respective quarterly IQVIA TRx to see how volume from additional indications impacts price/script.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "8d789c07c15bf0da",
      "text": "ABBV's Skyrizi and Rinvoq. Please refer to Exhibit 91 to Exhibit 93 for key Skyrizi charts and Exhibit96 to Exhibit 100 for key Rinvoq charts.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "c81d786cff3aad69",
      "text": "Seasonal respiratory vaccine tracking exhibits. See RSV vaccine weekly TRx launch chart in Exhibit 154 & Exhibit 155, and COVID vaccine weekly & monthly TRx launch trend chart in Exhibit 161 & Exhibit 162.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "1c8ba6d50408e35e",
      "text": "Comprehensive biosimilar adoption analysis. See adoption of biosimilars across various branded drugs in these charts—Actemra, Avastin, Epogen, Herceptin, Humalog, Humira, Lantus, Lucentis, Neulasta, Neupogen, Prolia, Remicade, Rituxan, and Stelara. For IV drugs, we track monthly IQVIA sales only. See Exhibit 19 for Biosimilars U.S. approval/launch time- line.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "b259830d054455e9",
      "text": "JNJ: Stelara biosimilar TRx share and sales charts (Exhibit 36 & Exhibit 37). Biocon's Yesintek has \\(\\sim 8\\%\\) and AMGN's Wezla has \\(\\sim 5\\%\\) share in latest week.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "6346ac2e19186391",
      "text": "AMGN: Prolia biosimilar TRx share chart (Exhibit 33). Sandoz's Jubbonti has started to appear from the week of June 13 and has negligible TRx in latest week.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "2c017e9fe19f7f5b",
      "text": "Exhibit 1: MS- Estimated Cobenfy TRx trajectory to achieve consensus estimates vs. schizophrenia launch analogs",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "ae3e0170fb68bd56",
      "text": "Source: IQVIA, MS Research; estimates for Vraylar, Lybalvi, and Rexulti are for schizophrenia TRx only",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "ca13565733771540",
      "text": "Exhibit 2: Cobenfy Launch vs. Recent antipsychotic launches (indications)",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "5e1b435ef7b50d1d",
      "text": "Source: IQVIA, MS Research",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "41960223cd990ac3",
      "text": "Exhibit 3: MS-Estimated Journax TRx trajectory based on gross to net (GTN) pricing for 14-day scripts",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "59b122bd66d050b3",
      "text": "Source: IQVIA, MS Research",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "431718cee687276a",
      "text": "Exhibit 4: GILD's Yeztugo and Descovy vs. GSK's Apretude TRx launch comparison",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "8b19faae196d1783",
      "text": "Exhibit 5: Key products TRx YOY % for US Major Pharma and Biotech",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "87ff84e9d88f5d36",
      "text": "TRx YOY %12-wk rolling4-wk rollingWeeklyABBVIE:",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "6eb6581ecd768673",
      "text": "Exhibit 6: Notable drug total prescriptions (TRx). All figures are rounded to the nearest hundred because IQVIA does not allow publication of exact Rx counts",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "e80d86fa6f53d616",
      "text": "~TRx / Week ending08/01/2508/08/2508/15/2508/22/25DIABETES (GLP-1)OBESITYVictoza (Novo)8001,1009001,500Xultophy (Novo)1,0001,0009001,000Ozempic (Novo)577,700578,600574,600574,400Rybelsus (Novo)54,50052,70052,10052,300Wegovy (Novo)282,200282,900280,500280,500Novo GLP-1 franchiseT2D633,900633,300628,500629,300Novo GLP-1 franchiseT2D+Obesity916,100916,200909,000909,800Trulicity (Eili Lilly)157,500156,300154,000155,500Mounjaro (LLY)608,700617,800621,400630,200Zepbound (Eili Lilly)421,900301,000414,400415,900LLY GLP-1 franchise766,200774,100775,400785,700LLY GLP-1 franchise T2D+Obesity1,188,1001,075,1001,189,8001,201,600ENDOMETRIOSISOrilissa (Abbvie)2,0002,0001,9002,000MIGRAINE (CGRPOTHERS)Aimovig* (Amgen)22,40021,80022,20021,800est. no. of injections14,20014,30014,40014,400Ajovy (Teva)21,90021,70021,80022,000est. no. of injections63,20063,50063,70064,600Emgality (Eili Lilly)38,60037,70038,20038,000est. no. of injections5,3005,4005,5005,500Ubrelvy (Abbvie)51,70051,20052,20053,100Quilpta (Abbvie)37,10036,90037,80038,100Nurtec (Pfizer)65,70065,40066,90067,600Reyvow (Eili Lilly)800900800900Vyepti (Lundeback)00000000ATOPIC DERMATITISNemluvio (Galderma)2,4002,5002,7002,800Eucrisa (Pfizer)3,9003,9004,0003,900Adbry (Leo)2,1002,2002,2002,100Ebglyss (LLY)2,0002,0002,1002,200Dupixent (Sanofi/Regeneron)91,30094,80094,60094,500Opzelura (Incyte)14,00014,10014,30014,100CDK 4/6 PI3KIbrance (Pfizer)3,0003,2003,1003,200Kisqali Franchise(Novartis)3,1003,3003,2003,200Piqray (Novartis)100100100100Verzenio (Eili Lilly)*4,0004,4004,1004,300BTK BCL-2 INHIBITORSImbruvica (Abbvie)2,1002,2002,6002,500Venclecta (Abbvie/Roche)1,4001,5001,5001,600Calquence (AZN)*2,6002,4002,5002,400",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "cf1ccc82fa04aeb1",
      "text": "Exhibit 6: Notable drug total prescriptions (TRx). All figures are rounded to the nearest hundred because IQVIA does not allow publication of exact Rx counts",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "49a16052c67cbb18",
      "text": "~TRx / Week ending08/01/2508/08/2508/15/2508/22/25DIABETES (GLP-1)OBESITYVictoza (Novo)8001,1009001,500Xultophy (Novo)1,0001,0009001,000Ozempic (Novo)577,700578,600574,600574,400Rybelsus (Novo)54,50052,70052,10052,300Wegovy (Novo)282,200282,900280,500280,500Novo GLP-1 franchiseT2D633,900633,300628,500629,300Novo GLP-1 franchiseT2D+Obesity916,100916,200909,000909,800Trulicity (Eili Lilly)157,500156,300154,000155,500Mounjaro (LLY)608,700617,800621,400630,200Zepbound (Eili Lilly)421,900301,000414,400415,900LLY GLP-1 franchise766,200774,100775,400785,700LLY GLP-1 franchise T2D+Obesity1,188,1001,075,1001,189,8001,201,600ENDOMETRIOSISOrilissa (Abbvie)2,0002,0001,9002,000MIGRAINE (CGRPOTHERS)Aimovig* (Amgen)22,40021,80022,20021,800est. no. of injections14,20014,30014,40014,400Ajovy (Teva)21,90021,70021,80022,000est. no. of injections63,20063,50063,70064,600Emgality (Eili Lilly)38,60037,70038,20038,000est. no. of injections5,3005,4005,5005,500Ubrelvy (Abbvie)51,70051,20052,20053,100Quilpta (Abbvie)37,10036,90037,80038,100Nurtec (Pfizer)65,70065,40066,90067,600Reyvow (Eili Lilly)800900800900Vyepti (Lundeback)00000000ATOPIC DERMATITISNemluvio (Galderma)2,4002,5002,7002,800Eucrisa (Pfizer)3,9003,9004,0003,900Adbry (Leo)2,1002,2002,2002,100Ebglyss (LLY)2,0002,0002,1002,200Dupixent (Sanofi/Regeneron)91,30094,80094,60094,500Opzelura (Incyte)14,00014,10014,30014,100CDK 4/6 PI3KIbrance (Pfizer)3,0003,2003,1003,200Kisqali Franchise(Novartis)3,1003,3003,2003,200Piqray (Novartis)100100100100Verzenio (Eili Lilly)*4,0004,4004,1004,300BTK BCL-2 INHIBITORSImbruvica (Abbvie)2,1002,2002,6002,500Venclecta (Abbvie/Roche)1,4001,5001,5001,600Calquence (AZN)*2,6002,4002,5002,400",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "146cfdd54cea79e9",
      "text": "Brukinsa (BeiGene)1,0001,1001,2001,100Jaypirca (LLY)250270220230Xospata (Astellas)100100100100OSTEOPOROSISEvenity (Amgen)*1,1001,3001,3001,400RA AND PSORIASISTaltz (Eili Lilly)13,40013,90013,90014,000Cosentyx (Novartis)20,50021,10021,40021,200Sotyktu (BMY)1,5001,5001,6001,600Otezla (Amgen)17,80017,90017,80018,600Xeljanz (Pfizer)8,7008,2008,3008,700Cibinqo (Pfizer)700700800800Olumiant (Eili Lilly)1,8001,9001,9001,900Rinvoq (Abbvie)26,20026,40027,50027,700Tremfya (JnJ)*11,80011,50012,10011,900Skyrizi (Abbvie)22,10022,50022,40022,100Kevzara (Sanofi/Regeneron)2,3002,3002,4002,400",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "7e366da11d615147",
      "text": "**Humira (since 8/23/19), Vyndaqel (5/31/19), Skyrizi (5/24/19), and Evenity (5/10/19): Prescriptions are restricted, due to a contractual condition between a supplier and the manufacturers.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "6b9ed85385bd5d2b",
      "text": "See respective therapeutic sections for comprehensive charts on categories and key drugs.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "42f53e90458f65da",
      "text": "The IQVIA databases are different for prescription (Rx) and sales (\\$), and the IQVIA sales dollars only reflect list prices of drugs and not rebates/discounts. TRx represents total prescription dispensed including refills. NRx represents new prescriptions — that is, all scripts written except refills. However, the NRx also includes renewals—the script patients get when they run out of refills.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "f8cf939fc369fed8",
      "text": "Exhibit7: Total Market weekly YOY TRx growth - see blue line for 2021 trend",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "75110646466b1a62",
      "text": "Note: TRx= Total Prescription. See definition above. Source: IQVIA",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "725bf2ab55f27bd7",
      "text": "Exhibit 8: Total market absolute TRx and NRx",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "c3a417366fc05c60",
      "text": "Note: NRx= New Prescription. See definition above. Source: IQVIA",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "221025af169ce1f4",
      "text": "Exhibit 9: Total market TRx and NRx growth since Jan-20",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "b8dd048064a4af55",
      "text": "Extended unit (EU) data trends were more positive than prescription (Rx) trends suggesting physicians were writing more 90- day prescriptions during that period (Exhibit 10 and Exhibit 11). EU figures (EUTRx / EUNRx) may represent a more accurate picture of demand because they take into account larger/longer- duration prescriptions while NRx / TRx figures count both a 30- day and a 90- day prescription the same.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "afb561ff20942174",
      "text": "Exhibit 10: Total market weekly NRX and EUNRx YOY growth since January 2020",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "e3eda7eccfa2d444",
      "text": "Exhibit 11: Total market weekly TRx and EUTRx YOY growth since January 2020",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "7e3ca8ab8f88b986",
      "text": "Exhibit 12: Total market YTD cumulative 2021, 2022, 2023, 2024 and 2025 EUTRx YOY trends",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "177f980f991c27ab",
      "text": "Exhibit13: U.S. market\\* including brands and generics monthly gross sales growth",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "242ce0aa56ff689e",
      "text": "\\\\*IQVIA reports brands, branded generics, generics and others. Source:IQVIA",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "dd402ed074b0e882",
      "text": "Exhibit14: Total market Branded\\* pharmaceutical monthly YOY volume vs. sales dollar growth",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "81082f9a8e5d2fd8",
      "text": "\\\\*Includes Brands and Branded Generics. Note IQVIA includes some branded drugs in branded generics (e.g. Lidoderm) Source: IQVIA",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "5aaaf2157f732dcc",
      "text": "Exhibit 15: Total market Generic pharmaceutical monthly YOY volume vs. sales dollar growth",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "85d99489933fee14",
      "text": "The IQVIA databases are different for sales \\(\\) and unit volumes, and the IQVIA sales dollars only reflect list prices of drugs and do not reflect rebates/discounts. We believe that branded net price realization is about half of what is implied by subtracting sales dollar growth minus volume growth.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "e46b93b940c9c561",
      "text": "Exhibit16: Key products from U.S. Major Pharma",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "db04d589f182f5b3",
      "text": "Trx Market Share*Weekly YOY4-Wk Rolling YOY12-Wk Rolling YOYCurrent WkRolling 4-WkRolling 12-WkABBVBotoxNANANA8%10%10%HCV franchise60.5%61.4%61.3%6%4%4%Humira13.6%13.7%14.6%-41%-40%-39%Imbruvica32.1%30.5%30.4%8%0%-9%LinzessNANANA10%11%11%Lumigan+Lumigan X4.9%4.9%4.9%-8%-9%-10%Quilpta24.0%24.1%23.8%27%28%29%Rinvoq11.8%11.6%11.5%39%36%37%Skyrizi9.4%9.6%9.4%42%45%44%Ubrelvy33.4%33.4%33.3%18%17%17%Venclexta20.7%19.6%19.3%12%-2%-10%Vraylar4.5%4.5%4.5%9%9%10%BMYCanzyosNANANA27%31%37%Elliquis69.7%69.6%69.2%8%9%9%Orencia3.4%3.4%3.3%15%16%16%Pomalyst18.4%18.8%18.7%11%12%12%Revlimid12.1%12.0%14.4%-31%-31%-20%Sotykta0.7%0.7%0.7%60%60%63%Sprycel10.2%10.1%10.1%-75%-75%-76%Zeposia5.4%5.2%5.2%11%6%8%JNJRisperdal Branded Franchise (incl. Invega Trinza)1.9%1.9%1.9%0%0%0%Simponi0.9%0.9%0.9%3%2%2%Erleada9.0%8.9%8.8%30%28%22%Spravato0.2%0.2%0.2%44%48%41%Stelara4.0%4.2%4.5%-29%-26%-21%Tremfya*5.1%5.1%4.9%41%35%31%Xarelto16.6%16.7%16.9%-7%-6%-6%LLYBasaglar5.5%5.4%5.5%-25%-25%-24%Emgality46.5%46.5%46.6%5%5%5%Humalog20.5%20.5%20.3%2%2%2%Humulin3.0%3.1%3.1%-13%-12%-9%Jardiance Franchise65.4%65.6%65.6%11%12%13%Jaypira2.9%3.2%3.1%69%72%72%Retevmo7.2%8.0%8.0%15%18%16%Taltz6.0%5.9%6.0%-7%-7%-7%Tradjenta Franchise20.4%20.3%20.2%-14%-13%-13%Trulicity10.9%11.0%11.2%-12%-14%-12%Mounjaro44.4%43.9%42.8%52%62%67%Zepbound47.0%45.1%47.4%184%191%232%Total GLP-1 franchise55.3%54.9%54.0%33%38%41%Verzenio*40.2%39.7%40.1%4%4%4%Vitrakvi3.5%3.4%3.3%31%32%21%MRKJanuvia Franchise (incl. Stelgato)79.6%79.7%79.7%-14%-14%-14%OGNNuvaRing0.2%0.3%0.5%-80%-74%-59%PFEAbrysvo45.0%46.0%45.1%25%33%20%Cibinpo0.3%0.3%0.3%34%30%32%Ibrance29.3%29.3%29.4%10%9%5%Elliquis69.7%69.6%69.2%8%9%9%Enbrel (PFE gets US royalties)11.8%11.8%11.8%7%7%6%EucrisaNANANA-16%-14%-15%Nutric42.0%42.6%42.9%11%11%12%Prevnar franchise58.0%58.9%59.4%-21%-23%-23%VyndaqelNANANA40%33%37%XeljanzXR3.7%3.7%3.7%-1%-1%-1%Xtandi*25.7%25.6%25.8%34%32%29%",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "fa80c4f50658ed9b",
      "text": "\\\\*Verzenio, Tremfya and HCV: A reporting restriction has been implemented in the mail channel for a portion of the sales and prescription volumes, due to a contractual condition between a supplier and the manufacturers. Source: IQVIA",
      "page": 10,
      "section": null
    },
    {
      "passage_id": "8e8d50be35a4805f",
      "text": "Exhibit 17: Key products from U.S. Biotech",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "702a610995a02a6c",
      "text": "Current WkWeekly YOY4-Wk Rolling YOY12-Wk Rolling YOYCurrent WkRolling 4-WkRolling 12-WkAMGNAlimovig26.6%26.9%27.0%-8%-7%-7%Aranesp20.7%19.5%18.8%-2%-7%-7%Enbrel11.8%11.8%11.8%7%7%6%Epogen39.8%39.0%40.9%-12%-16%-3%EvenityNMNMNM47%38%35%Otezla7.9%7.8%7.8%8%6%4%ProliaNMNMNM1%-6%-6%Repatha1.9%2.0%2.0%29%33%33%TaveosNMNMNM34%46%35%TazespireNMNMNM48%57%59%BIIBAvonex6.0%6.2%6.4%-1%1%1%Plegridy1.2%1.2%1.2%-2%-2%-5%Tecfidera1.4%1.3%1.3%-31%-36%-38%Tysabri1.5%1.5%1.4%3%-7%-10%Vumerity1.8%1.7%1.9%17%15%14%GILDGenvoya (% of total NRTI)5.0%5.1%5.1%-16%-16%-15%Odefsey TRx (% of total NRTI)3.6%3.7%3.7%-12%-10%-9%Descovy TRx (% of total NRTI)31.7%31.3%31.6%13%12%14%Biktary TRx (% of total NRTI)48.0%48.2%47.9%6%6%7%Total HIV Franchise (% of NRTI)89.5%89.4%89.4%4%4%5%Vemlidy52.8%53.0%53.1%3%8%7%VRTXKalydeco5.1%5.2%5.6%-17%-19%-18%Orkambi0.1%0.1%0.1%NM-36%-13%Symdeko0.7%0.8%0.8%-56%-48%-52%Trikafta TRx79.6%79.4%80.6%-37%-37%-37%Alyftrek TRx14.5%14.5%13.0%0%0%0%",
      "page": 11,
      "section": null
    },
    {
      "passage_id": "5abd36eba4621338",
      "text": "Exhibit18: Key products from ex-U.S. Pharma companies (covered by Mark Purcell)",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "1648ffe0c2ff11e1",
      "text": "TRx Market Share*Weekly YOY4-WK Rolling YOY12-WK Rolling YOYCurrent Wk Rolling4-Wk Rolling12-WkAZNBreztri19.0%18.9%18.1%20%20%21%Brilinta3.9%4.0%4.4%-59%-57%-53%Byetta/Bydureon Franchise0.0%0.0%0.0%-99%-99%-98%Calquence*30.3%32.3%32.9%26%29%18%Farxiga28.1%27.9%27.9%10%9%9%Xigduo XR1.4%1.4%1.5%-8%-8%-9%Farxiga franchise29.5%29.3%29.3%9%8%8%Symbicort36.0%35.8%35.6%15%15%16%GSKAdvair7.6%7.6%7.6%-19%-18%-16%Advair+Breo+A.G. franchise29.8%30.2%30.6%-15%-15%-14%Anoro Ellipta11.5%11.6%11.5%-16%-15%-15%Apretude2.4%2.5%2.4%73%63%65%Cabenuva3.6%3.4%3.4%37%29%27%Dovato12.4%12.5%12.4%16%18%19%Incuse Ellipta7.5%7.5%7.4%-2%-3%-3%NucalaNANANA19%17%14%Tivicay8.3%8.4%8.5%-10%-8%-7%Triumeq4.8%4.9%5.0%-23%-23%-22%Trelegy Ellipta72.4%73.3%72.4%11%12%12%NVSCosentyx9.0%9.1%8.9%11%14%14%Entresto3.6%4.2%5.0%-26%-14%4%Gilenya1.0%1.1%1.0%-19%-16%-22%Mayzent1.3%1.3%1.3%-14%-16%-19%Kesimpta26.0%26.0%25.5%28%30%29%Total MS franchise28.4%28.4%27.8%23%24%23%Kisqali franchise29.9%30.2%29.7%88%91%92%Tasigna6.3%6.7%7.3%-59%-59%-56%Novolin1.5%1.5%1.5%-9%-10%-14%Novolog13.8%13.8%13.7%0%-1%-2%Levemir0.0%0.0%0.0%-99%-99%-98%Tresiba7.7%7.7%7.7%-13%-12%-11%Insulin Franchise23.0%23.1%23.0%-11%-12%-13%Victoza0.1%0.1%0.1%-88%-89%-93%Xultophy0.1%0.1%0.1%-30%-35%-33%Ozempic40.4%40.8%41.6%-1%-1%1%Rybelsus3.7%3.7%3.9%-12%-11%-10%GLP-1 franchise44.3%44.7%45.6%-4%-3%-2%Wegovy31.7%33.0%30.1%34%37%32%RHBBY56.1%56.9%56.0%34%32%29%Rozlytrek4.6%3.2%3.9%-33%-53%-52%XolairNANANA26%26%27%SNYAmbien Franchise0.0%0.0%0.0%-100%-100%-100%DupixentNANANA27%29%28%KevzaraNANANA33%31%29%Lantus Franchise36.3%35.2%35.1%12%9%11%Soliqua0.4%0.4%0.4%-20%-18%-16%",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "5f7c797245eb74c5",
      "text": "\\\\*Calquence: A reporting restriction has been implemented in the mail channel for a portion of the sales and prescription volumes, due to a contractual condition between a supplier and the manufacturers.",
      "page": 12,
      "section": null
    },
    {
      "passage_id": "0d64498e7f1874aa",
      "text": "BrandBiosimilarActive ingredientCompanyApproved onLaunch actual/expectedHumiraAmjevitaadalimumab-attoAmgenSep 23, 2016Jan 31, 2023HumiraCyfrezadalimumab-attoBoehringer IngelheimAug 29, 2017Jul 1, 2023HumiraHyrimezadalimumab-adazSandozOct 31, 2018Sep 30, 2023HumiraAbriladaadalimumab-afzPfizerNov 18, 2019Nov 20, 2023HumiraHulioadalimumab-fkipViatrisJul 9, 2020Jul 31, 2023HumiraYusimryadalimumab-ayvhCoherusDec 20, 2021Jul 1, 2023HumiraHadlimaadalimumab-bwwdOrganon/Samsung BioepisAug 17, 2022Jul 1, 2023HumiraIdacioadalimumab-aacfFresenius KabiDec 14, 2022Jul 1, 2023HumiraYuflymaadalimumab-aatyCelltrionMay 24, 2023Jul 1, 2023HumiraSimlandiadalimumab-ryvkTeva/AlvotechFeb 23, 2024Feb 2024 est.LucentisByovozranibizumab-nunaBiogen/Samsung BioepisSept-21Jun 2, 2022LucentisCimerfiranibizumab-ecrnCoherusAug 3, 2022Oct 3, 2022NeulastaFulphilapegfilgrastim-jmdViatris/BioconJun 4, 2018Jul 9, 2018 est.NeulastaUdenycapegfilgrastim-cbqvCoherusNov 2, 2018Jan 3, 2019NeulastaZiextenzopegfilgrastim-bmzeNovartisNov 5, 2019Nov-19 estNeulastaNyvepriapegfilgrastim-apgfPfizerJun 11, 2020Jan-21 estNeulastaFylnetrapegfilgrastim-pbbkAmnealMay 27, 2022May 16, 2023NeulastaStimufendpegfilgrastim-fpgkFresenius KabiSep 2, 2022Mar-23 est.NeupogenZarxiofilgrastim-sndzNovartisMar 6, 2015Sep 3, 2015NeupogenNivestymfilgrastim-aafiPfizerJul 20, 2018Oct 1, 2018NeupogenReleukofilgrastim-ayowAmnealMar 1, 2022Nov 23, 2022AvastinMvasibevacizumab-awwbAmgen/AbbvieSep 14, 2017Jul 18, 2019AvastinZirabeybevacizumab-bvzrPfizerJun 28, 2019Dec 31, 2019AvastinAlymsysbevacizumab-malyAmnealApr 13, 2022Oct 3, 2022HerceptinOgivritrastuzumab-dkstViatris/BioconDec 1, 2017Dec 2, 2019HerceptinOntruzanttrastuzumab-dttbOrganon/Samsung BioepisJan 18, 2019Apr 15, 2020HerceptinTrazimeratrastuzumab-qqypPfizerMar 11, 2019Feb 19, 2020HerceptinKanjintitrastuzumab-annsAmgen/AbbvieJun 13, 2019Jul 18, 2019RituxanRuxiencerituximab-pvrvPfizerJul 23, 2019Jan-20RituxanRiabnirituximab-arrxAmgen/AbbvieDec 17, 2020Jan-21EpogenRetacritepoetin alfa-epbxPfizerMay 15, 2018Nov 12, 2018EnbrelErelzietanercept-szzsSandozAug 31, 2016TBDEnbrelEticovoetanercept-ykroSamsung BioepisApr 27, 2019TBDRemicade (sub-Q)Infectrainfliximab-dyybPfizerApr 5, 2016Nov 11, 2016Remicade (sub-Q)Zymfentrainfliximab-dyybCelltrionOct 23, 2023Mar 17, 2024RemicadeRenflexisinfliximab-abdaOrganonApr 24, 2017Jul 24, 2017RemicadeAvsolainfliximab-axxqAmgenDec 6, 2019Jul-20 est.LantusSemgleeinsulin glargine-yfgnBiocon/ViatrisJul 28, 2021Nov 16, 2021LantusRezvoglarinsulin glargine-agirEli LillyDec 17, 2021Apr 1, 2023TysabriTyrukonatalizumab-sztnNovartisAug 25, 2023TBDStelaraWezianaustekinumab-awubAmgenOct 31, 2023Jan 17, 2025StelaraSelarsdiustekinumab-aehnTeva/AlvotechApr 16, 2024Feb 21, 2025StelaraPzychivaustekinumab-ttweSandoz/Samsung BioepisJul 1, 2024Feb 24, 2025StelaraOtuffiustekinumab-awuzFresenius KabiOct 2, 2024Mar 3, 2025StelaraSteqeymaustekinumab-stbaCelltrionDec 17, 2024Mar 12, 2025StelaraYesintekustekinumab-kfceBioconDec 2, 2024Feb 24, 2025ActemraTofidencetocilizumab-baviBiogenSep 29, 2023TBDActemraTynenetocilizumab-aazgFresenius KabiMar 7, 2024Apr-24EyleaYesafilialfibercept-jbvfBioconMay 20, 2024TBDEyleaOpuvizalfibercept-yszySamsung BioepisMay 20, 2024TBDEyleaAhzantivealfibercept-mrbbFormyconJul 1, 2024TBDEyleaEnzeevualfibercept-abzvSandozAug 12, 2024TBDEyleaPavblualfibercept-ayyhAmgenSep 17, 2024TBDProliaBonnytradenosumabFresenius KabiMar 26, 20252H25ProliaJubbontidenosumab-bbdzSandozMar 5, 2024Jun 2, 2025ProliaOspomyydenosumabSamsung BioepisFeb 13, 2025TBDProliaStobocolodenosumab-bmwoCelltrionMar 3, 2025Jun-25XgevaConexxencedenosumabFresenius KabiMar 26, 20252H25XgevaWyostdenosumab-bbdzSandozMar 5, 2024Jun 2, 2025XgevaXbrykdenosumabSamsung BioepisFeb 13, 2025TBDXgevaOsenveltdenosumab-bmwoCelltrionMar 3, 2025Jun-25",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "cf45b4cad70bc65f",
      "text": "Source: Company data, FDA, Morgan Stanley Research",
      "page": 13,
      "section": null
    },
    {
      "passage_id": "377716b6c7c2beb1",
      "text": "Actemra's first biosimilar Fresenius's Tyenne launched in April- 24 and second biosimilar BIIB's Tofidence launched in June- 24.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "0fdefa00ec85b95e",
      "text": "Exhibit 20: Biosimilar Actemra 52-week TRx share",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "982c59ffe18921b5",
      "text": "AMGN's Mvasi launched in Jul- 19. PFE's Zirabev was launched on December 31, 2019. AMRX's Alysms was launched on October 3, 2022.",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "71b9e06260229978",
      "text": "Exhibit 21: Biosimilar Avastin monthly sales share",
      "page": 14,
      "section": null
    },
    {
      "passage_id": "41da28dfa93d55b0",
      "text": "Exhibit 22: Biosimilar Epogen monthly sales share",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "273c23251c76f4f4",
      "text": "Exhibit 23: Biosimilar Epogen 52-week TRx share. Epogen is administered as an IV as well as Sub-Q",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "820a3c8d919aef89",
      "text": "AMGN's Kanjinti launched in July- 19 and has gained share rapidly. Mylan/Biocon's Ogivri launched on December 2, 2019, PFE's Trazimera was launched on February 19, 2020 and Teva's Herzuma was launched on March 16, 2020. OGN's Ontruzant was launched on April 16, 2020 and data are available from Jun- 20 in IQVIA. We have also added Daiichi's brand drug Enhertu (Novel brand), which was launched in Dec- 19 and is approved for treating HER2- positive breast cancer.",
      "page": 15,
      "section": null
    },
    {
      "passage_id": "0fefa6cdf223e71d",
      "text": "Exhibit 24: Biosimilar Herceptin monthly sales share",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "3a8c52acb6577fb0",
      "text": "See Exhibit67 for weekly TRx share chart.",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "5e807f6db1b2c705",
      "text": "Exhibit 25: Biosimilar Humalog monthly sales share. We include Humalog A.G. (Insulin Lispro) in Humalog franchise",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "98a86290f6198a85",
      "text": "Humira first biosimilar AMGN's Amjevita has had slow launch based on IQVIA TRx (data are restricted). Three other biosimilars have launched out of which two (Hadlima and Hyrimoz) have started to appear in IQVIA, but have limited TRx data due to data restriction, as further discussed above.",
      "page": 16,
      "section": null
    },
    {
      "passage_id": "99bcc66477a04acf",
      "text": "Exhibit 26: Biosimilar Humira 52-week TRx share",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "e65887ab3f057871",
      "text": "See Exhibit69 to Exhibit73 for weekly charts on biosimilar Lantus.",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "b27b3a1e135043e0",
      "text": "Exhibit 27: Biosimilar Lantus monthly sales share",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "f472034f15044dad",
      "text": "BIIB and Samsung Bioepis's Byooviz was launched on June 2, 2022 and data are available from Jul- 22 in IQVIA. Coherus's Cimreli was launched on October 3, 2022. IQVIA (announced on 11/4/22) prescriptions are restricted, due to a contractual condition between a supplier and the manufacturers.",
      "page": 17,
      "section": null
    },
    {
      "passage_id": "aa08ef66dae363b2",
      "text": "Exhibit 28: Biosimilar Lucentis monthly sales share",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "02507db9d130359f",
      "text": "Neulasta biosimilar Biocon's Fulphila market share (monthly sales) has flattened after January inflection, but there may be a reporting restriction in place. Biocon's Fulphila (biosimilar Neulasta) sales are available in IQVIA in July 2018. On Aug. 24 2018, IQVIA noted that a reporting restriction was implemented in the mail channel for a portion of the sales and prescription volumes for Fulphila, due to a contractual condition between a supplier and the manufacturer. IQVIA has not been able to confirm restriction since this supplier has never dispensed this product.",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "d8a8076e040bc3d2",
      "text": "Sandoz's biosimilar Ziextenzo picked up share in 2H20, but has flattened since the launch of PFE's Nyvepria in January 2021.",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "2995634c1f11ef2c",
      "text": "Exhibit 29: Biosimilar Neulasta monthly sales share",
      "page": 18,
      "section": null
    },
    {
      "passage_id": "ef0f2b8991e22468",
      "text": "Exhibit 30: Biosimilar Neulasta 52-week TRx share. Neulasta is Sub-Q",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "3194a956e778ce24",
      "text": "Exhibit 31: Biosimilar Neupogen monthly sales share",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "c758b520111782a9",
      "text": "Exhibit 32: Biosimilar Neupogen 52-week TRx share. Neupogen is administered as an IV as well as Sub-Q",
      "page": 19,
      "section": null
    },
    {
      "passage_id": "3cb4025b855dc325",
      "text": "Exhibit 33: Biosimilar Stelara 52-week TRx share",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "cc2f0c1248f4045a",
      "text": "Remicade biosimilar PFE's Inflectra adoption has decreased in recent months. OGN's Renflexis is slow to be adopted. PFE's Inflectra has been on the market for \\(>3\\) years (launched in mid Dec- 16). MRK's Renflexis, launched in late July- 17, started to appear in IQVIA from September, 2017 only. We believe payers are choosing not to support the biosimilar because the pricing is not low enough below the net pricing of branded Remicade and because they would lose branded rebates on existing Remicade patients who remain on the brand. AMGN's A vsola was approved on Dec. 6, 2019 and launched in July 2020. Pfizer has decided not to launch ixifi in the US.",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "dbbe7a7826da0b32",
      "text": "Exhibit 34: Biosimilar Remicade monthly sales share. We track IQVIA sales rather than Rx because Remicade is an IV",
      "page": 20,
      "section": null
    },
    {
      "passage_id": "362b33ffb91dcc14",
      "text": "Teva's Truxima was launched in Nov- 19 and is approved for all indications except pemphigus vulgaris (PV), which is immaterial. Pfizer's Ruxience launched on January 23, 2020. It currently lacks the rheumatoid arthritis (RA) and pemphigus vulgaris (PV) indications. Amgen's Riabini was launched in Jan- 21 and was approved for RA on June 6, 2022. Per Roche, RA comprises \\(\\sim 20\\%\\) of branded Rituxan sales. Commentary suggests that skinny- labels are more of an issue for physicians than payers.",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "efae41da258eb86b",
      "text": "Exhibit 35: Biosimilar Rituxan monthly sales share",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "6729294fa7b482ac",
      "text": "Exhibit 36: Biosimilar Stelara 52-week TRx share.",
      "page": 21,
      "section": null
    },
    {
      "passage_id": "6520b45cf3a6ee11",
      "text": "Exhibit 37: Biosimilar Stelara monthly sales share",
      "page": 22,
      "section": null
    },
    {
      "passage_id": "958f3c089ab956ff",
      "text": "Exhibit38: Anti-coagulants TRx market share",
      "page": 23,
      "section": null
    },
    {
      "passage_id": "699aa80d93c81247",
      "text": "Source: IQVIA [Note: Total anti-coagulant market includes drugs above plus Warfarin/Coumadin TRx]",
      "page": 23,
      "section": null
    },
    {
      "passage_id": "1278674b9b777f77",
      "text": "Exhibit39: Anti-Coagulants TRx YOY",
      "page": 23,
      "section": null
    },
    {
      "passage_id": "b4ee4ff55978f58c",
      "text": "Exhibit40: Novel oral anti-coagulants launch comparison",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "4395c66ba869eba3",
      "text": "FDA approved Xarelto for deep vein thrombosis in July 2011; launch trends above capture Xarelto TRx following AF approval in Nov. 2011 (e. exclude Xarelto TRx in July-Oct). Pradaxa launched in week of 10/29/10; Eliquis launched in week of 1/18/13; Savaysa launched in week of 2/13/15 Source: IQVIA",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "9b3395e6dc4d224d",
      "text": "Exhibit 41: Lipid lowering absolute TRx: Amarin's Vascepa, Sanofi's Praluent, AMGN's Repatha. Vascepa is EPA indicated for high triglycerides. Praluent and Repatha are PCSK9s indicated for high LDL. Nexletol is ACLI indicated for high LDL.",
      "page": 24,
      "section": null
    },
    {
      "passage_id": "a2d4a38e854c4497",
      "text": "Exhibit 42: PCSK9 TRx share: Sanofi's Praluent vs AMGN's Repatha. We do not include Vascepa because it is indicated for high triglycerides and not LDL. Nexletol is indicated for high LDL so there may be minimal usage in combination with PCSK9.",
      "page": 25,
      "section": null
    },
    {
      "passage_id": "2851e5aba1569f85",
      "text": "Exhibit 43: TRx YOY growth",
      "page": 25,
      "section": null
    },
    {
      "passage_id": "dd4108f621a8b41a",
      "text": "Exhibit 44: Vyndaql TRx launch trend",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "6244666fde7a1cb1",
      "text": "Exhibit 45: Vyndaql franchise absolute TRx and YOY",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "3a28070d7ed98857",
      "text": "Exhibit 46: Entresto TRx launch trend",
      "page": 26,
      "section": null
    },
    {
      "passage_id": "8c1928fe096848ff",
      "text": "Diabetes trends. The drugs can be used in combination so share gain/loss does not necessarily mean switching between classes.",
      "page": 27,
      "section": null
    },
    {
      "passage_id": "f91307d3791575cc",
      "text": "Exhibit 47: TRx share by class",
      "page": 27,
      "section": null
    },
    {
      "passage_id": "bdbde53d4417021b",
      "text": "Exhibit48: DPP- 4, SGLT- 2 and GLP- 1 TRx as % of total DPP- 4 + SGLT- 2 + GLP- 1 TRx. The drugs can be used in combination with each other so \"share loss\" does not necessarily mean switching.",
      "page": 27,
      "section": null
    },
    {
      "passage_id": "0bc184bf64a81023",
      "text": "Exhibit49: DPP- 4 and SGLT- 2 TRx as % of total DPP- 4 + SGLT- 2 TRxs. The drugs can be used in combination with each other so \"share loss\" does not necessarily mean switching.",
      "page": 28,
      "section": null
    },
    {
      "passage_id": "6b804f003ff88ffc",
      "text": "Exhibit50: Individual DPP-4 and SGLT-2 TRx as % of total DPP-4 + SGLT-2 TRxs",
      "page": 28,
      "section": null
    },
    {
      "passage_id": "274d88eee01bb4f8",
      "text": "Exhibit51: DPP-4 TRx market share",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "d88cccb1320012f3",
      "text": "Exhibit52: DPP-4s TRx YOY",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "ee0dd3a1ec9f398c",
      "text": "Exhibit53: DPP-4s launch comparison",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "9dd0807e927854c3",
      "text": "Onglyza launched in week of 8/14/09, Tradjenta launched in week of 5/20/11, Nesina launched in week of 6/14/13 Source:IQVIA",
      "page": 29,
      "section": null
    },
    {
      "passage_id": "4412a5db982512a4",
      "text": "Exhibit54: SGLT-2 TRx market share",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "fc4d63aff4edcbc1",
      "text": "Farxiga franchise includes Farxiga and Xigduo XR. Jardiance franchise includes Jardiance, Glyxambi, and Synjardy. Stelgatro franchise in Stelgatro and Stelgujan. MRK records global revenues, which is recognized after MRK sells to 3rd party, PFE and MRK operating profit split is 40/60. PFE records revenues on product sold to MRK, product is sold at a price that will achieve PFE's share of the profit split. PFE revenues will be reflected on its own product revenue line (not in Alliance Revenues).Source: IQVIA",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "910fda02200f8f4f",
      "text": "Exhibit55: SGLT-2s TRx YOY",
      "page": 30,
      "section": null
    },
    {
      "passage_id": "999cd4ee7415d1ea",
      "text": "Exhibit56: SGLT-2s launch comparison",
      "page": 31,
      "section": null
    },
    {
      "passage_id": "c3d60b4983ac8a2b",
      "text": "Invokana launched in week of 4/12/13, Farxiga launched in week of 1/24/14, Jardiance launched in week 8/29/14, Steglatro launched in week of 2/2/18. Source: IQVIA",
      "page": 31,
      "section": null
    },
    {
      "passage_id": "76570f2ea2e33139",
      "text": "Exhibit 57: GLP-1 TRx launches",
      "page": 31,
      "section": null
    },
    {
      "passage_id": "35a260f43b6f10da",
      "text": "Exhibit 58: Rybelsus (GLP-1) launch vs. Invokana (SGLT-2) and Jardiance (SGLT-2)",
      "page": 32,
      "section": null
    },
    {
      "passage_id": "7e5db6e3a0bb5f11",
      "text": "Exhibit 59: Rybelsus (GLP-1) launch vs. Januvia/Janumet (DPP-4)",
      "page": 32,
      "section": null
    },
    {
      "passage_id": "68d6fce167a30128",
      "text": "Exhibit 60: LLY's Mounjaro launch vs. recent GLP-1 launches, Wegovy and Saxenda",
      "page": 32,
      "section": null
    },
    {
      "passage_id": "9b47bdb2cee4a2dd",
      "text": "Exhibit61: GLP-1 TRx market share",
      "page": 33,
      "section": null
    },
    {
      "passage_id": "504b961fcc496e87",
      "text": "\\\\*Bydureon includes BCise Source:IQVIA",
      "page": 33,
      "section": null
    },
    {
      "passage_id": "2bfcb7ed98552f68",
      "text": "Exhibit 62: GLP-1 NRx market share",
      "page": 33,
      "section": null
    },
    {
      "passage_id": "3726996dc2855247",
      "text": "Exhibit63: GLP-1s TRx YOY",
      "page": 33,
      "section": null
    },
    {
      "passage_id": "ac38dc93fbffbcec",
      "text": "Exhibit 64:  Truicity 52-week absolute TRx and YOY performance",
      "page": 34,
      "section": null
    },
    {
      "passage_id": "b81cd50ba728c56d",
      "text": "Exhibit 65:  LLY GLP-1 franchise 52-week absolute TRx and YOY performance",
      "page": 34,
      "section": null
    },
    {
      "passage_id": "a88f868b9e8bb885",
      "text": "Exhibit 66:  Novo GLP-1 franchise 52-week absolute TRx and YOY performance",
      "page": 34,
      "section": null
    },
    {
      "passage_id": "bed4c2f1eb4506c9",
      "text": "Exhibit67: LLY insulin franchise (Humalog+Humulin) vs. Novo insulin franchise (Novolog+Novolin) TRx market share. Sanofi's Admelog (generic Humalog) launched in March 2018. We await MYL/Biocon's Semglee.",
      "page": 35,
      "section": null
    },
    {
      "passage_id": "d0c73b99989ab73b",
      "text": "Exhibit68: LLY insulin franchise (Humalog+Humulin) vs. Novo insulin franchise (Novolog+Novolin) TRx vs. SNY insulin franchise (Admelog) weekly YOY growth",
      "page": 35,
      "section": null
    },
    {
      "passage_id": "2a3a26543a9f6d03",
      "text": "Exhibit69: Long- acting insulin market share. Branded insulin glargine is Lantus/ Solostar and Toujeo; Basaglar and Semglee are biosimilar insulin glargine.",
      "page": 36,
      "section": null
    },
    {
      "passage_id": "9f5470a3f9fe9461",
      "text": "Exhibit70: Long-acting insulin TRx YOY",
      "page": 36,
      "section": null
    },
    {
      "passage_id": "589db48d452efba8",
      "text": "Exhibit 71: Lantus+Lantus Solostar vs Basaglar TRx share",
      "page": 36,
      "section": null
    },
    {
      "passage_id": "c217cdbb1dd80309",
      "text": "Exhibit 72: Insulin glargine branded (Lantus, Solostar, Toujeo) vs. biosimilar (Basaglar) TRx share; Lantus, Solostar, and Basaglar are 100 units/mL while Toujeo is 300 units/mL.",
      "page": 37,
      "section": null
    },
    {
      "passage_id": "7ca4c2fec4e48c9a",
      "text": "Exhibit73: Recent long- acting insulin launches: Basaglar vs. Tresiba vs. Toujeo vs. Soliqua vs. Xultophy vs. Semglee",
      "page": 37,
      "section": null
    },
    {
      "passage_id": "4e8a84fec11543a6",
      "text": "Exhibit 74: Total SFU 52-week absolute TRx and YOY performance",
      "page": 38,
      "section": null
    },
    {
      "passage_id": "b2c6bbde6b7679bc",
      "text": "Exhibit 75: Autoimmune drugs with their MOA and approved indications",
      "page": 39,
      "section": null
    },
    {
      "passage_id": "5c620ee5e2e5d3b1",
      "text": "Drug nameRouteMOAIndicationCimzia (UCB)SQAnti-TNFRA, Psoriatic arthritis, Ankylosing spondylitis, Crohn&#x27;s disease, Plaque psoriasis, Axial spondyloarthritis (nr-axSpA)Enbrel (Amgen)SQAnti-TNFRA, Idiopathic arthritis, Psoriatic arthritis, Ankylosing spondylitis, Plaque psoriasisHumira (Abbvie)SQAnti-TNFRA, Idiopathic arthritis, Psoriatic arthritis, Ankylosing spondylitis, Crohn&#x27;s disease (adult &amp;amp; Ped), UC, Plaque psoriasis, Uveitis, Hidradenitis SuppurativaRemicade (JNJ/Merck)IVAnti-TNFCrohn&#x27;s disease, UC, RA, Ankylosing spondylitis, Plaque psoriasis, Psoriatic arthritisSimponi (JNJ)SQAnti-TNFAnkylosing spondylitis, Psoriatic arthritis, RA, UCKineret (Sobi)SQIL-1RA, Cryopyrin-Associated Periodic SyndromesDupixentSQIL-4Atopic dermatitis, AsthmaActemra (Roche)IV+SQIL-6RA, Idiopathic arthritis, Cytokine Release Syndrome, Giant Cell ArteritisKevzara (SNV/REGN)SQIL-6RAEligbrys (LLY)SQIL-13Atopic dermatitisAdbry (Leo Pharma)SQIL-13Atopic dermatitisCosentyx (Novartis)SQIL-17Plaque psoriasis, Psoriatic arthritis, Ankylosing spondylitis, Axial spondyloarthritis (nr-axSpA)Siliq (Bausch)SQIL-17Plaque psoriasisTaltz (LLY)SQIL-17Plaque psoriasis, Psoriatic arthritis, Ankylosing spondylitis, Axial spondyloarthritis (nr-axSpA)Bimex (USB)SQIL-17Plaque psoriasisStelara (InJ)IV+SQIL-12 and IL-23Plaque psoriasis, Psoriatic arthritis, Crohn&#x27;s disease, Ulcerative colitisOmovh (LLY)IV+SQIL-23Ulcerative colitisSkylzi (Abbvie)SQIL-23Plaque psoriasis, Psoriatic arthritisTremfya (InJ)SQIL-23Plaque psoriasis, Psoriatic ArthritisIlumya (Sun)SQIL-23Plaque psoriasisNemluvio (Galderma)SQIL-31Atopic dermatitis, Prurigo nodularisXeljanz/XR (PFE)OralJAKRA, Psoriatic arthritis, Ulcerative colitisCibinpo (PFE)OralJAKAtopic dermatitisRinvoq (ABB)OralJAKRA, Psoriatic arthritis, Atopic dermatitisOlumiant (LLY)OralJAKRAEntyvio (Takeda)IVintegrin receptorUC, Crohn&#x27;s diseaseVelsipity (PFE)OralS1PUlcerative ColitisZeposia (BMY)OralS1PMultiple Sclerosis, Ulcerative ColitisOrencia (BMY)IV+SQT cell costimulation modulatorRA, Idiopathic arthritis, Psoriatic arthritisSotykut (BMY)OralTYK2Plaque psoriasisBryhal (Bausch)LotioncorticosteroidPlaque psoriasisDuobri (Bausch)Lotionhalobetasol propionate and tazarotenePlaque psoriasisVtama (Roviant)Ointmentaryl hydrocarbon receptorPlaque psoriasisZoryve (Arcutis)OintmentPDE4Plaque psoriasis, Atopic dermatitisOtezla (Amgen)OralPDE4Plaque psoriasis, Psoriatic arthritis, Oral ulcers associated with Behcet&#x27;s diseaseEucrisaOintmentPDE4Atopic dermatitisOpzeluraOintmentJAKAtopic dermatitis",
      "page": 39,
      "section": null
    },
    {
      "passage_id": "9d40f1275af51fc0",
      "text": "SQ= Injection for subcutaneous use; IV= Injection for Intravenous use; RA= Rheumatoid arthritis; UC= Ulcerative colitis. We do not add Entyvio in any of the charts since it is an IV and approved only for UC and Crohn's disease. Source: Morgan Stanley Research",
      "page": 39,
      "section": null
    },
    {
      "passage_id": "4faae2ce8abc9afd",
      "text": "We divide the quarterly reported sales by quarterly TRx to arrive \\(\\Phi /\\mathrm{TRx}\\)",
      "page": 39,
      "section": null
    },
    {
      "passage_id": "07e628b6fd708a32",
      "text": "Exhibit 76: Stelara \\(\\Phi /\\mathrm{TRx}\\) vs. TRx",
      "page": 39,
      "section": null
    },
    {
      "passage_id": "2c27124e7622c6ee",
      "text": "Source: IQVIA, Company data",
      "page": 39,
      "section": null
    },
    {
      "passage_id": "df4ef261d77db2a9",
      "text": "Exhibit 77: Tremfya S/TRx vs. TRx",
      "page": 40,
      "section": null
    },
    {
      "passage_id": "a0caa5d8af5a00ee",
      "text": "Source:IQVIA,Company data",
      "page": 40,
      "section": null
    },
    {
      "passage_id": "6d4a870bfc5b3d93",
      "text": "Exhibit 78: Cosentyx S/TRx vs. TRx",
      "page": 40,
      "section": null
    },
    {
      "passage_id": "830d028e9cd8d022",
      "text": "Source:IQVIA,Company data",
      "page": 40,
      "section": null
    },
    {
      "passage_id": "9623832dee8d27e1",
      "text": "Exhibit 79: Dupixent S/TRx vs. TRx",
      "page": 40,
      "section": null
    },
    {
      "passage_id": "234e58a7bd9b2717",
      "text": "Source:IQVIA,Company data",
      "page": 40,
      "section": null
    },
    {
      "passage_id": "2b63da8f90e1efac",
      "text": "Exhibit 80: Rinvoq S/TRx vs. TRx",
      "page": 41,
      "section": null
    },
    {
      "passage_id": "539949af25a38075",
      "text": "Source:IQVIA,Company data",
      "page": 41,
      "section": null
    },
    {
      "passage_id": "0d2561a00d3e622a",
      "text": "Exhibit 81: Skyrizi S/TRx vs. TRx",
      "page": 41,
      "section": null
    },
    {
      "passage_id": "5a6a6031664f0428",
      "text": "Source:IQVIA,Company data",
      "page": 41,
      "section": null
    },
    {
      "passage_id": "c75ce1c4dd96bb61",
      "text": "Exhibit82: Rheumatoid (RA) drugs TRx market share. Xeljanz, Rinvoq and Olumiant are oral, and all others are injectables. Orencia (IV + SQ) and Remicade (IV only) are understated. Indications differ among all the drugs. Refer to exhibit above.",
      "page": 41,
      "section": null
    },
    {
      "passage_id": "7482efc29d27a00f",
      "text": "Exhibit 83: Weekly TRx YOY for IL- 17, IL- 23 and JAK inhibitor drugs. See above Exhibit 75 for details.",
      "page": 42,
      "section": null
    },
    {
      "passage_id": "53d6c517f108545f",
      "text": "Exhibit 84: IL- 13 launches: Adbry (Leo), Ebglyss (LLY) and IL- 4 Dupixent (SNY/REGN)",
      "page": 42,
      "section": null
    },
    {
      "passage_id": "05031e64381c2fbe",
      "text": "Exhibit 85: IL-13 weekly TRx market share",
      "page": 43,
      "section": null
    },
    {
      "passage_id": "4a1ce1405f8b391c",
      "text": "Exhibit 86: IL- 17A and IL- 23 combined weekly TRx market share: Cosentyx (NVS), Siliq (VRX), Taltz (LLY), Stelara (JNJ), Tremfya (JNJ), Skyrizi (ABBV), Omvoh (LLY), and Ilumya (Sun Pharma)",
      "page": 43,
      "section": null
    },
    {
      "passage_id": "1d4e9102de5de8a3",
      "text": "Tremfya scripts are restricted and unreliable. Source:IQVIA",
      "page": 43,
      "section": null
    },
    {
      "passage_id": "9f8dec7032543c68",
      "text": "Exhibit 87: IL-17A weekly TRx market share: Cosentyx (NVS), Siliq (VRX), and Taltz (LLY)",
      "page": 44,
      "section": null
    },
    {
      "passage_id": "2453d4f56ab6c617",
      "text": "Cosentyx launched in Feb-15, Taltz launched in Apr-16. Source: IQVIA",
      "page": 44,
      "section": null
    },
    {
      "passage_id": "4809374186a63515",
      "text": "Exhibit 88: Taltz 52-week absolute TRx and YOY performance",
      "page": 44,
      "section": null
    },
    {
      "passage_id": "bbf3a804484559a7",
      "text": "Exhibit 89: Cosentyx 52-week absolute TRx and YOY performance",
      "page": 44,
      "section": null
    },
    {
      "passage_id": "93930e68fd519b13",
      "text": "Exhibit90: IL-17A launches: Cosentyx (NVS), Siliq (Bausch/Ortho Dermatologics), and Taltz (LLY)",
      "page": 45,
      "section": null
    },
    {
      "passage_id": "ebb6bcff1ec8afe4",
      "text": "Cosentyx launched in Feb-15, Taltz launched in Apr-16, Siliq launched in Aug-17. Taltz was approved for ankylosing spondylitis on Aug. 26, 2019. Source: IQVIA",
      "page": 45,
      "section": null
    },
    {
      "passage_id": "3d808abc4d44d297",
      "text": "Comparison is confounded by different indications and dosing schedules. Stelara is approved for plaque psoriasis, psoriatic arthritis, Crohn's disease and Ulcerative Colitis whereas Tremfya, Skyrizi, and Ilumya are approved for plaque psoriasis and Omvoh is approve only for Ulcerative Colitis. Also, TRxs may not be directly comparable because Stelara and Tremfya are dosed every eight weeks while Skyrizi and Ilumya are dosed every 12 weeks. Lastly, IQVIA data for Tremfya are unreliable due to restrictions.",
      "page": 45,
      "section": null
    },
    {
      "passage_id": "848894f4a04a089e",
      "text": "Exhibit 91: IL-23 launches: Tremfya, Skyrizi, Ilumya and Omvoh (we do not have Stelara launch data)",
      "page": 45,
      "section": null
    },
    {
      "passage_id": "e5c4b10f6d472039",
      "text": "Both Tremfya and Skyrizi scripts are restricted and unreliable. Tremfya launched in July-17. Skyrizi launched in April-19. Ilumya launched in Oct-18. Omvoh launched in Dec-23. Source: IQVIA",
      "page": 45,
      "section": null
    },
    {
      "passage_id": "7fd6a0f554e8545f",
      "text": "Exhibit 92: IL-23 weekly TRx market share",
      "page": 46,
      "section": null
    },
    {
      "passage_id": "f3c615945a36cf8a",
      "text": "Tremfya and Skyrizi scripts are restricted and unreliable. Source: IQVIA",
      "page": 46,
      "section": null
    },
    {
      "passage_id": "4d4afdfeb987717e",
      "text": "Exhibit 93: Skyrizi (ABBV) 52-week absolute TRx and YOY performance",
      "page": 46,
      "section": null
    },
    {
      "passage_id": "79d972e21d8dd6d8",
      "text": "Exhibit 94: Tremfya (JNJ) 52-week absolute TRx and YOY performance",
      "page": 46,
      "section": null
    },
    {
      "passage_id": "5cb9b171024dbf99",
      "text": "Exhibit 95: Stelara (JNJ) 52-week absolute TRx and YOY performance",
      "page": 47,
      "section": null
    },
    {
      "passage_id": "71e60c1fe2cedf8d",
      "text": "Exhibit96: JAK inhibitor launches. Supplier restrictions were removed for Rinvoq starting Feb 3, 2023",
      "page": 48,
      "section": null
    },
    {
      "passage_id": "31cb53ee254b911b",
      "text": "Xeljanz launched in week of 11/23/12, Olumiant launched in week of 7/13/18, Rinvoq launched in week of 8/30/19, Cibinqo launched in week of 3/4/22. Source: IQVIA",
      "page": 48,
      "section": null
    },
    {
      "passage_id": "9fc89a0cb7cf44f9",
      "text": "Exhibit 97: JAK inhibitor TRx market share",
      "page": 48,
      "section": null
    },
    {
      "passage_id": "2923ee5fb56aedac",
      "text": "Exhibit 98: JAK inhibitor 52-week absolute TRx and YOY performance",
      "page": 49,
      "section": null
    },
    {
      "passage_id": "96450b3bd66d7419",
      "text": "Exhibit99: Xeljanz + XR (PFE) 52-week absolute TRx and YOY performance",
      "page": 50,
      "section": null
    },
    {
      "passage_id": "fa44172289183869",
      "text": "Exhibit 100: Rinvoq (ABBV) 52-week absolute TRx and YOY performance. Rinvoq scripts benefited from removal of reporting restrictions starting Feb 2023",
      "page": 51,
      "section": null
    },
    {
      "passage_id": "e21d4f7a35be0b60",
      "text": "Exhibit 101: Galderma's Nemluvio launch trend",
      "page": 51,
      "section": null
    },
    {
      "passage_id": "85e7ac4b615f5dad",
      "text": "Exhibit 102:BMY's Sotykitu vs JAKs, IL-17s, IL-23s and Otezla launch",
      "page": 52,
      "section": null
    },
    {
      "passage_id": "0f900f48dc6845fd",
      "text": "Exhibit 103: Sotykitu vs other recent Plaque Psoriasis approved only launches. See Exhibit 75 for approved indications",
      "page": 52,
      "section": null
    },
    {
      "passage_id": "bb9cf4893cda1f2c",
      "text": "Exhibit 104: AMGN's Otezla vs BMY's SotykTu TRx since launch",
      "page": 53,
      "section": null
    },
    {
      "passage_id": "973e96c922f583e9",
      "text": "Exhibit 105: Otezla 52-week TRx absolute and YOY performance",
      "page": 53,
      "section": null
    },
    {
      "passage_id": "71af79db1e3727e5",
      "text": "Eucrisa (PFE) and Dupixent (SNY/REGN) TRxs may not be directly comparable. Eucrisa is an ointment while Dupixent is an injectable with limited data capture. We understand there are no significant capture rate issues, so TRx should be a fair representation of true demand. Eucrisa is indicated for mild- moderate atopic dermatitis while Dupixent is indicated for moderate- severe atopic dermatitis. Dupixent is also approved for moderate- severe asthma.",
      "page": 53,
      "section": null
    },
    {
      "passage_id": "d0992f58ec469593",
      "text": "Exhibit 106: Atopic dermatitis launches: Dupixent (SNY/REGN), Eucrisa (PFE) and Opzelura (INCY). However, TRxs may not be directly comparable because Eucrisa (PDE4) is an ointment that comes in 60g and 100g tubes, and is applied in a thin layer twice daily to affected areas, while Dupixent (IL- 4 and IL- 13) comes in a syringe (300 mg/ 2mL) and is given every other week.",
      "page": 54,
      "section": null
    },
    {
      "passage_id": "7138f203da6c35a2",
      "text": "Exhibit 107: Atopic dermatitis launches: Dupixent (SNY/REGN) and Eucrisa (PFE). TRxs may not be directly comparable because Eucrisa (PDE4) is an ointment that comes in 60g and 100g tubes, and is applied in a thin layer twice daily to affected areas, while Dupixent (IL- 4 and IL- 13) comes in a syringe (300 mg/ 2mL) and is given every other week.",
      "page": 54,
      "section": null
    },
    {
      "passage_id": "1ad62dc1f5bf1cf6",
      "text": "Dupixent got approved for Asthma on 10/21/2018. Source: IQVIA",
      "page": 54,
      "section": null
    },
    {
      "passage_id": "722375a604b4c4a9",
      "text": "Exhibit 108: Dupixent 52-week absolute and YOY TRx",
      "page": 55,
      "section": null
    },
    {
      "passage_id": "b287f421583e5b2e",
      "text": "Exhibit 109: HCV TRx market share",
      "page": 56,
      "section": null
    },
    {
      "passage_id": "69bd03dd4196eb31",
      "text": "Exhibit110: Integrase inhibitor TRx market share",
      "page": 56,
      "section": null
    },
    {
      "passage_id": "55dc179a71ff511e",
      "text": "Exhibit 111: GILD's Biktarvy vs ViiV's Dovato, Cabenuva TRx launch trends",
      "page": 57,
      "section": null
    },
    {
      "passage_id": "acc6fd4930378a8b",
      "text": "Exhibit 112: Biktarvy weekly TRx and YOY growth",
      "page": 57,
      "section": null
    },
    {
      "passage_id": "bb6606016633b0bf",
      "text": "**Exhibit 113:** Truvada vs Descovy vs Apretude TRx share. Descovy was approved for PrEP (pre-exposure prophylaxis) on October 3, 2019. We are unable to separate the prescriptions by indication and the data are for all indications. Generic Truvada started to appear from week ending Oct. 9, 2020.",
      "page": 58,
      "section": null
    },
    {
      "passage_id": "9fef8e4604849b3d",
      "text": "Exhibit 114: GILD's Descovy and Yeztugo vs GSK's Apretude TRx launch comparison",
      "page": 58,
      "section": null
    },
    {
      "passage_id": "dcd7b4468a48d741",
      "text": "**Exhibit 115:** GILD's Descovy and Yeztugo vs GSK's Apretude TRx launch comparison. We are unable to separate the prescriptions by indication and the data are for all indications.",
      "page": 59,
      "section": null
    },
    {
      "passage_id": "2315e751f24e1af0",
      "text": "Exhibit 116: Paxlovid vs Molnupiravir TRx trends",
      "page": 59,
      "section": null
    },
    {
      "passage_id": "ec55f3b1fda6cc8e",
      "text": "Exhibit 117:Migraine drugs with their MOA and approved indications",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "cfaf99f5a97c4866",
      "text": "Drug nameRouteMOAIndicationAimovig (Amgen)SQCGRPMigraine preventionEmgality (Eli Lilly)SQCGRPMigraine prevention, cluster headacheAjovy (Teva)SQCGRPMigraine preventionUbrelvy (Abbvie)OralCGRPAcute treatment of migraine with or without auraQuilpta (Abbvie)OralCGRPMigraine preventionNurtec (Biohaven)OralCGRPAcute treatment and Migraine preventionVyepti (Lundeback)IVCGRPMigraine preventionReyvow (Eli Lilly)Oralserotonin (5-HT) 1F receptor agonistAcute treatment of migraine with or without auraZomig (Amneal)Oralserotonin (5-HT) 1B/1D receptor agonistAcute treatment of migraine with or without aura",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "f84a19fc2d8a406a",
      "text": "SQ= Injection for subcutaneous use; IV= Injection for Intravenous use. Source: Morgan Stanley Research",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "b84e733579fbf2b9",
      "text": "Aimovig (AMGN) script trends: Amgen processes all claims via its hub in batches, and sometimes there are catch- ups in the figures sent to IQVIA.",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "2cb39cc3584da5cb",
      "text": "Emgality (LLY) is also approved for treatment of cluster headaches. The approval was on June 4, 2019. We are unable to identify scripts by indication so Emgality TRx includes both migraine and cluster headache.",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "360a1120df09f50f",
      "text": "Ajovy is also available as auto- injector. Ajovy launched autojector on April 27, 2020.",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "7b99baa59a687664",
      "text": "TRx may not be a good metric for comparing the three drugs over time due to differences in dosing frequency. Amgen's Aimovig is dosed either 70 mg or 140 mg (70 x 2 injections) every month, Teva's Ajovy is dosed either 225 mg every month or 675 mg (225 x 3 injections) every three months, and Lilly's Emgality is dosed 120 mg every month but with a 240 mg loading dose administered as two consecutive 120 mg injections for the first month.",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "0bb020587bbaeb35",
      "text": "One TRx for one drug may represent different numbers of months of therapy and/or doses. For example, assuming simplistically that one TRx represents one course of treatment, one Aimovig TRx represents one month of drug, one Ajovy TRx could represent one or three months' worth of drug, and one Emgality TRx could represent one month but could be one injection or three injections (including loading dose).",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "107143d61583abae",
      "text": "Oral CGRP (Ubrelvy and Nurtec) launches are trending above injectable Emgality. Both Ubrelvy and Nurtec TRx launch trends are above Emgality (Exhibit 125) and orals continue to gain share in overall market (Exhibit 118 & Exhibit 119).",
      "page": 60,
      "section": null
    },
    {
      "passage_id": "824ab1f0329b3f5c",
      "text": "**Exhibit 118:** CGRP Injectable vs Oral. Injectable includes Aimovig, Ajovy, Emgality, and Vyepti; Oral includes Ubrelvy, and Nurtec. Vyepti is an IV, hence TRx is not captured by IQVIA completely.",
      "page": 61,
      "section": null
    },
    {
      "passage_id": "d80f84fda5ef383d",
      "text": "Exhibit 119: Migraine weekly TRx share %, but indications are different among the drugs. Vyepti is an IV, hence EUTRx/TRx is not captured by IQVIA completely. Refer to Exhibit 75 for details.",
      "page": 61,
      "section": null
    },
    {
      "passage_id": "51963d9031999103",
      "text": "**Exhibit 120: Injectable (sub-Q) CGRP weekly TRx share % of total injectables. Emgality** was also approved for cluster headache on June 4, 2019. Vyepti is an IV, hence TRx is not captured by IQVIA completely.",
      "page": 62,
      "section": null
    },
    {
      "passage_id": "33445b91ab60bc98",
      "text": "Exhibit 121: Oral CGRP weekly TRx share % of total oral CGRP",
      "page": 62,
      "section": null
    },
    {
      "passage_id": "1fd129cc41058636",
      "text": "Exhibit 122: Migraine weekly TRx. \\*Total CGRP includes Aimovig, Ajovy, Emgality, Ubrelvy, Quilpta, Nurtec and Vyepti. Vyepti is an IV, hence TRx is not captured by IQVIA completely",
      "page": 63,
      "section": null
    },
    {
      "passage_id": "53b7c58908f544e0",
      "text": "Exhibit 123: Injectable CGRP weekly TRx YOY",
      "page": 63,
      "section": null
    },
    {
      "passage_id": "bd98960baf30c98c",
      "text": "Exhibit 124: Oral CGRP weekly TRx YOY",
      "page": 64,
      "section": null
    },
    {
      "passage_id": "b553c64b05c03ab2",
      "text": "Exhibit 125: Migraine TRx launches. Aimovig, Ajovy, Emgality, Qulipta (oral CGRP) and Vyepti (inj CGRPs) are indicated for migraine prevention. Ubrelvy, Nurtec (oral CGRP) and Reyvow are indicated for acute treatment of migraine. Emgality was also approved for cluster headache on June 4, 2019. Reyvow is not a CGRP. Vyepti is an IV, hence TRx is not captured by IQVIA completely. Refer to Exhibit 75 for more details.",
      "page": 64,
      "section": null
    },
    {
      "passage_id": "af9e0057e27652e6",
      "text": "Source:IQVIA,Morgan Stanley Research",
      "page": 64,
      "section": null
    },
    {
      "passage_id": "8ae031fdee9de154",
      "text": "Exhibit 126: Recent oral migraine launches. Note Revyow is not a CGRP. Refer to Exhibit 75 for more details.",
      "page": 65,
      "section": null
    },
    {
      "passage_id": "fca872de45cb1828",
      "text": "Another helpful metric to compare may be number of injections. We estimate the number of injections prescribed as another means of comparison. For Aimovig and Emgality we assume no. of injections to be equal to EUTRx (mL) and for Ajovy 1 injection = EUTRx/1.5, because Aimovig and Emgality are 1 mL injections, while Ajovy is a 1.5 mL injection. Unfortunately, this would still be a confounded comparison because the reality is much more complicated than our assumption suggests—for example, for one Aimovig TRx with two doses, we cannot distinguish whether that would be for one month or two months.",
      "page": 65,
      "section": null
    },
    {
      "passage_id": "9beed5a8b7045174",
      "text": "Exhibit 127: CGRP weekly no. of injections since launch. Vyepti is an IV, hence EUTRx/ TRx is not captured by IQVIA completely",
      "page": 65,
      "section": null
    },
    {
      "passage_id": "2a2331b999602409",
      "text": "Exhibit 128: CGRP drugs IQVIA monthly sales trend",
      "page": 66,
      "section": null
    },
    {
      "passage_id": "dd3d5a4dd5ef2178",
      "text": "Exhibit129: Oral multiple sclerosis launches",
      "page": 66,
      "section": null
    },
    {
      "passage_id": "e80dd4921672ae65",
      "text": "Note: Gilenya launched in week of 10/8/10; Aubagio launched in week of 10/12/12; Tecfidera launched in week of 4/5/13; Mayzent launched in week of 5/10/19; Zeposia launched in week of 6/19/20. Source: IQVIA",
      "page": 66,
      "section": null
    },
    {
      "passage_id": "bf928f860860b3ff",
      "text": "Exhibit 130: S1P1 TRx market share: NVS' Gilenya and Mayzent and BMY's Zeposia. Zeposia was approved for Ulcerative Colitis on 5/28/21",
      "page": 67,
      "section": null
    },
    {
      "passage_id": "4192e000709ae4ef",
      "text": "Exhibit 131: Vumerity conversion TRx share",
      "page": 67,
      "section": null
    },
    {
      "passage_id": "48b4d0d1707f4e85",
      "text": "Exhibit 132: BIIB's injectable MS franchise IQVIA sales trend",
      "page": 67,
      "section": null
    },
    {
      "passage_id": "93043f856413c473",
      "text": "**Exhibit133:** Vraylar and Lybalvi are approved for schizophrenia and bipolar disorder. At the time of launch, Latuda and Caplyta were approved only for schizophrenia and later got approved for bipolar disorder. Rexulti is approved for schizophrenia and MDD.",
      "page": 68,
      "section": null
    },
    {
      "passage_id": "7d0e63321d6ae3aa",
      "text": "Exhibit 134: Recent antipsychotic launches",
      "page": 68,
      "section": null
    },
    {
      "passage_id": "b0a99a2cd7adf0a5",
      "text": "Exhibit 135: Antipsychotic TRx",
      "page": 69,
      "section": null
    },
    {
      "passage_id": "eff6b6cea5324d88",
      "text": "Exhibit 136: Vraylar 52-week absolute TRx and YOY performance",
      "page": 69,
      "section": null
    },
    {
      "passage_id": "4eb75feaf687867d",
      "text": "Exhibit 137: Leqembi and Kisunla IQVIA sales trend",
      "page": 69,
      "section": null
    },
    {
      "passage_id": "566e800ca2400dfe",
      "text": "Exhibit 138: Leqembi vs Kisunla launch trend",
      "page": 70,
      "section": null
    },
    {
      "passage_id": "a914f65f1a909fb7",
      "text": "Exhibit 139: Leqembi and Kisunla IQVIA US sales comparison",
      "page": 70,
      "section": null
    },
    {
      "passage_id": "9af05dd59316b596",
      "text": "Exhibit 140: Leqembi and Kisunla reported US sales comparison",
      "page": 71,
      "section": null
    },
    {
      "passage_id": "53af8a8847c7ff8a",
      "text": "Note: 2Q23 to 4Q23 Leqembi sales are reported Ww sales. Source: Company data, Morgan Stanley Research",
      "page": 71,
      "section": null
    },
    {
      "passage_id": "d59b392acbf3bf9d",
      "text": "Exhibit 141: Obesity drug launches",
      "page": 72,
      "section": null
    },
    {
      "passage_id": "ac57f3439604fb73",
      "text": "Note: FDA requested the withdrawal of Belviq on Feb 13.2020. Source:IQVIA",
      "page": 72,
      "section": null
    },
    {
      "passage_id": "647e3f599628cfd7",
      "text": "Exhibit 142: Mounjaro and Wegovy launch vs Ozempic vs Rybelsus",
      "page": 72,
      "section": null
    },
    {
      "passage_id": "9271166d2a95d8a2",
      "text": "Exhibit 143: Dry Eye TRx market share",
      "page": 73,
      "section": null
    },
    {
      "passage_id": "7737c131ebdcc0ab",
      "text": "Exhibit 144: Dry Eye 52-week TRx trend",
      "page": 73,
      "section": null
    },
    {
      "passage_id": "54102091fb002cff",
      "text": "Exhibit 145: ALNY's Onpatro monthly sales trend. We normalize sales in March, June, September, and December to a 4- week basis to better compare with the other months",
      "page": 74,
      "section": null
    },
    {
      "passage_id": "b38e0ba862853ded",
      "text": "Exhibit 146: ARGX's Vygart monthly sales trend. We normalize sales in March, June, September, and December to a 4- week basis to better compare with the other months",
      "page": 74,
      "section": null
    },
    {
      "passage_id": "f0b0d3112f21dede",
      "text": "Exhibit147: Inhaled LABA-ICS combo TRx market share. Wixela is Mylan's generic Advair",
      "page": 75,
      "section": null
    },
    {
      "passage_id": "d7138fe1edb93525",
      "text": "Exhibit148: Advair+Breo+Advair authorized generic weekly TRx YoY",
      "page": 75,
      "section": null
    },
    {
      "passage_id": "bd4fa43ec9aa8d76",
      "text": "Exhibit 149: Advair brand vs generics weekly TRx market share",
      "page": 76,
      "section": null
    },
    {
      "passage_id": "d67d88f7f5abebd2",
      "text": "Exhibit150: Inhaled LAMA/Combo TRx market share",
      "page": 76,
      "section": null
    },
    {
      "passage_id": "db55d1c0259b9c2c",
      "text": "Exhibit151: Trelogy Ellipta (LAMA+LABA+ICS) launch way above its peers",
      "page": 76,
      "section": null
    },
    {
      "passage_id": "b207411bb6ee8765",
      "text": "Exhibit 152: Ohtuvayre launch vs Daliresp",
      "page": 77,
      "section": null
    },
    {
      "passage_id": "3e2aa8fc1beff7fa",
      "text": "Exhibit 153: AMGN's Prolia vs Evenity TRx launch trends",
      "page": 78,
      "section": null
    },
    {
      "passage_id": "5de482c36427e082",
      "text": "Exhibit 154:RSV vaccine launch",
      "page": 79,
      "section": null
    },
    {
      "passage_id": "f18b277db534febf",
      "text": "Exhibit 155:RSV vaccine as of launch chart",
      "page": 79,
      "section": null
    },
    {
      "passage_id": "7721eb6b4f3e3f1b",
      "text": "Exhibit 156: Prevran franchise absolute TRx and YOY",
      "page": 80,
      "section": null
    },
    {
      "passage_id": "8158d3714fd9a2cd",
      "text": "Exhibit 157: Pneumovax absolute TRx and YOY",
      "page": 80,
      "section": null
    },
    {
      "passage_id": "aff8fad47187c560",
      "text": "Exhibit 158: Gardasil absolute TRx and YOY",
      "page": 80,
      "section": null
    },
    {
      "passage_id": "fec1e6bad6fea51a",
      "text": "Exhibit 159:Comirnaty absolute TRx and YOY",
      "page": 81,
      "section": null
    },
    {
      "passage_id": "1023366366dad934",
      "text": "Exhibit 160:Spikevax absolute TRx and YOY",
      "page": 81,
      "section": null
    },
    {
      "passage_id": "0ae01392e94c6189",
      "text": "Exhibit 161:Covid Vaccine weekly TRx since August 2023",
      "page": 81,
      "section": null
    },
    {
      "passage_id": "c68975b335b39345",
      "text": "Exhibit 162: Covid Vaccine monthly TRx (Mn) since launch",
      "page": 82,
      "section": null
    },
    {
      "passage_id": "a1df956a36c409d3",
      "text": "ChannelsNPA (National Prescription Audit) Monthly and WeeklyNSP (National Sales Perspectives)Chain Pharmacies**Independent Pharmacies**Mass Merchandisers (grouped w/Chain Pharmacies)**Foodstores w/Pharmacies**Mail Service Providers**Long-Term Care**HMOs**Non-federal Hospitals**Federal Facilities**Clinics**Home Healthcare**Miscellaneous - Prisons, Universities, Veterinarians**",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "c17e7960c2f7c87e",
      "text": "Monthly TRx (NPA) and Sales (NSP) channel sources",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "f71305473c8986d6",
      "text": "TRx represents total prescriptions dispensed including refills.",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "f7b5d53f3d7f3387",
      "text": "NRx represents new prescriptions including renewals and excluding refills, so it does not represent new patient starts. Renewals are the scripts patients get to continue the drug when they run out of refills.",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "626c81a6902214c2",
      "text": "EUTRx / EUNRx (Extended Units) figures can represent a more accurate picture of demand because they include weighting of larger/longer duration Rx. Standard NRx / TRx / NRx count both a 30- day and a 90- day prescription the same. Counts include dispensed tablets, capsules, milliliters, and so forth. For solids, this is the number of tablets; for creams, grams; and liquids, mls.",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "47dd0e0a00576be1",
      "text": "NPA: \"National estimates of prescriptions, or the rate at which drugs move out of the pharmacy and into the hands of a consumer via formal dispensed prescriptions\".",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "4b2ef7f801b472a6",
      "text": "NSP: \"National sales estimates of product packages into retail drugstores, hospitals, clinics, and other nonretail type outlets\".",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "11a9663628f20490",
      "text": "NSP units: \"Total amount of packages sold of a particular drug to the dispensing outlet/ chain/hospital.\"",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "7fc26ff5d0e064f8",
      "text": "NSP Price: \"Is based on a number of sources, depending upon Class of Trade (Channel). It generally represents a best estimation of Net price without the impact of proprietary rebating by the manufacturer. Equation = Sales \\(\\Phi\\) / Units\".",
      "page": 83,
      "section": null
    },
    {
      "passage_id": "ab1ebe16605472f0",
      "text": "NSP Sales \\(\\Phi\\) : \"Total amount of the sales into the dispensing outlets, chain, and health care providers from the manufacturers and distribution centers expressed in US dollars.\"",
      "page": 84,
      "section": null
    },
    {
      "passage_id": "6bbe645b9389ac28",
      "text": "IQVIA sales data (NSP) is captured weekly, and grouped into 4 or 5 week 'months.' The weeks start in January, so the 5 week month falls at the end of each quarter: March, June, September, and December. Periodically, an extra week is added in November to ensure that DDD reporting months do not deviate too far from calendar months.",
      "page": 84,
      "section": null
    },
    {
      "passage_id": "b95fb2002d4b46f1",
      "text": "Brief from IQVIA on NSP Price: Note that NSP reflects significant Class Of Trade discounts and is often well below Gross Price even though it does not reflect rebates manufacturers pay to payers. \"Our NSP Sales \\(\\Phi\\) 's represent a trade price or transaction price. It is the actual cost that was charged to acquire the pharmaceutical products as seen on the purchase invoice. NSP is a projected database. What that means is IQVIA collects the data from the sample (which for NSP represents about \\(88\\%\\) ) and using IQVIA methodology, the data is projected to \\(100\\%\\) of the universe. The prices reflected in IQVIA National Sales Perspectives\" are the prices outlets (i.e. pharmacies, hospitals, clinics) pay for the products, whether purchased directly from a manufacturer or indirectly via a wholesaler or chain warehouse. Invoice line item discounts are included. Prompt- payment discounts and bottom- line invoice discounts are not included. Rebates, typically paid by the manufacturer directly to a customer, insurer, or PBM (Pharmacy Benefits Manager), are not reflected.\"",
      "page": 84,
      "section": null
    },
    {
      "passage_id": "7ce56574c831aa41",
      "text": "Morgan Stanley & Co. International plc (\"Morgan Stanley\") is acting as financial advisor to TEVA PHARMACEUTICAL INDUSTRIES LTD. (\"Teva\") in relation to its intention to divest its active pharmaceutical ingredient (API) business as announced on January 31 2024. Teva has agreed to pay fees to Morgan Stanley for its financial services. Please refer to the notes at the end of the report.",
      "page": 85,
      "section": null
    },
    {
      "passage_id": "4c9eb888d3d88dd8",
      "text": "The information and opinions in Morgan Stanley Research were prepared by Morgan Stanley & Co. LLC, and/or Morgan Stanley C.T.V.M. S.A., and/or Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V., and/or Morgan Stanley Canada Limited. As used in this disclosure section, Morgan Stanley includes Morgan Stanley & Co. LLC, Morgan Stanley C.T.V.M. S.A., Morgan Stanley Mexico, Casa de Bolsa, S.A. de C.V., Morgan Stanley Canada Limited and their affiliates as necessary.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "561b5a70e4904d05",
      "text": "For mportant dislures, stck price chrt and qity rating histories regarding companie that are the subject of this report, please see the Morgan Stanley Research Disclosre Website at www.morganstanley.com/researchdisclosures, or contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY, 10036 USA.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "958bb31ee8e2e2ff",
      "text": "For valuation methodology and risks associated with any recommendation, rating or price target referenced in this research report, please contact the Client Support Team as follows: US/Canada +1 800 303- 2495; Hong Kong +852 2848- 5999; Latin America +1 718 754- 5444 (U.S.); London +44 (0)20- 7425- 8169; Singapore +65 6834- 6860; Sydney +61 (0)2- 9770- 1505; Tokyo +81 (0)3- 6836- 9000. Alternatively you may contact your investment representative or Morgan Stanley Research at 1585 Broadway, (Attention: Research Management), New York, NY 10036 USA.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "1b8db7b3fe7fc502",
      "text": "Morgan Stanley Research has been published in accordance with our conflict management policy, which is available at www.morganstanley.com/institutional/research/conflict policies. A Portuguese version of the policy can be found at www.morganstanley.com.br",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "c35f137a32f1f8dc",
      "text": "As of July 31, 2025, Morgan Stanley beneficially owned 1% or more of a class of common equity securities of the following companies covered in Morgan Stanley Research: 4D Molecular Therapeutics Inc, Abbvie Inc, Acadia Pharmaceuticals Inc, Akero Therapeutics Inc, Amgen Inc, Amicus Therapeutics Inc, Apellis Pharmaceuticals Inc, Arcus Biosciences Inc, Arcutis Biotherapeutics, Inc, argenx SE, Arrowhead Pharmaceuticals Inc, Arvinas Inc, Ascendis Pharma A/S, Axsome Therapeutics, Bicycle Therapeutics Plc, Biogen Inc, Biomarin Pharmaceutical Inc, Bristol Myers Squibb Co, C4 Therapeutics, Cabaletta Bio Inc, Centessa Pharmaceuticals, Inc, Certara Inc, CG Oncology, Cytokinetics Inc, Denali Therapeutics Inc, Dyne Therapeutics Inc, Eli Lilly & Co, Exelixis Inc, Galapagos NV, Gennab A/S, Gilead Sciences Inc, Halozyme Therapeutics, Inc, Incyte Corp, Intellia Therapeutics Inc, Ionis Pharmaceuticals Inc, Johnson & Johnson, Merck & Co, Inc, Mirum Pharmaceuticals, Moderna Inc, Neurocrine Biosciences Inc, Nurx Therapeutics Inc, Organon & Co, Pfizer Inc, ProKidney Corp, Recursion Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, Regenxbio Inc, Rocket Pharmaceuticals Inc, Royalty Pharma Plc, Sarepta Therapeutics Inc, Schrodinger Inc, Silence Therapeutics Plc, Structure Therapeutics Inc, Trevi Therapeutics Inc, Tscan Therapeutics Inc, Vertex Pharmaceuticals, Viking Therapeutics Inc, Vir Biotechnology Inc, Zentalis Pharmaceuticals Inc.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "013e19a46b2ce4f9",
      "text": "Within the last 12 months, Morgan Stanley managed or co- managed a public offering (or 144A offering) of securities of Aardvark Therapeutics Inc, Abbvie Inc, ABSCI CORP, Akero Therapeutics Inc, Ascendis Pharma A/S, Bicara Therapeutics, BioAge Labs Inc, Biogen Inc, Biohaven Ltd, CG Oncology, Cricntics Pharmaceuticals, Dyne Therapeutics Inc, Eli Lilly & Co, Gilead Sciences Inc, Ionis Pharmaceuticals Inc, Kymera Therapeutics Inc, Pfizer Inc, Pharvaris NV, Rhythm Pharmaceuticals Inc, Rocket Pharmaceuticals Inc, Sana Biotechnology, Inc, Trevi Therapeutics Inc, Vertex Pharmaceuticals, Zenas Biopharma Inc.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "18c06f90ad8be214",
      "text": "Within the last 12 months, Morgan Stanley has received compensation for investment banking services from Aardvark Therapeutics Inc, Abbvie Inc, ABSCI CORP, Akero Therapeutics Inc, Amicus, Ascendis Pharma A/S, Bicara Therapeutics, BioAge Labs Inc, Biogen Inc, Biohaven Ltd, Bristol Myers Squibb Co, CG Oncology, Contineum Therapeutics, Cricntics Pharmaceuticals, Dyne Therapeutics Inc, Eli Lilly & Co, Gilead Sciences Inc, Ionis Pharmaceuticals Inc, Kymera Therapeutics Inc, Pfizer Inc, Pharvaris NV, Rhythm Pharmaceuticals Inc, Rocket Pharmaceuticals Inc, Royalty Pharma Plc, Sana Biotechnology, Inc, Sarepta Therapeutics Inc, Trevi Therapeutics Inc, Zenas Biopharma Inc.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "202ce946bb461824",
      "text": "In the next 3 months, Morgan Stanley expects to receive or intends to seek compensation for investment banking services from Aardvark Therapeutics Inc, Abbvie Inc, Abivax, ABSCI CORP, Acadia Pharmaceuticals Inc, Adagene Inc, Akero Therapeutics Inc, Alcon, Alnylam Pharmaceuticals Inc, Alumis Inc, Amgen Inc, Amicus Therapeutics Inc, Apellis Pharmaceuticals Inc, Arcus Biosciences Inc, Arvinas Inc, Ascendis Pharma A/S, Axsome Therapeutics, BeOne Medicines, Bicara Therapeutics Inc, Tscan Therapeutics Inc, Ultragenyx Pharmaceutical Inc, Vertex Pharmaceuticals, Viking Therapeutics Inc, Vir Biotechnology Inc, Y-mABs Therapeutics Inc, Zenas Biopharma Inc, Zentalis Pharmaceuticals Inc.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "adfc4479e8bb00ad",
      "text": "Within the last 12 months, Morgan Stanley has received compensation for products and services other than investment banking services from Abbvie Inc, Amgen Inc, BeOne Medicines, Biogen Inc, Bristol Myers Squibb Co, Certara Inc, Eli Lilly & Co, Gennab A/S, Gilead Sciences Inc, Incyte Corp, Johnson & Johnson, Merck & Co, Inc, Moderna Inc, Organon & Co, Pfizer Inc, Royalty Pharma Plc.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "df582aba37515066",
      "text": "Within the last 12 months, Morgan Stanley has provided or is providing investment banking services to, or has an investment banking client relationship with, the following company: Aardvark Therapeutics Inc, Abbvie Inc, Abivax, ABSCI CORP, Acadia Pharmaceuticals Inc, Adagene Inc, Akero Therapeutics Inc, Alcon, Alnylam Pharmaceuticals Inc, Alumis Inc, Amgen Inc, Amicus Therapeutics Inc, Apellis Pharmaceuticals Inc, Arcus Biosciences Inc, Arcus Biotherapeutics, Inc, argenx SE, Arvinas Inc, Ascendis Pharma A/S, Axsome Therapeutics, BeOne Medicines, Bicara Therapeutics, BioAge Labs Inc, Biogen Inc, Biohaven Ltd, Biomarin Pharmaceutical Inc, BioNTech SE, Bristol Myers Squibb Co, Centessa Pharmaceuticals, Inc, Certara Inc, CG Oncology, Compass Pathways PLC, Contineum Therapeutics, Cricntics Pharmaceuticals, CRISPR Therapeutics Acs, Cullinan Therapeutics, Cytokinetics Inc, Denali Therapeutics Inc, Disc Medicine Inc, Dyne Therapeutics Inc, Eli Lilly & Co, Erasca, Inc, Exelixis Inc, Fracity Health Inc, Galapagos NV, Gennab A/S, Gilead Sciences Inc, Halozyme Therapeutics, Inc, Immunocore Holdings Ltd, Incyte Corp, Insmed Inc, IO Biotech, Ionis Pharmaceuticals Inc, Johnson & Johnson, Kymera Therapeutics Inc, Kymera Therapeutics, Legend Biotech Corp, Merck & Co, Inc, Mirum Pharmaceuticals, Moderna Inc, Neurocrine Biosciences Inc, Organon & Co, Pfizer Inc, Pharvaris NV, Prime Medicine Inc, ProKidney Corp, PTC Therapeutics, Recursion Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, Regenxbio Inc, Rhythm Pharmaceuticals Inc, Rocket Pharmaceuticals Inc, Royalty Pharma Plc, Sana Biotechnology, Inc, Sarepta Therapeutics Inc, Schrodinger Inc, Silence Therapeutics Plc, Structure Therapeutics Inc, Tenaya Therapeutics Inc, Trevi Therapeutics Inc, Tscan Therapeutics Inc, Ultragenyx Pharmaceutical Inc, Vertex Pharmaceuticals, Viking Therapeutics Inc, Vir Biotechnology Inc, Y-mABs Therapeutics Inc, Zenas Biopharma Inc, Zentalis Pharmaceuticals Inc.",
      "page": 86,
      "section": null
    },
    {
      "passage_id": "0239f6f3fde435d9",
      "text": "Within the last 12 months, Morgan Stanley has either provided or is providing non- investment banking, securities- related services to and/or in the past has entered into an agreement to provide services or has a client relationship with the following company: Abbvie Inc., Amgen Inc., BeOn Medicines, Biogen Inc, BioNTech SE, Bristol Myers Squibb Co, Certara Inc, Cytokinetics Inc, Eli Lilly & Co., Genmab A/S, Gilead Sciences Inc, Incyte Corp, Johnson & Johnson, Merck & Co., Inc., Moderna Inc, Organon & Co., Pfizer Inc, Royalty Pharma Plc, Vertex Pharmaceuticals. An employee, director or consultant of Morgan Stanley is a director of Merck & Co., Inc. This person is not a research analyst or a member of a research analyst's household. Morgan Stanley & Co. LLC makes a market in the securities of 4D Molecular Therapeutics Inc, Aardvark Therapeutics Inc, ABSCI CORP, Alector Inc, Amgen Inc, Amicus Therapeutics Inc, Arcellix Inc, Arcus Biosciences Inc, Arctis Biotherapeutics, Inc., Arrowhead Pharmaceuticals Inc, Arvinas Inc, Bicycle Therapeutics Plc, Biohaven Ltd, C4 Therapeutics, Celldex Therapeutics Inc, Centessa Pharmaceuticals, Inc, Certara Inc, CG Oncology, Cricentics Pharmaceuticals, Cullinan Therapeutics, Cytokinetics Inc, Denali Therapeutics Inc, Disc Medicine Inc, Dyne Therapeutics Inc, Erasca, Inc., Immunocore Holdings Ltd, Insmed Inc, Intellia Therapeutics Inc, IO Biotech, Ionis Pharmaceuticals Inc, Kymera Therapeutics Inc, Kyverna Therapeutics, Mirum Pharmaceuticals, Nurix Therapeutics Inc, Prime Medicine Inc, ProKidney Corp, PTC Therapeutics, Regenxbio Inc, Rhythm Pharmaceuticals Inc, Rocket Pharmaceuticals Inc, Schrodinger Inc, Silence Therapeutics Plc, Ultragenyx Pharmaceutical Inc, United Therapeutics Corp, Vir Biotechnology Inc, Y- mABs Therapeutics Inc, Zentalis Pharmaceuticals Inc.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "24598f381811a669",
      "text": "The equity research analysts or strategists principally responsible for the preparation of Morgan Stanley Research have received compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors, firm revenues and overall investment banking revenues. Equity Research analysts' or strategists' compensation is not linked to investment banking or capital markets transactions performed by Morgan Stanley or the profitability or revenues of particular trading desks.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "bc0543f2f53b6af9",
      "text": "Morgan Stanley and its affiliates do business that relates to companies/instruments covered in Morgan Stanley Research, including market making, providing liquidity, fund management, commercial banking, extension of credit, investment services and investment banking. Morgan Stanley sells to and buys from customers the securities/instruments of companies covered in Morgan Stanley Research on a principal basis. Morgan Stanley may have a position in the debt of the Company or instruments discussed in this report. Morgan Stanley trades or may trade as principal in the debt securities (or in related derivatives) that are the subject of the debt research report.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "911765e04af69a05",
      "text": "Morgan Stanley uses a relative rating system using terms such as Overweight, Equal- weight, Not- Rated or Underweight (see definitions below). Morgan Stanley does not assign ratings of Buy, Hold or Sell to the stocks we cover. Overweight, Equal- weight, Not- Rated and Underweight are not the equivalent of buy, hold and Sell. Investors should carefully read the definitions of all ratings used in Morgan Stanley Research. In addition, since Morgan Stanley Research contains more complete information concerning the analyst's views, investors should carefully read Morgan Stanley Research, in its entirety, and not infer the contents from the rating alone. In any case, ratings (or research) should not be used or relied upon as investment advice. An investor's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "e8646dcc2b028c0b",
      "text": "(as of July 31, 2025)",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "27ea4a1876c6ed64",
      "text": "The Stock Ratings described below apply to Morgan Stanley's Fundamental Equity Research and do not apply to Debt Research produced by the Firm. For disclosure purposes only (in accordance with FINRA requirements), we include the category headings of Buy, Hold, and Sell alongside our ratings of Overweight, Equal- weight, Not- Rated and Underweight. Morgan Stanley does not assign ratings of Buy, Hold or Sell to the stocks we cover. Overweight, Equal- weight, Not- Rated and Underweight are not the equivalent of buy, hold, and sell but represent recommended relative weightings (see definitions below). To satisfy regulatory requirements, we correspond Overweight, our most positive stock rating, with a buy recommendation; we correspond Equal- weight and Not- Rated to hold and Underweight to sell recommendations, respectively.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "8ad6d9ef6a8f26f3",
      "text": "Coverage UniverseInvestment Banking Clients (IBC)Other Material Investment Services Clients (MISC)Stock Rating CategoryCount% of TotalCount% of Total IBC% of Rating CategoryCount% of Total Other MISCOverweight/Buy149540%37845%25%70141%Equal-weight/Hold160743%37445%23%76645%Not-Rated/Hold50%00%0%20%Underweight/Sell58816%8310%14%23614%Total3,6958351705",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "442fa5083e409201",
      "text": "Data include common stock and ADRs currently assigned ratings. Investment Banking Clients are companies from whom Morgan Stanley received investment banking compensation in the last 12 months. Due to rounding off of decimals, the percentages provided in the \\(\\%\\) of total' column may not add up to exactly 100 percent.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "d0e3a78226e87738",
      "text": "Overweight (O). The stock's total return is expected to exceed the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next 12- 18 months.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "2c87964d18e68f6e",
      "text": "Equal- weight (E). The stock's total return is expected to be in line with the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next 12- 18 months.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "3e5548ba4256d86f",
      "text": "Not- Rated (NR). Currently the analyst does not have adequate conviction about the stock's total return relative to the average total return of the analyst's industry (or industry team's) coverage universe, on a risk- adjusted basis, over the next 12- 18 months.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "66f9f84e378c693f",
      "text": "Underweight (U). The stock's total return is expected to be below the average total return of the analyst's industry (or industry team's) coverage universe, on a risk- adjusted basis, over the next 12- 18 months.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "4f15b7e733fdf702",
      "text": "Unless otherwise specified, the time frame for price targets included in Morgan Stanley Research is 12 to 18 months.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "9f7f8d68eeb3345f",
      "text": "Attractive (A): The analyst expects the performance of his or her industry coverage universe over the next 12- 18 months to be attractive vs. the relevant broad market benchmark, as indicated below.",
      "page": 87,
      "section": null
    },
    {
      "passage_id": "28ad4e70449f5fa0",
      "text": "In- Line (): The analyst expects the performance of his or her industry coverage universe over the next 12- 18 months to be in line with the relevant broad market benchmark, as indicated below. Cautious (C): The analyst views the performance of his or her industry coverage universe over the next 12- 18 months with caution vs. the relevant broad market benchmark, as indicated below. Benchmarks for each region are as follows: North America - S&P 500; Latin America - relevant MSCI country index or MSCI Latin America Index; Europe - MSCI Europe; Japan - TOPIX; Asia - relevant MSCI country index or MSCI sub- regional index or MSCI AC Asia Pacific ex Japan Index.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "2542f7bf583d1dae",
      "text": "A member of Research who had or could have had access to the research prior to completion owns securities (or related derivatives) in the Eli Lilly & Co. This person is not a research analyst or a member of research analyst's household.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "fa97385ef53f13d1",
      "text": "Morgan Stanley Research policy is to update research reports as and when the Research Analyst and Research Management deem appropriate, based on developments with the issuer, the sector, or the market that may have a material impact on the research views or opinions stated therein. In addition, certain Research publications are intended to be updated on a regular periodic basis (weekly/monthly/quarterly/annual) and will ordinarily be updated with that frequency, unless the Research Analyst and Research Management determine that a different publication schedule is appropriate based on current conditions.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "c4b443b898cf97a4",
      "text": "Morgan Stanley is not acting as a municipal advisor and the opinions or views contained herein are not intended to be, and do not constitute, advice within the meaning of Section 975 of the Dodd- Frank Wall Street Reform and Consumer Protection Act.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "3fb05e80ff993dc3",
      "text": "Morgan Stanley produces an equity research product called a \"Tactical Idea.\" Views contained in a \"Tactical Idea\" on a particular stock may be contrary to the recommendations or views expressed in research on the same stock. This may be the result of differing time horizons, methodologies, market events, or other factors. For all research available on a particular stock, please contact your sales representative or go to Matrix at http://www.morganstanley.com/matrix.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "c5926c0a85aee58c",
      "text": "Morgan Stanley Research is provided to our clients through our proprietary research portal on Matrix and also distributed electronically by Morgan Stanley to clients. Certain, but not all, Morgan Stanley Research products are also made available to clients through third- party vendors or redistributed to clients through alternate electronic means as a convenience. For access to all available Morgan Stanley Research, please contact your sales representative or go to Matrix at http://www.morganstanley.com/matrix.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "0680fa3d04f2c771",
      "text": "Any access and/or use of Morgan Stanley Research is subject to Morgan Stanley's Terms of Use (http://www.morganstanley.com/terms.html). By accessing and/or using Morgan Stanley Research, you are indicating that you have read and agree to be bound by our Terms of Use (http://www.morganstanley.com/terms.html). In addition you consent to Morgan Stanley processing your personal data and using cookies in accordance with our Privacy Policy and our Global Cookies Policy (http://www.morganstanley.com/privacy_pledge.html), including for the purposes of setting your preferences and to collect readership data so that we can deliver better and more personalized service and products to you. To find out more information about how Morgan Stanley processes personal data, how we use cookies and how to reject cookies see our Privacy Policy and our Global Cookies Policy (http://www.morganstanley.com/privacy_pledge.html).",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "cc2b5dc6bab4df54",
      "text": "If you do not agree to our Terms of Use and/or if you do not wish to provide your consent to Morgan Stanley processing your personal data or using cookies please do not access our research. Morgan Stanley Research does not provide individually tailored investment advice. Morgan Stanley Research has been prepared without regard to the circumstances and objectives of those who receive it. Morgan Stanley recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. The appropriateness of an investment or strategy will depend on an investor's circumstances and objectives. The securities, instruments, or strategies discussed in Morgan Stanley Research may not be suitable for all investors, and certain investors may not be eligible to purchase or participate in some or all of them. Morgan Stanley Research is not an offer to buy or sell or the solicitation of an offer to buy or sell any security/instrument or to participate in any particular trading strategy. The value of and income from your investments may vary because of changes in interest rates, foreign exchange rates, default rates, prepayment rates, securities/instruments prices, market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in securities/instruments transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. If provided, and unless otherwise stated, the closing price on the cover page is that of the primary exchange for the subject company's securities/instruments.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "603e698b0edbfff0",
      "text": "The fixed income research analysts, strategists or economists principally responsible for the preparation of Morgan Stanley Research have received compensation based upon various factors, including quality, accuracy and value of research, firm profitability or revenues (which include fixed income trading and capital markets profitability or revenues), client feedback and competitive factors. Fixed Income Research analysts, strategists or economists' compensation is not linked to investment banking or capital markets transactions performed by Morgan Stanley or the profitability or revenues of particular trading desks.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "eb5019c44cdf5536",
      "text": "The Important Regulatory Disclosures on Subject Companies' section in Morgan Stanley Research lists all companies mentioned where Morgan Stanley owns 1% or more of a class of common equity securities of the companies. For all other companies mentioned in Morgan Stanley Research, Morgan Stanley may have an investment of less than 1% in securities/instruments or derivatives of securities/instruments of companies and may trade them in ways different from those discussed in Morgan Stanley Research. Employees of Morgan Stanley not involved in the preparation of Morgan Stanley Research may have investments in securities/instruments or derivatives of securities/instruments of companies mentioned and may trade them in ways different from those discussed in Morgan Stanley Research. Derivatives may be issued by Morgan Stanley or associated persons.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "d6afdeebefd06c9d",
      "text": "With the exception of information regarding Morgan Stanley, Morgan Stanley Research is based on public information. Morgan Stanley makes every effort to use reliable, comprehensive information, but we make no representation that it is accurate or complete. We have no obligation to tell you when opinions or information in Morgan Stanley Research change apart from when we intend to discontinue equity research coverage of a subject company. Facts and views presented in Morgan Stanley Research have not been reviewed by, and may not reflect information known to, professionals in other Morgan Stanley business areas, including investment banking personnel.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "64e947e68dd340ed",
      "text": "Morgan Stanley Research personnel may participate in company events such as site visits and are generally prohibited from accepting payment by the company of associated expenses unless pre- approved by authorized members of Research management.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "4dd615012300cb33",
      "text": "Morgan Stanley may make investment decisions that are inconsistent with the recommendations or views in this report.",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "bb94293655a87462",
      "text": "To our readers based in Taiwan or trading in Taiwan securities/instruments: Information on securities/instruments that trade in Taiwan is distributed by Morgan Stanley Taiwan Limited (MSTL). Such information is for your reference only. The reader should independently evaluate the investment risks and is solely responsible for their investment decisions. Morgan Stanley Research may not be distributed to the public media or quoted or used by the public media without the express written consent of Morgan Stanley. Any non- customer reader within the scope of Article",
      "page": 88,
      "section": null
    },
    {
      "passage_id": "9b488057b0b6876e",
      "text": "7- 1 of the Taiwan Stock Exchange Recommendation Regulations accessing and/or receiving Morgan Stanley Research is not permitted to provide Morgan Stanley Research to any third party (including but not limited to related parties, affiliated companies and any other third parties) or engage in any activities regarding Morgan Stanley Research which may create or give the appearance of creating a conflict of interest. Information on securities/instruments that do not trade in Taiwan is for informational purposes only and is not to be construed as a recommendation or a solicitation to trade in such securities/instruments. MSTL may not execute transactions for clients in these securities/instruments.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "18d6e09fb5a2cf30",
      "text": "Morgan Stanley is not incorporated under PRC law and the research in relation to this report is conducted outside the PRC. Morgan Stanley Research does not constitute an offer to sell or the solicitation of an offer to buy any securities in the PRC. PRC investors shall have the relevant qualifications to invest in such securities and shall be responsible for obtaining all relevant approvals, licenses, verifications and/or registrations from the relevant governmental authorities themselves. Neither this report nor any part of it is intended as, or shall constitute, provision of any consultancy or advisory service of securities investment as defined under PRC law. Such information is provided for your reference only.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "08dd54442cb1e4ab",
      "text": "The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co. International plc (DIFC Branch), regulated by the Dubai Financial Services Authority (the DFSA) or by Morgan Stanley & Co. International plc (ADGM Branch), regulated by the Financial Services Regulatory Authority Abu Dhabi (the FSRA), and is directed at Professional Clients only, as defined by the DFSA or the FSRA, respectively. The financial products or financial services to which this research relates will only be made available to a customer who we are satisfied meets the regulatory criteria of a Professional Client. A distribution of the different MS Research ratings or recommendations, in percentage terms for Investments in each sector covered, is available upon request from your sales representative.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "0815d014fdeb4ba7",
      "text": "The information in Morgan Stanley Research is being communicated by Morgan Stanley & Co. International plc (QFC Branch), regulated by the Qatar Financial Centre Regulatory Authority (the QFCRA), and is directed at business customers and market counterparties only and is not intended for Retail Customers as defined by the QFCRA.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "f27f577b7ff0e3ab",
      "text": "As required by the Capital Markets Board of Turkey, investment information, comments and recommendations stated here, are not within the scope of investment advisory activity. Investment advisory service is provided exclusively to persons based on their risk and income preferences by the authorized firms. Comments and recommendations stated here are general in nature. These opinions may not fit to your financial status, risk and return preferences. For this reason, to make an investment decision by relying solely to this information stated here may not bring about outcomes that fit your expectations.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "fd8a940c234a3218",
      "text": "The trademarks and service marks contained in Morgan Stanley Research are the property of their respective owners. Third-party data providers make no warranties or representations relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages relating to such data. The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of MSCI and S&P.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "fd3aaafaee67d316",
      "text": "Morgan Stanley Research, or any portion thereof may not be reprinted, sold or redistributed without the written consent of Morgan Stanley. Indicators and trackers referenced in Morgan Stanley Research may not be used as, or treated as, a benchmark under Regulation EU 2016/101, or any other similar framework. The issuers and/or fixed income products recommended or discussed in certain fixed income research reports may not be continuously followed. Accordingly, investors should regard those fixed income research reports as providing stand-alone analysis and should not expect continuing analysis or additional reports relating to such issuers and/or individual fixed income products. Morgan Stanley may hold, from time to time, material financial and commercial interests regarding the company subject to the Research report.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "641099ea137739f8",
      "text": "Registration granted by SEBI and certification from the National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "0065a20878c134e4",
      "text": "PRICE\\* (08/28/2025)",
      "page": 89,
      "section": null
    },
    {
      "passage_id": "78e11ed384eb7183",
      "text": "Terence C Flynn, Ph.D.Abbvie Inc. (ABBV.N)O (05/11/2020)&#36;207.92Bristol Myers Squibb Co (BMY.N)U (04/06/2022)&#36;46.88Eli Lilly & Co. (LLY.N)O (09/03/2020)&#36;731.96Johnson & Johnson (JNJ.N)E (09/07/2021)&#36;175.45Merck & Co., Inc. (MRK.N)E (09/07/2021)&#36;83.21Organon & Co. (OGN.N)E (06/11/2021)&#36;9.18Pfizer Inc (PFE.N)E (07/30/2019)&#36;24.60Royalty Pharma Plc (RPRX.O)O (05/16/2025)&#36;35.62",
      "page": 90,
      "section": null
    },
    {
      "passage_id": "86d33ea96662de18",
      "text": "Stock Ratings are subject to change. Please see latest research for each company.",
      "page": 90,
      "section": null
    },
    {
      "passage_id": "16a65b05920609cf",
      "text": "* Historical prices are not split adjusted.",
      "page": 90,
      "section": null
    },
    {
      "passage_id": "e522f49b404a00d0",
      "text": "COMPANY (TICKER)RATING (AS OF)PRICE* (08/28/2025)Judah C. Frommer, CFA4D Molecular Therapeutics Inc (FDMTO)U (11/21/2024)&#36;6.18Abivax (ABVX.O)O (07/23/2025)&#36;81.64Apellis Pharmaceuticals Inc (APLS.O)E (11/21/2024)&#36;28.05Arcelix Inc (ACLX.O)O (03/07/2024)&#36;70.25Arcutis Biotherapeutics, Inc. (ARQT.O)O (07/02/2025)&#36;15.49Bicara Therapeutics (BCAX.O)O (10/08/2024)&#36;11.91Celldex Therapeutics Inc (CLDX.O)O (03/20/2025)&#36;22.38Compass Pathways PLC (CMPS.O)O (08/08/2025)&#36;4.81enGene Holdings Inc. (ENGN.O)O (03/08/2024)&#36;4.75Galapagos NV (GLPG.O)U (02/13/2025)&#36;32.41Genmab A/S (GMAB.O)E (07/02/2025)&#36;25.11Incyte Corp (INCY.O)E (07/02/2025)&#36;83.70Kymera Therapeutics Inc (KYMR.O)O (07/02/2025)&#36;41.75Mural Oncology (MURA.O)E (03/25/2025)&#36;2.07ProKidney Corp (PROK.O)E (11/10/2022)&#36;2.50PTC Therapeutics (PTCT.O)O (03/06/2025)&#36;49.79Regenxbio Inc (RGNX.O)O (11/15/2024)&#36;9.01Trevi Therapeutics Inc (TRVI.O)O (08/21/2025)&#36;7.21Zenas Biopharma Inc (ZBIO.O)O (07/02/2025)&#36;16.26Maxwell SkorAdagene Inc. (ADAG.O)E (01/30/2025)&#36;2.22Amicus Therapeutics Inc. (FOLD.O)O (07/16/2025)&#36;7.65Ascendis Pharma A/S (ASND.O)O (05/05/2025)&#36;193.90Atea Pharmaceuticals Inc (AVIR.O)E (08/12/2024)&#36;3.47Bicycle Therapeutics Plc (BCYC.O)E (02/14/2022)&#36;7.08Crinetics Pharmaceuticals (CRNX.O)O (01/16/2024)&#36;30.65Cytokinetics Inc (CYTK.O)O (02/13/2025)&#36;37.35Inspired Inc (INSM.O)E (08/12/2025)&#36;134.97Pharvaris N.V. (PHVS.O)O (08/15/2023)&#36;22.84Sana Biotechnology, Inc (SANA.O)O (03/01/2021)&#36;3.01Tscan Therapeutics Inc (TCRX.O)O (03/13/2025)&#36;1.82Ultragenyx Pharmaceutical Inc (RARE.O)O (03/27/2019)&#36;30.30Michael E UlzAardvark Therapeutics Inc. (AARD.O)O (03/10/2025)&#36;8.49Akero Therapeutics Inc (AKRO.O)O (01/27/2023)&#36;46.94Alnylam Pharmaceuticals Inc (ALNY.O)E (09/09/2022)&#36;452.33Arrowhead Pharmaceuticals Inc (ARWR.O)E (09/09/2022)&#36;22.34BioAge Labs Inc (BIOA.O)U (12/09/2024)&#36;4.80Cabaletta Bio Inc (CABA.O)O (01/27/2023)&#36;1.50",
      "page": 90,
      "section": null
    },
    {
      "passage_id": "a6bf60b8ffb671d8",
      "text": "Dyne Therapeutics Inc (DYN.O)O (04/30/2024)$13.75Fractyl Health Inc (GUTS.O)O (02/27/2024)$0.99IO Biotech (IOBT.O)O (11/30/2021)$1.58Ionis Pharmaceuticals Inc (IONS.O)O (07/30/2025)$42.62Kyverna Therapeutics (KYTX.O)O (03/04/2024)$3.70Mirum Pharmaceuticals (MIRM.O)O (11/13/2023)$75.53Rhythm Pharmaceuticals Inc (RYTM.O)O (12/19/2023)$104.23Rocket Pharmaceuticals Inc (RCKT.O)E (05/27/2025)$3.35Sarepta Therapeutics Inc (SRPT.O)E (06/16/2025)$18.34Silence Therapeutics Plc (SLN.O)O (05/08/2023)$5.10Tenaya Therapeutics Inc (TNYA.O)O (08/24/2021)$1.13Viking Therapeutics Inc (VKTX.O)O (06/27/2024)$27.58Vir Biotechnology Inc (VIR.O)O (01/08/2025)$5.04Y-mABs Therapeutics Inc. (YMAB.O)E (08/05/2025)$8.54Zentalis Pharmaceuticals Inc (ZNTL.O)E (06/18/2024)$1.76",
      "page": 91,
      "section": null
    },
    {
      "passage_id": "9802213405061764",
      "text": "ABSCI CORP (ABSI.O)O (07/03/2024)$2.47Acadia Pharmaceuticals Inc (ACAD.O)E (08/06/2024)$26.23Alector Inc (ALEC.O)U (11/26/2024)$2.39argenx SE (ARGX.O)O (07/02/2025)$704.07Axsome Therapeutics (AXSM.O)O (04/29/2024)$121.75BeOne Medicines (ONC.O)O (12/02/2024)$297.96Biomarin Pharmaceutical Inc (BMRN.O)O (07/02/2025)$57.68Centessa Pharmaceuticals, Inc (CNTA.O)O (09/19/2024)$16.56Certara Inc (CERT.O)E (01/05/2021)$10.87CG Oncology (CGON.O)O (02/19/2024)$26.72Contineum Therapeutics (CTNM.O)O (04/30/2024)$10.05Cullinan Therapeutics (CGEM.O)O (03/06/2025)$7.61Denali Therapeutics Inc (DNLI.O)O (03/06/2025)$15.65Disc Medicine Inc (IRON.O)O (11/04/2024)$59.66Erasca, Inc. (ERAS.O)E (08/17/2025)$1.57Exelixis Inc. (EXEL.O)O (01/26/2025)$37.90Halozyme Therapeutics, Inc (HALO.O)O (08/05/2025)$72.81Immunocore Holdings Ltd (IMCR.O)E (12/12/2024)$32.24Neurocrine Biosciences Inc (NBIX.O)O (03/06/2025)$138.94Recursion Pharmaceuticals Inc (RXRX.O)E (05/22/2023)$4.87Schrodinger Inc. (SDGR.O)E (11/19/2021)$19.76",
      "page": 91,
      "section": null
    },
    {
      "passage_id": "533731bd660ed180",
      "text": "Alumis Inc. (ALMS.O)O (05/30/2025)$4.70Amgen Inc. (AMGN.O)E (10/16/2023)$285.61Arcus Biosciences Inc. (RCUS.N)O (10/11/2022)$10.61Arvinas Inc (ARVN.O)E (04/06/2022)$7.76Biogen Inc (BIIB.O)E (10/31/2024)$132.65Biohaven Ltd (BHVN.N)O (07/24/2024)$15.52BioNTech SE (BNTX.O)O (09/23/2024)$101.93C4 Therapeutics (CCCC.O)E (11/06/2023)$2.55CRISPR Therapeutics AG (CRSP.O)U (10/11/2022)$53.05Gilead Sciences Inc. (GILD.O)O (01/10/2025)$112.56Intellia Therapeutics Inc (NTLA.O)E (01/26/2025)$11.60Legend Biotech Corp (LEGN.O)O (01/31/2022)$34.37Moderna Inc (MRNA.O)E (12/16/2020)$24.47Nurix Therapeutics Inc. (NRIX.O)E (10/11/2022)$9.41Prime Medicine Inc (PRME.O)E (11/14/2022)$3.44Regeneron Pharmaceuticals Inc. (REGN.O)O (09/09/2022)$579.61Structure Therapeutics Inc (GPCR.O)O (09/22/2024)$19.14",
      "page": 91,
      "section": null
    },
    {
      "passage_id": "3cb28d26e1ec4534",
      "text": "United Therapeutics Corp (UTHR.O) E (07/11/2024) \\$307.24",
      "page": 92,
      "section": null
    },
    {
      "passage_id": "284687059a795f2f",
      "text": "Vertex Pharmaceuticals (VRTX.O) E (05/03/2022) \\$392.05",
      "page": 92,
      "section": null
    },
    {
      "passage_id": "2ea85ae37b03387b",
      "text": "Stock Ratings are subject to change. Please see latest research for each company.",
      "page": 92,
      "section": null
    },
    {
      "passage_id": "90cbbaf05bd7d1c6",
      "text": "* Historical prices are not split adjusted.",
      "page": 92,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "5dc8f59a60c48918",
      "name": "ADGM Branch",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "394218ab3d61ca43",
      "name": "Aardvark Therapeutics",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f443b8b74e05708c",
      "name": "Aardvark Therapeutics Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "4a4bef43c7bfa9f1",
      "name": "Abbvie Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ed49291dd8535b70",
      "name": "Abu Dhabi",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7a8acf40cea751b9",
      "name": "Acadia Pharmaceuticals",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6a2ad8c9a1d57a63",
      "name": "Acadia Pharmaceuticals Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ae7ce8b9eb194b93",
      "name": "Actemra\n\nActemra",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ad3baf6ab633d43b",
      "name": "Adagene Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "bb0cfde65adfa861",
      "name": "Aimovig TRx",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6b94c01d23c056ed",
      "name": "Ajovy TRx",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "5116c8ebe3678cc0",
      "name": "Akero Therapeutics",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f3b6b3f250f42fb9",
      "name": "Akero Therapeutics Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e970e25f5b33fddb",
      "name": "Alector Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "9073f5b876dce613",
      "name": "Alliance Revenues",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ce2ccb36242da64f",
      "name": "Alnylam Pharmaceuticals",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "65911636744ff4ec",
      "name": "Alnylam Pharmaceuticals Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "9612cce96a083c31",
      "name": "Alumis Inc",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "f100debe799791af",
      "name": "Alyftrek TRx",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "96269396581e9575",
      "name": "Ambien Franchise",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "line",
        "title": null,
        "page": 3,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "Rx/Week",
            "range": {
              "min": 0,
              "max": 35000
            }
          }
        },
        "series": [
          {
            "name": "Journevs Actual",
            "unit": "Rx/Week",
            "values": [
              0,
              100,
              300,
              600,
              1000,
              1500,
              2000,
              2500,
              3000,
              3500,
              4000,
              4500,
              5000,
              4800,
              5200,
              5500,
              6000,
              5800,
              6200,
              6000,
              6500,
              6800,
              7000
            ]
          },
          {
            "name": "Grossed up with hospital scripts",
            "unit": "Rx/Week",
            "values": [
              0,
              200,
              500,
              1000,
              1500,
              2000,
              2800,
              3500,
              4200,
              5000,
              5800,
              6500,
              7000,
              6800,
              7500,
              8000,
              8500,
              8200,
              8800,
              8500,
              9200,
              9500,
              9800
            ]
          },
          {
            "name": "50% GTN",
            "unit": "Rx/Week",
            "values": [
              0,
              200,
              500,
              1000,
              1500,
              2000,
              2800,
              3500,
              4200,
              5000,
              5800,
              6500,
              7000,
              7500,
              8000,
              8500,
              9000,
              9500,
              10000,
              10500,
              11000,
              11500,
              12000,
              12500,
              13000,
              13500,
              14000,
              14500,
              15000,
              15500,
              16000,
              16500,
              17000,
              17500,
              18000,
              18500,
              19000,
              19500,
              20000,
              20500,
              21000,
              21500,
              22000,
              22500
            ]
          },
          {
            "name": "75% GTN",
            "unit": "Rx/Week",
            "values": [
              0,
              300,
              750,
              1500,
              2250,
              3000,
              4200,
              5250,
              6300,
              7500,
              8700,
              9750,
              10500,
              11250,
              12000,
              12750,
              13500,
              14250,
              15000,
              15750,
              16500,
              17250,
              18000,
              18750,
              19500,
              20250,
              21000,
              21750,
              22500,
              23250,
              24000,
              24750,
              25500,
              26250,
              27000,
              27750,
              28500,
              29250,
              30000,
              30750,
              31500,
              32250,
              33000,
              33750
            ]
          }
        ],
        "figure_id": "dddeb6897f85ab53",
        "provenance": {
          "page": 3
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 3,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 4000
            }
          }
        },
        "series": [
          {
            "name": "Apretude (ViiV)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Descovy (Gilead)",
            "unit": "TRx",
            "values": [
              0,
              0,
              100,
              200,
              300,
              450,
              600,
              850,
              950,
              970,
              1200,
              1500,
              1800,
              2000,
              2500,
              2550,
              2900,
              3000,
              3400,
              3500,
              3700,
              3800,
              3750,
              3700,
              3650
            ]
          },
          {
            "name": "Yeztugo oral (Gilead)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              50,
              150,
              100,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50
            ]
          },
          {
            "name": "Yeztugo Inj (Gilead)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              50,
              100,
              150,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200
            ]
          }
        ],
        "figure_id": "d9d3092d70575e5f",
        "provenance": {
          "page": 3
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 7,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jan",
              "Feb",
              "Mar",
              "Apr",
              "May",
              "Jun",
              "Jul",
              "Aug",
              "Sep",
              "Oct",
              "Nov",
              "Dec"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -20,
              "max": 20
            }
          }
        },
        "series": [
          {
            "name": "2025",
            "unit": "%",
            "values": [
              -1.5,
              11,
              -3,
              4.5,
              3.5,
              4.5,
              2.5,
              3.5,
              0,
              3,
              2.5,
              4,
              2.5,
              3.5,
              2.5,
              3.5,
              2.5,
              3,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5
            ]
          },
          {
            "name": "2024",
            "unit": "%",
            "values": [
              1,
              2,
              -2,
              5,
              1,
              4,
              0,
              2,
              -1,
              3,
              1,
              2,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1,
              0,
              1
            ]
          }
        ],
        "figure_id": "4528c06fb8dadc69",
        "provenance": {
          "page": 7
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 7,
        "axes": {
          "x": {
            "type": "time",
            "labels": [
              "1/4/19",
              "12/16/19",
              "11/26/20",
              "11/7/21",
              "10/19/22",
              "9/30/23",
              "9/10/24",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "'000",
            "range": {
              "min": 0,
              "max": 120000
            }
          }
        },
        "series": [
          {
            "name": "TRx",
            "unit": "'000",
            "values": []
          },
          {
            "name": "NRx",
            "unit": "'000",
            "values": []
          }
        ],
        "figure_id": "d95e4ca43b49a59c",
        "provenance": {
          "page": 7
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 8,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1/3/20",
              "10/23/20",
              "8/13/21",
              "6/3/22",
              "3/24/23",
              "1/12/24",
              "11/1/24",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -30,
              "max": 50
            }
          }
        },
        "series": [
          {
            "name": "NRx YoY",
            "unit": "%",
            "values": [
              5,
              -15,
              33,
              -2,
              2,
              0,
              23,
              3.1
            ]
          },
          {
            "name": "TRx YoY",
            "unit": "%",
            "values": [
              2,
              -5,
              17,
              -1,
              1,
              0,
              10,
              2.3
            ]
          }
        ],
        "figure_id": "41bce2c2a519f00b",
        "provenance": {
          "page": 8
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 9,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1/3/20",
              "10/23/20",
              "8/13/21",
              "6/3/22",
              "3/24/23",
              "1/12/24",
              "11/1/24",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -25,
              "max": 30
            }
          }
        },
        "series": [
          {
            "name": "TRx YoY",
            "unit": "%",
            "values": []
          },
          {
            "name": "EUTrx YoY",
            "unit": "%",
            "values": []
          }
        ],
        "figure_id": "8b5f1a32dc34094a",
        "provenance": {
          "page": 9
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 9,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1-Jan",
              "15-Jan",
              "29-Jan",
              "12-Feb",
              "26-Feb",
              "12-Mar",
              "26-Mar",
              "9-Apr",
              "23-Apr",
              "7-May",
              "21-May",
              "4-Jun",
              "18-Jun",
              "2-Jul",
              "16-Jul",
              "30-Jul",
              "13-Aug",
              "27-Aug",
              "10-Sep",
              "24-Sep",
              "8-Oct",
              "22-Oct",
              "5-Nov",
              "19-Nov",
              "3-Dec",
              "17-Dec",
              "31-Dec"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -10,
              "max": 12
            }
          }
        },
        "series": [
          {
            "name": "2021YTD EUTR YOY",
            "unit": "%",
            "values": [
              -5.5,
              -6.5,
              -7.5,
              -7.8,
              -7.5,
              -7.0,
              -8.0,
              -7.0,
              -6.0,
              -4.5,
              -3.0,
              -2.0,
              -1.5,
              -1.0,
              -0.5,
              0.0,
              0.5,
              0.8,
              1.0,
              1.2,
              1.5,
              1.8,
              2.0,
              2.2,
              2.5,
              2.8,
              3.0
            ]
          },
          {
            "name": "2022YTD EUTR YOY",
            "unit": "%",
            "values": [
              4.0,
              3.5,
              4.0,
              4.5,
              5.0,
              5.5,
              6.0,
              6.2,
              6.3,
              6.4,
              6.2,
              6.0,
              5.8,
              5.5,
              5.3,
              5.2,
              5.0,
              4.8,
              4.7,
              4.6,
              4.5,
              4.4,
              4.3,
              4.2,
              4.1,
              4.0,
              3.9
            ]
          },
          {
            "name": "2023YTD EUTR YOY",
            "unit": "%",
            "values": [
              4.0,
              5.0,
              5.5,
              5.0,
              4.8,
              4.5,
              4.3,
              4.2,
              4.0,
              3.8,
              3.6,
              3.4,
              3.2,
              3.0,
              2.8,
              2.6,
              2.4,
              2.2,
              2.0,
              1.8,
              1.6,
              1.4,
              1.2,
              1.0,
              0.8,
              0.6,
              0.4
            ]
          },
          {
            "name": "2024YTD EUTR YOY",
            "unit": "%",
            "values": [
              10.0,
              4.0,
              3.0,
              3.5,
              3.0,
              2.5,
              2.0,
              2.5,
              2.0,
              1.8,
              1.6,
              1.5,
              1.4,
              1.3,
              1.2,
              1.1,
              1.0,
              0.9,
              0.8,
              0.7,
              0.6,
              0.5,
              0.4,
              0.3,
              0.2,
              0.1,
              0.0
            ]
          },
          {
            "name": "2025YTD EUTR YOY",
            "unit": "%",
            "values": [
              -1.0,
              4.0,
              2.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0
            ]
          }
        ],
        "figure_id": "37994c1b9fdc2c41",
        "provenance": {
          "page": 9
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 10,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jan-14",
              "Apr-14",
              "Jul-14",
              "Oct-14",
              "Jan-15",
              "Apr-15",
              "Jul-15",
              "Oct-15",
              "Jan-16",
              "Apr-16",
              "Jul-16",
              "Oct-16",
              "Jan-17",
              "Apr-17",
              "Jul-17",
              "Oct-17",
              "Jan-18",
              "Apr-18",
              "Jul-18",
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -20,
              "max": 20
            }
          }
        },
        "series": [
          {
            "name": "TRx",
            "unit": "%",
            "values": [
              0.5,
              4.5,
              7.5,
              4.5,
              6.5,
              4.5,
              7.5,
              4.5,
              6.5,
              4.5,
              7.5,
              4.5,
              -2.5,
              2.5,
              5.5,
              2.5,
              0.5,
              2.5,
              0.5,
              2.5,
              0.5,
              2.5,
              0.5,
              2.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5,
              0.5,
              5.5
            ]
          },
          {
            "name": "Sales",
            "unit": "%",
            "values": [
              9.5,
              16.5,
              11.5,
              16.5,
              11.5,
              8.5,
              6.5,
              8.5,
              6.5,
              8.5,
              6.5,
              8.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              9.5,
              -2.5,
              -7.5,
              -2.5,
              -17.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5,
              -2.5,
              -7.5
            ]
          }
        ],
        "figure_id": "ae9e18e8840b40b1",
        "provenance": {
          "page": 10
        }
      },
      {
        "type": "line",
        "title": "IMS Monthly Sales share",
        "page": 15,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Aug-19",
              "Oct-19",
              "Dec-19",
              "Feb-20",
              "May-20",
              "Jul-20",
              "Sep-20",
              "Dec-20",
              "Feb-21",
              "Apr-21",
              "Jul-21",
              "Sep-21",
              "Nov-21",
              "Jan-22",
              "Apr-22",
              "Jun-22",
              "Aug-22",
              "Nov-22",
              "Jan-23",
              "Mar-23",
              "Jun-23",
              "Aug-23",
              "Oct-23",
              "Dec-23",
              "Mar-24",
              "May-24",
              "Jul-24",
              "Oct-24",
              "Dec-24",
              "Feb-25",
              "May-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Actemra (Roche)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              99.5,
              98,
              95,
              92,
              90,
              88,
              85,
              82
            ]
          },
          {
            "name": "Tyenne (Fresenius)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.2,
              0.5,
              1,
              2,
              4,
              6,
              8,
              10
            ]
          },
          {
            "name": "Tofidence (OGN)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.4,
              0.5,
              0.6,
              0.7,
              0.8
            ]
          }
        ],
        "figure_id": "322307e4bed43710",
        "provenance": {
          "page": 15
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 15,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Avastin (ROG)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              98,
              90,
              80,
              70,
              60,
              50,
              45,
              40,
              35,
              30,
              28,
              26,
              25,
              27,
              28,
              25,
              22,
              20,
              18,
              15,
              10,
              15,
              20,
              22
            ]
          },
          {
            "name": "Mvasi (AMGN)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              5,
              10,
              20,
              30,
              40,
              43,
              45,
              43,
              42,
              40,
              40,
              40,
              42,
              42,
              40,
              40,
              40,
              45,
              55,
              50,
              48,
              45,
              43
            ]
          },
          {
            "name": "Zirabev (PFE)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              5,
              10,
              15,
              20,
              25,
              30,
              32,
              35,
              35,
              30,
              28,
              25,
              20,
              18,
              15,
              10,
              15,
              20,
              22,
              25
            ]
          },
          {
            "name": "Alymsys (AMRX)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              2,
              5,
              7,
              8,
              9,
              10,
              8,
              7,
              6,
              5
            ]
          }
        ],
        "figure_id": "be52dd17240932f9",
        "provenance": {
          "page": 15
        }
      },
      {
        "type": "line",
        "title": "IQVIA Monthly Sales share",
        "page": 16,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Apr-18",
              "Jul-18",
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Epogen (AMGM)",
            "unit": "%",
            "values": [
              99,
              95,
              90,
              87,
              85,
              83,
              80,
              77,
              78,
              76,
              75,
              68,
              76,
              75,
              72,
              70,
              75,
              82,
              80,
              60,
              55,
              40,
              50,
              58,
              48,
              45,
              40,
              38,
              58,
              30
            ]
          },
          {
            "name": "Retacrit (PFE)",
            "unit": "%",
            "values": [
              1,
              5,
              10,
              13,
              15,
              17,
              20,
              23,
              22,
              24,
              25,
              32,
              24,
              25,
              28,
              30,
              25,
              18,
              20,
              45,
              55,
              60,
              50,
              42,
              52,
              55,
              60,
              62,
              68,
              65
            ]
          }
        ],
        "figure_id": "4eefc6ca334ac2e4",
        "provenance": {
          "page": 16
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 16,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 80
            }
          }
        },
        "series": [
          {
            "name": "Epogen (AMGN)",
            "unit": "%",
            "values": [
              46,
              48,
              44,
              42,
              45,
              42,
              45,
              46,
              42,
              45,
              50,
              60,
              72,
              68,
              52,
              45,
              40,
              39
            ]
          },
          {
            "name": "Retacrit (PFE)",
            "unit": "%",
            "values": [
              54,
              52,
              56,
              58,
              55,
              58,
              55,
              54,
              58,
              55,
              50,
              40,
              28,
              32,
              48,
              55,
              60,
              61
            ]
          }
        ],
        "figure_id": "b5a291eb9b2763a6",
        "provenance": {
          "page": 16
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 17,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Feb-18",
              "May-18",
              "Aug-18",
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jun-19",
              "Sep-19",
              "Dec-19",
              "Feb-20",
              "May-20",
              "Aug-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Sep-21",
              "Dec-21",
              "Mar-22",
              "May-22",
              "Aug-22",
              "Nov-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Dec-23",
              "Mar-24",
              "Jun-24",
              "Feb-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Humalog franchise (LLY)",
            "unit": "%",
            "values": [
              99.5,
              98.5,
              96.5,
              94.5,
              92.0,
              91.0,
              91.5,
              94.0,
              94.5,
              95.0,
              95.5,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              96.0,
              93.0,
              93.0,
              93.0,
              93.0,
              93.0,
              93.0
            ]
          },
          {
            "name": "Admelog (SNY)",
            "unit": "%",
            "values": [
              0.5,
              1.0,
              2.0,
              4.0,
              6.0,
              8.0,
              9.0,
              6.0,
              5.5,
              5.0,
              4.5,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              7.0,
              7.0,
              7.0,
              7.0,
              7.0,
              7.0
            ]
          }
        ],
        "figure_id": "2a9eac1abe564d17",
        "provenance": {
          "page": 17
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 18,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Humira (ABBV+Covardis)",
            "unit": "%",
            "values": [
              83.5,
              82.5,
              82.5,
              82.0,
              82.5,
              82.0,
              82.0,
              91.0,
              89.0,
              88.0,
              87.5,
              87.0,
              87.0,
              86.0,
              85.0,
              81.0,
              80.0,
              81.0
            ]
          },
          {
            "name": "Amjevita (AMGN)",
            "unit": "%",
            "values": [
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              3.0,
              4.0,
              5.0,
              5.5,
              6.0,
              6.5,
              7.0,
              7.5,
              10.0,
              10.5,
              11.0
            ]
          },
          {
            "name": "Hadlima (OGN)",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              1.0,
              1.5,
              2.0,
              2.5,
              3.0,
              3.0,
              3.5,
              4.0,
              5.0,
              5.5,
              6.0
            ]
          },
          {
            "name": "Hyrimoz (SDZ+Covardis)",
            "unit": "%",
            "values": [
              13.0,
              14.0,
              13.0,
              13.0,
              13.0,
              13.0,
              13.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              1.0,
              2.0
            ]
          },
          {
            "name": "Others",
            "unit": "%",
            "values": [
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0,
              0.0
            ]
          }
        ],
        "figure_id": "3904eef3d8eede5d",
        "provenance": {
          "page": 18
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 18,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Aug-17",
              "Jan-18",
              "Jun-18",
              "Nov-18",
              "Apr-19",
              "Sep-19",
              "Feb-20",
              "Jul-20",
              "Dec-20",
              "May-21",
              "Oct-21",
              "Mar-22",
              "Aug-22",
              "Jan-23",
              "Jun-23",
              "Nov-23",
              "Apr-24",
              "Sep-24",
              "Feb-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Lantus franchise (SNY)",
            "unit": "%",
            "values": [
              99.5,
              99.5,
              99.5,
              99.5,
              99.5,
              99.5,
              98,
              99,
              98,
              95,
              93,
              92,
              91,
              90,
              89,
              88,
              78,
              79,
              76,
              82,
              77,
              80,
              82,
              85
            ]
          },
          {
            "name": "Semglee (Biocon)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              1,
              1,
              2,
              11,
              4,
              2,
              1,
              1,
              11,
              4,
              5,
              6,
              7,
              7,
              29,
              22,
              23,
              20,
              25,
              10
            ]
          },
          {
            "name": "Rezvoglar (LLY)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              1,
              1,
              1,
              1
            ]
          }
        ],
        "figure_id": "51024fb828e34fa4",
        "provenance": {
          "page": 18
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 19,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Aug-19",
              "Oct-19",
              "Dec-19",
              "Feb-20",
              "May-20",
              "Jul-20",
              "Sep-20",
              "Dec-20",
              "Feb-21",
              "Apr-21",
              "Jul-21",
              "Sep-21",
              "Nov-21",
              "Jan-22",
              "Apr-22",
              "Jun-22",
              "Aug-22",
              "Nov-22",
              "Jan-23",
              "Mar-23",
              "Jun-23",
              "Aug-23",
              "Oct-23",
              "Dec-23",
              "Mar-24",
              "May-24",
              "Jul-24",
              "Oct-24",
              "Dec-24",
              "Feb-25",
              "May-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Lucentis (Roche)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              99,
              95,
              85,
              72,
              60,
              55,
              48,
              35,
              32,
              35,
              33,
              38,
              35,
              45,
              55,
              70,
              85,
              95
            ]
          },
          {
            "name": "Byooviz (BIIB)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              1,
              3,
              5,
              10,
              15,
              25,
              35,
              40,
              45,
              50,
              55,
              48,
              40,
              30,
              15,
              5
            ]
          },
          {
            "name": "Cimerli (Sandoz)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          }
        ],
        "figure_id": "6afcc7832b59a563",
        "provenance": {
          "page": 19
        }
      },
      {
        "type": "line",
        "title": "IQVIA Monthly Sales share",
        "page": 19,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jun-18",
              "Nov-18",
              "Apr-19",
              "Sep-19",
              "Feb-20",
              "Jul-20",
              "Dec-20",
              "May-21",
              "Oct-21",
              "Mar-22",
              "Aug-22",
              "Jan-23",
              "Jun-23",
              "Nov-23",
              "Apr-24",
              "Sep-24",
              "Feb-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Neulasta (AMGN)",
            "unit": "%",
            "values": [
              100,
              95,
              88,
              80,
              76,
              75,
              73,
              68,
              65,
              65,
              63,
              62,
              60,
              68,
              45,
              40,
              45,
              30
            ]
          },
          {
            "name": "Fulphila (BIOCON)",
            "unit": "%",
            "values": [
              0,
              2,
              8,
              10,
              12,
              10,
              8,
              7,
              6,
              7,
              8,
              10,
              15,
              18,
              25,
              35,
              25,
              28
            ]
          },
          {
            "name": "Udenyca (Accord)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              5,
              15,
              18,
              20,
              18,
              16,
              15,
              12,
              10,
              12,
              18,
              30,
              20,
              35,
              30
            ]
          },
          {
            "name": "Stimufend (Fresenius Kabi)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Fylnetra (AMRX)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Ziextenzo (NVS)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Nyvepriya (PFE)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          }
        ],
        "figure_id": "dbbd67056bb6a86f",
        "provenance": {
          "page": 19
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 20,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Neulasta (AMGN)",
            "unit": "%",
            "values": [
              34,
              40,
              35,
              38,
              44,
              38,
              47,
              40,
              48,
              41,
              34,
              38,
              37,
              39,
              32,
              35,
              32,
              32
            ]
          },
          {
            "name": "Udenyca (Coherus)",
            "unit": "%",
            "values": [
              7,
              12,
              9,
              6,
              3,
              1,
              3,
              5,
              3,
              6,
              7,
              6,
              8,
              11,
              9,
              12,
              9,
              9
            ]
          },
          {
            "name": "Fulphila (VTRS)",
            "unit": "%",
            "values": [
              10,
              12,
              10,
              12,
              13,
              10,
              14,
              12,
              15,
              18,
              19,
              17,
              21,
              18,
              19,
              17,
              20,
              19
            ]
          },
          {
            "name": "Ziextenzo (SDZ)",
            "unit": "%",
            "values": [
              6,
              8,
              7,
              5,
              4,
              6,
              7,
              5,
              7,
              4,
              5,
              6,
              4,
              6,
              3,
              4,
              3,
              4
            ]
          },
          {
            "name": "Nyvepria (PFE)",
            "unit": "%",
            "values": [
              37,
              35,
              38,
              36,
              33,
              39,
              32,
              33,
              31,
              34,
              32,
              30,
              35,
              37,
              44,
              37,
              35,
              37
            ]
          }
        ],
        "figure_id": "7067b7e04f48d15d",
        "provenance": {
          "page": 20
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 20,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jul-15",
              "Oct-15",
              "Jan-16",
              "Apr-16",
              "Jul-16",
              "Oct-16",
              "Jan-17",
              "Apr-17",
              "Jul-17",
              "Oct-17",
              "Jan-18",
              "Apr-18",
              "Jul-18",
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Neupogen (AMGN)",
            "unit": "%",
            "values": [
              100,
              98,
              95,
              92,
              88,
              85,
              80,
              75,
              70,
              65,
              60,
              55,
              50,
              48,
              45,
              42,
              40,
              38,
              35,
              33,
              30,
              28,
              26,
              24,
              22,
              20,
              20,
              22,
              20,
              18,
              18,
              20,
              22,
              20,
              18,
              18,
              20,
              22,
              20,
              18,
              18
            ]
          },
          {
            "name": "Nivestym (PFE)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              2,
              5,
              8,
              10,
              12,
              14,
              16,
              18,
              20,
              22,
              24,
              26,
              28,
              30,
              32,
              34,
              36,
              38,
              40,
              42,
              40,
              38,
              36,
              34,
              32,
              30,
              28
            ]
          },
          {
            "name": "Releuko (AMRX)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              2,
              4,
              6,
              8,
              10,
              12,
              14,
              16,
              18,
              20,
              22,
              24,
              26
            ]
          },
          {
            "name": "Zarxio (NVS)",
            "unit": "%",
            "values": [
              0,
              2,
              5,
              8,
              12,
              15,
              20,
              25,
              30,
              35,
              40,
              45,
              50,
              52,
              55,
              58,
              60,
              62,
              65,
              67,
              70,
              72,
              74,
              76,
              78,
              80,
              80,
              78,
              80,
              82,
              82,
              80,
              78,
              76,
              78,
              80,
              82,
              84,
              82,
              80,
              78
            ]
          }
        ],
        "figure_id": "e86bb542475bd58f",
        "provenance": {
          "page": 20
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 20,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Zarxio (SDZ)",
            "unit": "%",
            "values": [
              23,
              21,
              22,
              20,
              23,
              24,
              20,
              28,
              20,
              23,
              18,
              23,
              16,
              20,
              19,
              23,
              19,
              21
            ]
          },
          {
            "name": "Neupogen (AMGN)",
            "unit": "%",
            "values": [
              32,
              34,
              33,
              36,
              34,
              30,
              37,
              30,
              37,
              35,
              36,
              38,
              36,
              37,
              40,
              35,
              41,
              41
            ]
          },
          {
            "name": "Nivestym (PFE)",
            "unit": "%",
            "values": [
              44,
              40,
              43,
              41,
              42,
              49,
              42,
              35,
              47,
              42,
              40,
              45,
              39,
              38,
              44,
              37,
              39,
              39
            ]
          }
        ],
        "figure_id": "8f788c22a3654e15",
        "provenance": {
          "page": 20
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 21,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Jubbonti (SDZ)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Prolia (AMGN)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100
            ]
          }
        ],
        "figure_id": "b0ec010dbdc1e23e",
        "provenance": {
          "page": 21
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 21,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Oct-16",
              "Jan-17",
              "Apr-17",
              "Jul-17",
              "Oct-17",
              "Jan-18",
              "Apr-18",
              "Jul-18",
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Remicade (JNJ)",
            "unit": "%",
            "values": [
              99.5,
              99.0,
              98.5,
              98.0,
              97.5,
              97.0,
              96.5,
              96.0,
              95.0,
              94.0,
              93.0,
              91.5,
              90.0,
              88.0,
              85.0,
              82.0,
              78.0,
              74.0,
              70.0,
              68.0,
              66.0,
              62.0,
              58.0,
              55.0,
              52.0,
              51.0,
              51.5,
              52.0,
              51.0,
              51.5,
              52.0,
              53.0,
              54.0,
              56.0,
              42.0,
              58.0
            ]
          },
          {
            "name": "Inflectra (PFE)",
            "unit": "%",
            "values": [
              0.5,
              1.0,
              1.5,
              2.0,
              2.5,
              3.0,
              3.5,
              4.0,
              5.0,
              6.0,
              7.0,
              8.5,
              10.0,
              12.0,
              15.0,
              18.0,
              22.0,
              26.0,
              30.0,
              32.0,
              34.0,
              38.0,
              32.0,
              30.0,
              28.0,
              27.0,
              27.5,
              28.0,
              27.0,
              27.5,
              28.0,
              29.0,
              27.0,
              28.0,
              40.0,
              30.0
            ]
          },
          {
            "name": "Renflexis (OGN)",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          {
            "name": "Avsola (AMGN)",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        ],
        "figure_id": "63c2b7bb61de5f12",
        "provenance": {
          "page": 21
        }
      },
      {
        "type": "line",
        "title": "IQVIA Monthly Sales share",
        "page": 22,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Rituxan (ROG)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              100,
              85,
              92,
              85,
              78,
              70,
              65,
              60,
              55,
              50,
              48,
              50,
              48,
              47,
              46,
              45,
              44,
              43,
              42,
              41,
              40,
              40,
              39,
              39
            ]
          },
          {
            "name": "Truxima (TEVA)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              15,
              5,
              10,
              15,
              18,
              20,
              22,
              25,
              40,
              20,
              22,
              23,
              24,
              25,
              26,
              25,
              26,
              27,
              27,
              27,
              27,
              27,
              27
            ]
          },
          {
            "name": "Ruxience (PFE)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              5,
              10,
              15,
              20,
              25,
              28,
              27,
              28,
              28,
              27,
              26,
              25,
              24,
              25,
              26,
              27,
              27,
              27,
              27
            ]
          },
          {
            "name": "Riabni (AMGN)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          }
        ],
        "figure_id": "b08bb8104e29a540",
        "provenance": {
          "page": 22
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 22,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "9/6/24",
              "9/20/24",
              "10/4/24",
              "10/18/24",
              "11/1/24",
              "11/15/24",
              "11/29/24",
              "12/13/24",
              "12/27/24",
              "1/10/25",
              "1/24/25",
              "2/7/25",
              "2/21/25",
              "3/7/25",
              "3/21/25",
              "4/4/25",
              "4/18/25",
              "5/2/25",
              "5/16/25",
              "5/30/25",
              "6/13/25",
              "6/27/25",
              "7/11/25",
              "7/25/25",
              "8/8/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Stelara (JNJ)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              99.9,
              99.8,
              99.5,
              99,
              98.5,
              97.5,
              96,
              94,
              92.5,
              91.5,
              91,
              91,
              91
            ]
          },
          {
            "name": "Otulfi (Fresenius)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.5,
              0.7,
              1,
              1.5,
              2,
              2.5,
              3,
              3.5,
              4,
              4
            ]
          },
          {
            "name": "Steqeyma (Celltrion)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.5,
              0.7,
              1,
              1.2,
              1.5,
              1.8,
              2,
              2
            ]
          },
          {
            "name": "Pyzchiva (Cordavis)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.5,
              0.7,
              1,
              1.2,
              1.5,
              1.8,
              2,
              2
            ]
          },
          {
            "name": "Wezlana (AMGN)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.5,
              0.7,
              1,
              1.2,
              1.5,
              1.8,
              2,
              2
            ]
          },
          {
            "name": "Selarsdi (Teva)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.5,
              0.7,
              1,
              1.2,
              1.5,
              1.8,
              2,
              2
            ]
          },
          {
            "name": "Yesintek (Biocon)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.1,
              0.2,
              0.3,
              0.5,
              0.7,
              1,
              1.2,
              1.5,
              1.8,
              2,
              2
            ]
          }
        ],
        "figure_id": "d491c6f455ead8eb",
        "provenance": {
          "page": 22
        }
      },
      {
        "type": "area",
        "title": null,
        "page": 23,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jun-22",
              "Jul-22",
              "Aug-22",
              "Sep-22",
              "Oct-22",
              "Nov-22",
              "Dec-22",
              "Jan-23",
              "Feb-23",
              "Mar-23",
              "Apr-23",
              "May-23",
              "Jun-23",
              "Jul-23",
              "Aug-23",
              "Sep-23",
              "Oct-23",
              "Nov-23",
              "Dec-23",
              "Jan-24",
              "Feb-24",
              "Mar-24",
              "Apr-24",
              "May-24",
              "Jun-24",
              "Jul-24",
              "Aug-24",
              "Sep-24",
              "Oct-24",
              "Nov-24",
              "Dec-24",
              "Jan-25",
              "Feb-25",
              "Mar-25",
              "Apr-25",
              "May-25",
              "Jun-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Stelara (JNJ)",
            "unit": "%",
            "values": [
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              100,
              99.5,
              98.5,
              97,
              95,
              92,
              88
            ]
          },
          {
            "name": "Wezlana (Amgen/Nuvaila)",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.5,
              1.5,
              3,
              5,
              8,
              12
            ]
          }
        ],
        "figure_id": "72360659409c2f6b",
        "provenance": {
          "page": 23
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx Market Share",
        "page": 24,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 80
            }
          }
        },
        "series": [
          {
            "name": "Coumadin/warfarin",
            "unit": "%",
            "values": [
              15.0,
              15.0,
              15.0,
              15.0,
              15.0,
              14.5,
              14.5,
              14.5,
              14.5,
              14.5,
              14.5,
              14.5,
              14.5,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0
            ]
          },
          {
            "name": "Pradaxa",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          },
          {
            "name": "Xarelto",
            "unit": "%",
            "values": [
              18.0,
              18.0,
              18.0,
              18.0,
              18.0,
              17.5,
              17.5,
              17.5,
              17.5,
              17.5,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0
            ]
          },
          {
            "name": "Eliquis",
            "unit": "%",
            "values": [
              66.0,
              66.5,
              66.5,
              67.0,
              67.0,
              67.0,
              67.0,
              67.5,
              67.5,
              68.0,
              68.0,
              68.0,
              68.5,
              68.5,
              69.0,
              69.0,
              69.5,
              70.0
            ]
          },
          {
            "name": "Savaysa",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        ],
        "figure_id": "d0c7aef1ccc80735",
        "provenance": {
          "page": 24
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 24,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -70,
              "max": 30
            }
          }
        },
        "series": [
          {
            "name": "Total Anti-Coagulants (ex Warfarin)",
            "unit": "%",
            "values": [
              8,
              7,
              8,
              7,
              6,
              10,
              8,
              7,
              8,
              7,
              7,
              7,
              8,
              8,
              8,
              8,
              7,
              4
            ]
          },
          {
            "name": "Pradaxa",
            "unit": "%",
            "values": [
              -30,
              -39,
              -35,
              -38,
              -37,
              -50,
              -45,
              -48,
              -59,
              -55,
              -53,
              -56,
              -52,
              -55,
              -60,
              -53,
              -65,
              -60
            ]
          },
          {
            "name": "Xarelto",
            "unit": "%",
            "values": [
              -5,
              -3,
              -4,
              -3,
              -2,
              -19,
              -9,
              -9,
              -10,
              -6,
              -7,
              -6,
              -5,
              -5,
              -6,
              -5,
              -6,
              -7
            ]
          },
          {
            "name": "Eliquis",
            "unit": "%",
            "values": [
              10,
              8,
              9,
              8,
              8,
              22,
              12,
              10,
              10,
              9,
              9,
              9,
              10,
              9,
              9,
              9,
              9,
              8
            ]
          }
        ],
        "figure_id": "e13b300bc001358a",
        "provenance": {
          "page": 24
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 25,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 800000
            }
          }
        },
        "series": [
          {
            "name": "Pradaxa (BI)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 20000
              },
              {
                "x": 100,
                "y": 50000
              },
              {
                "x": 150,
                "y": 50000
              },
              {
                "x": 200,
                "y": 40000
              },
              {
                "x": 250,
                "y": 30000
              },
              {
                "x": 300,
                "y": 20000
              },
              {
                "x": 350,
                "y": 15000
              },
              {
                "x": 400,
                "y": 10000
              },
              {
                "x": 450,
                "y": 5000
              },
              {
                "x": 500,
                "y": 2000
              },
              {
                "x": 550,
                "y": 1000
              },
              {
                "x": 600,
                "y": 0
              },
              {
                "x": 650,
                "y": 0
              },
              {
                "x": 700,
                "y": 0
              }
            ]
          },
          {
            "name": "Xarelto (JNJ)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 10000
              },
              {
                "x": 100,
                "y": 40000
              },
              {
                "x": 150,
                "y": 80000
              },
              {
                "x": 200,
                "y": 140000
              },
              {
                "x": 250,
                "y": 160000
              },
              {
                "x": 300,
                "y": 180000
              },
              {
                "x": 350,
                "y": 200000
              },
              {
                "x": 400,
                "y": 200000
              },
              {
                "x": 450,
                "y": 200000
              },
              {
                "x": 500,
                "y": 200000
              },
              {
                "x": 550,
                "y": 200000
              },
              {
                "x": 600,
                "y": 190000
              },
              {
                "x": 650,
                "y": 180000
              },
              {
                "x": 700,
                "y": 170000
              }
            ]
          },
          {
            "name": "Eliquis (BMY/PFE)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 10000
              },
              {
                "x": 150,
                "y": 30000
              },
              {
                "x": 200,
                "y": 80000
              },
              {
                "x": 250,
                "y": 150000
              },
              {
                "x": 300,
                "y": 250000
              },
              {
                "x": 350,
                "y": 350000
              },
              {
                "x": 400,
                "y": 450000
              },
              {
                "x": 450,
                "y": 500000
              },
              {
                "x": 500,
                "y": 550000
              },
              {
                "x": 550,
                "y": 600000
              },
              {
                "x": 600,
                "y": 650000
              },
              {
                "x": 650,
                "y": 680000
              },
              {
                "x": 700,
                "y": 700000
              }
            ]
          },
          {
            "name": "Savaysa (Daiichi)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 0
              },
              {
                "x": 100,
                "y": 0
              },
              {
                "x": 150,
                "y": 0
              },
              {
                "x": 200,
                "y": 0
              },
              {
                "x": 250,
                "y": 0
              },
              {
                "x": 300,
                "y": 0
              },
              {
                "x": 350,
                "y": 0
              },
              {
                "x": 400,
                "y": 0
              },
              {
                "x": 450,
                "y": 0
              },
              {
                "x": 500,
                "y": 0
              },
              {
                "x": 550,
                "y": 0
              },
              {
                "x": 600,
                "y": 0
              },
              {
                "x": 650,
                "y": 0
              },
              {
                "x": 700,
                "y": 0
              }
            ]
          }
        ],
        "figure_id": "4858bf97d6ae20ba",
        "provenance": {
          "page": 25
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 25,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 120000
            }
          }
        },
        "series": [
          {
            "name": "Vascepa (Bx+Gx)",
            "unit": "TRx",
            "values": [
              62000,
              66000,
              65000,
              64000,
              65000,
              57000,
              70000,
              56000,
              65000,
              61000,
              65000,
              68000,
              64000,
              63000,
              65000,
              62000,
              66000,
              58000,
              66000,
              64000,
              63000
            ]
          },
          {
            "name": "Praluent",
            "unit": "TRx",
            "values": [
              9000,
              9500,
              9800,
              9800,
              9800,
              9500,
              10000,
              9000,
              9500,
              9000,
              9500,
              9800,
              9500,
              9500,
              9800,
              9500,
              9800,
              9500,
              9800,
              9800,
              9800
            ]
          },
          {
            "name": "Repatha",
            "unit": "TRx",
            "values": [
              78000,
              85000,
              82000,
              85000,
              85000,
              80000,
              95000,
              72000,
              90000,
              80000,
              90000,
              85000,
              95000,
              90000,
              98000,
              95000,
              100000,
              95000,
              105000,
              98000,
              108000,
              98000,
              105000,
              108000,
              105000,
              102000
            ]
          },
          {
            "name": "Nexletol",
            "unit": "TRx",
            "values": [
              5000,
              5500,
              5800,
              5800,
              5800,
              5500,
              6000,
              5000,
              5500,
              5000,
              5500,
              5800,
              5500,
              5500,
              5800,
              5500,
              5800,
              5500,
              5800,
              5800,
              5800
            ]
          }
        ],
        "figure_id": "b9aac842dc4c4d22",
        "provenance": {
          "page": 25
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 26,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 90
            }
          }
        },
        "series": [
          {
            "name": "Praluent (Sanofi)",
            "unit": "%",
            "values": [
              9.0,
              9.0,
              9.0,
              9.0,
              9.0,
              8.5,
              8.0,
              8.0,
              8.0,
              8.0,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              8.0
            ]
          },
          {
            "name": "Repatha (Amgen)",
            "unit": "%",
            "values": [
              82.0,
              82.0,
              82.0,
              82.0,
              82.0,
              82.5,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0,
              83.0
            ]
          },
          {
            "name": "Nexletol (Esperion)",
            "unit": "%",
            "values": [
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0
            ]
          }
        ],
        "figure_id": "c07af4cd513b98be",
        "provenance": {
          "page": 26
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 26,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -60,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Vascepa (Amarin)",
            "unit": "%",
            "values": [
              -12,
              -10,
              -15,
              -18,
              -15,
              -10,
              -20,
              -15,
              -25,
              -20,
              -25,
              -22,
              -25,
              -25,
              -25,
              -25,
              -2,
              -1,
              -1,
              -5
            ]
          },
          {
            "name": "Praluent (Sanofi)",
            "unit": "%",
            "values": [
              -30,
              -28,
              -25,
              -28,
              -25,
              -30,
              -45,
              -20,
              -35,
              -20,
              -25,
              -20,
              -15,
              -10,
              -5,
              -2,
              -5,
              -2,
              -1,
              -1
            ]
          },
          {
            "name": "Repatha (Amgen)",
            "unit": "%",
            "values": [
              45,
              42,
              45,
              48,
              45,
              42,
              15,
              55,
              40,
              45,
              25,
              40,
              35,
              45,
              40,
              35,
              38,
              35,
              32,
              30,
              29
            ]
          },
          {
            "name": "Nexletol (Esperion)",
            "unit": "%",
            "values": [
              48,
              45,
              45,
              45,
              48,
              50,
              80,
              40,
              55,
              40,
              55,
              40,
              50,
              45,
              40,
              42,
              38,
              35,
              35,
              32,
              30
            ]
          }
        ],
        "figure_id": "26f503bc347fd1cd",
        "provenance": {
          "page": 26
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 27,
        "axes": {
          "x": {
            "type": "numeric",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 2500
            }
          }
        },
        "series": [
          {
            "name": "Vyndaqel Franchise (Pfizer)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 5,
                "y": 350
              },
              {
                "x": 10,
                "y": 100
              },
              {
                "x": 15,
                "y": 150
              },
              {
                "x": 20,
                "y": 200
              },
              {
                "x": 25,
                "y": 150
              },
              {
                "x": 30,
                "y": 250
              },
              {
                "x": 35,
                "y": 200
              },
              {
                "x": 40,
                "y": 300
              },
              {
                "x": 45,
                "y": 350
              },
              {
                "x": 50,
                "y": 300
              },
              {
                "x": 55,
                "y": 350
              },
              {
                "x": 60,
                "y": 400
              },
              {
                "x": 65,
                "y": 350
              },
              {
                "x": 70,
                "y": 400
              },
              {
                "x": 75,
                "y": 450
              },
              {
                "x": 80,
                "y": 400
              },
              {
                "x": 85,
                "y": 450
              },
              {
                "x": 90,
                "y": 500
              },
              {
                "x": 95,
                "y": 450
              },
              {
                "x": 100,
                "y": 500
              },
              {
                "x": 105,
                "y": 550
              },
              {
                "x": 110,
                "y": 500
              },
              {
                "x": 115,
                "y": 600
              },
              {
                "x": 120,
                "y": 550
              },
              {
                "x": 125,
                "y": 650
              },
              {
                "x": 130,
                "y": 600
              },
              {
                "x": 135,
                "y": 700
              },
              {
                "x": 140,
                "y": 650
              },
              {
                "x": 145,
                "y": 750
              },
              {
                "x": 150,
                "y": 700
              },
              {
                "x": 155,
                "y": 800
              },
              {
                "x": 160,
                "y": 750
              },
              {
                "x": 165,
                "y": 850
              },
              {
                "x": 170,
                "y": 800
              },
              {
                "x": 175,
                "y": 900
              },
              {
                "x": 180,
                "y": 850
              },
              {
                "x": 185,
                "y": 950
              },
              {
                "x": 190,
                "y": 900
              },
              {
                "x": 195,
                "y": 1000
              },
              {
                "x": 200,
                "y": 950
              },
              {
                "x": 205,
                "y": 1050
              },
              {
                "x": 210,
                "y": 1000
              },
              {
                "x": 215,
                "y": 1100
              },
              {
                "x": 220,
                "y": 1050
              },
              {
                "x": 225,
                "y": 1200
              },
              {
                "x": 230,
                "y": 1150
              },
              {
                "x": 235,
                "y": 1300
              },
              {
                "x": 240,
                "y": 1250
              },
              {
                "x": 245,
                "y": 1400
              },
              {
                "x": 250,
                "y": 1500
              },
              {
                "x": 255,
                "y": 1600
              },
              {
                "x": 260,
                "y": 1700
              },
              {
                "x": 265,
                "y": 1800
              },
              {
                "x": 270,
                "y": 1900
              },
              {
                "x": 275,
                "y": 2000
              },
              {
                "x": 280,
                "y": 2100
              },
              {
                "x": 285,
                "y": 2000
              },
              {
                "x": 290,
                "y": 2100
              }
            ]
          }
        ],
        "figure_id": "11c03e77a8cfc4f4",
        "provenance": {
          "page": 27
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 27,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 3000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": 0,
                "max": 160
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              2100,
              1900,
              2000,
              1950,
              2100,
              1800,
              2150,
              2000,
              2400,
              2300,
              2450,
              2350,
              2400,
              2500,
              2600,
              2300,
              2600,
              2700
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              100,
              90,
              95,
              85,
              120,
              80,
              90,
              70,
              50,
              80,
              60,
              50,
              45,
              55,
              40,
              20,
              30,
              40
            ]
          }
        ],
        "figure_id": "2be67d345781d14d",
        "provenance": {
          "page": 27
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 27,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 160000
            }
          }
        },
        "series": [
          {
            "name": "Entresto (Novartis)",
            "unit": "TRx",
            "values": [
              [
                0,
                0
              ],
              [
                10,
                1000
              ],
              [
                20,
                2000
              ],
              [
                30,
                3000
              ],
              [
                40,
                4500
              ],
              [
                50,
                6000
              ],
              [
                60,
                7500
              ],
              [
                70,
                9000
              ],
              [
                80,
                11000
              ],
              [
                90,
                13000
              ],
              [
                100,
                15000
              ],
              [
                110,
                17500
              ],
              [
                120,
                20000
              ],
              [
                130,
                22500
              ],
              [
                140,
                25000
              ],
              [
                150,
                27000
              ],
              [
                160,
                29000
              ],
              [
                170,
                31000
              ],
              [
                180,
                33000
              ],
              [
                190,
                35000
              ],
              [
                200,
                37000
              ],
              [
                210,
                39000
              ],
              [
                220,
                41000
              ],
              [
                230,
                43000
              ],
              [
                240,
                45000
              ],
              [
                250,
                47000
              ],
              [
                260,
                49000
              ],
              [
                270,
                51000
              ],
              [
                280,
                53000
              ],
              [
                290,
                55000
              ],
              [
                300,
                57000
              ],
              [
                310,
                59000
              ],
              [
                320,
                61000
              ],
              [
                330,
                63000
              ],
              [
                340,
                65000
              ],
              [
                350,
                67000
              ],
              [
                360,
                69000
              ],
              [
                370,
                71000
              ],
              [
                380,
                73000
              ],
              [
                390,
                75000
              ],
              [
                400,
                77000
              ],
              [
                410,
                79000
              ],
              [
                420,
                81000
              ],
              [
                430,
                83000
              ],
              [
                440,
                85000
              ],
              [
                450,
                87000
              ],
              [
                460,
                89000
              ],
              [
                470,
                91000
              ],
              [
                480,
                93000
              ],
              [
                490,
                95000
              ],
              [
                500,
                97000
              ],
              [
                510,
                99000
              ],
              [
                520,
                101000
              ],
              [
                530,
                103000
              ],
              [
                540,
                105000
              ],
              [
                550,
                107000
              ],
              [
                560,
                109000
              ],
              [
                570,
                111000
              ],
              [
                580,
                113000
              ],
              [
                590,
                115000
              ],
              [
                600,
                117000
              ]
            ]
          }
        ],
        "figure_id": "3e2e2068942b5510",
        "provenance": {
          "page": 27
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 28,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 35
            }
          }
        },
        "series": [
          {
            "name": "Total Metformin TRx",
            "unit": "%",
            "values": [
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.5,
              29.0,
              28.5,
              28.5,
              28.0,
              28.0
            ]
          },
          {
            "name": "Total GLP-1",
            "unit": "%",
            "values": [
              24.5,
              24.5,
              24.5,
              24.5,
              24.5,
              25.0,
              25.0,
              25.0,
              25.5,
              26.0,
              26.0,
              26.5,
              26.5,
              27.0,
              27.0,
              27.0,
              27.0,
              27.0
            ]
          },
          {
            "name": "Total Insulin TRx",
            "unit": "%",
            "values": [
              17.5,
              17.5,
              17.5,
              17.5,
              17.5,
              17.5,
              17.5,
              17.5,
              17.5,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0,
              17.0
            ]
          },
          {
            "name": "Total SGLT-2 TRx",
            "unit": "%",
            "values": [
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0,
              14.0
            ]
          },
          {
            "name": "Total Sulfonylureas TRx",
            "unit": "%",
            "values": [
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.0,
              8.0,
              8.0,
              8.0,
              8.0
            ]
          },
          {
            "name": "Total DPP-4 TRx",
            "unit": "%",
            "values": [
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              4.0,
              3.5,
              3.5,
              3.5,
              3.5,
              3.0,
              3.0,
              3.0,
              3.0,
              3.0
            ]
          },
          {
            "name": "Total Glitazones TRx",
            "unit": "%",
            "values": [
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.0,
              2.0,
              2.0,
              2.0,
              2.0
            ]
          }
        ],
        "figure_id": "599f9b7e5f4d34da",
        "provenance": {
          "page": 28
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 28,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 70
            }
          }
        },
        "series": [
          {
            "name": "DPP-4",
            "unit": "%",
            "values": [
              9.5,
              9.5,
              9.3,
              9.2,
              9.0,
              8.9,
              8.8,
              8.5,
              8.3,
              8.0,
              7.9,
              7.8,
              7.7,
              7.6,
              7.5,
              7.4,
              7.3,
              7.0
            ]
          },
          {
            "name": "SGLT-2",
            "unit": "%",
            "values": [
              30.0,
              30.2,
              30.5,
              30.6,
              30.7,
              30.8,
              30.9,
              31.0,
              30.8,
              30.9,
              31.0,
              30.9,
              30.8,
              30.7,
              30.5,
              29.8,
              30.0,
              30.0
            ]
          },
          {
            "name": "GLP-1",
            "unit": "%",
            "values": [
              61.0,
              61.2,
              61.0,
              60.8,
              60.5,
              60.2,
              59.8,
              60.0,
              60.5,
              60.8,
              61.0,
              61.2,
              61.5,
              61.8,
              62.0,
              62.5,
              62.2,
              62.0
            ]
          }
        ],
        "figure_id": "ce321e1806ee8b11",
        "provenance": {
          "page": 28
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 29,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 90
            }
          }
        },
        "series": [
          {
            "name": "DPP-4",
            "unit": "%",
            "values": [
              22.5,
              22.0,
              21.8,
              21.5,
              21.2,
              20.8,
              20.5,
              20.3,
              20.0,
              19.8,
              19.7,
              19.5,
              19.3,
              19.2,
              19.1,
              19.0,
              19.0,
              19.0
            ]
          },
          {
            "name": "SGLT-2",
            "unit": "%",
            "values": [
              77.5,
              78.0,
              78.2,
              78.5,
              78.8,
              79.2,
              79.5,
              79.7,
              80.0,
              80.2,
              80.3,
              80.5,
              80.7,
              80.8,
              80.9,
              81.0,
              81.0,
              81.0
            ]
          }
        ],
        "figure_id": "5365360a6591d835",
        "provenance": {
          "page": 29
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 29,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Januvia Franchise",
            "unit": "%",
            "values": [
              50,
              50.5,
              50.8,
              51,
              51.2,
              51.5,
              52,
              52.5,
              52.8,
              53,
              53,
              53,
              53,
              53,
              53,
              53,
              53,
              53
            ]
          },
          {
            "name": "Farxiga Franchise",
            "unit": "%",
            "values": [
              23,
              23.5,
              23.8,
              24,
              24,
              24,
              22,
              22,
              22.5,
              23,
              23.5,
              23.8,
              24,
              24,
              24,
              24,
              24,
              24
            ]
          },
          {
            "name": "Jardiance Franchise",
            "unit": "%",
            "values": [
              18,
              17.8,
              17.5,
              17,
              16.8,
              16.5,
              16,
              15.8,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15
            ]
          },
          {
            "name": "Onglyza Franchise",
            "unit": "%",
            "values": [
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4
            ]
          },
          {
            "name": "Invokana",
            "unit": "%",
            "values": [
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3
            ]
          },
          {
            "name": "Tradjenta Franchise",
            "unit": "%",
            "values": [
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2
            ]
          },
          {
            "name": "Farxiga Franchise generic",
            "unit": "%",
            "values": [
              1,
              1,
              1,
              1,
              1,
              1,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4
            ]
          },
          {
            "name": "Nesina Franchise",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          }
        ],
        "figure_id": "04872b20c5e9d597",
        "provenance": {
          "page": 29
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 30,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 90
            }
          }
        },
        "series": [
          {
            "name": "Januvia Franchise",
            "unit": "%",
            "values": [
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.0,
              79.0,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5,
              79.5
            ]
          },
          {
            "name": "Onglyza Franchise",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          },
          {
            "name": "Tradjenta Franchise",
            "unit": "%",
            "values": [
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.5,
              20.5,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0
            ]
          },
          {
            "name": "Nesina Franchise",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        ],
        "figure_id": "da688d44fd0a879d",
        "provenance": {
          "page": 30
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 30,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -100,
              "max": 20
            }
          }
        },
        "series": [
          {
            "name": "Total DPP-4",
            "unit": "%",
            "values": [
              -10,
              -8,
              -7,
              -6,
              -5,
              -2,
              -10,
              -15,
              -10,
              -12,
              -10,
              -10,
              -10,
              -10,
              -10,
              -10,
              -10,
              -14
            ]
          },
          {
            "name": "Januvia franchise",
            "unit": "%",
            "values": [
              -12,
              -10,
              -9,
              -8,
              -7,
              -1,
              -12,
              -18,
              -12,
              -14,
              -12,
              -12,
              -12,
              -12,
              -12,
              -12,
              -12,
              -14
            ]
          },
          {
            "name": "Onglyza franchise",
            "unit": "%",
            "values": [
              -90,
              -90,
              -90,
              -90,
              -90,
              -95,
              -85,
              -85,
              -85,
              -85,
              -85,
              -85,
              -85,
              -85,
              -85,
              -85,
              -85,
              -93
            ]
          },
          {
            "name": "Tradjenta Franchise",
            "unit": "%",
            "values": [
              -15,
              -13,
              -12,
              -11,
              -10,
              -5,
              -15,
              -20,
              -15,
              -17,
              -15,
              -15,
              -15,
              -15,
              -15,
              -15,
              -15,
              -14
            ]
          }
        ],
        "figure_id": "a48ac3b1ac711556",
        "provenance": {
          "page": 30
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx market share",
        "page": 31,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 70
            }
          }
        },
        "series": [
          {
            "name": "Invokana",
            "unit": "%",
            "values": [
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01
            ]
          },
          {
            "name": "Farxiga Franchise",
            "unit": "%",
            "values": [
              0.3,
              0.3,
              0.3,
              0.3,
              0.3,
              0.3,
              0.29,
              0.28,
              0.28,
              0.29,
              0.29,
              0.29,
              0.29,
              0.29,
              0.29,
              0.29,
              0.29,
              0.3
            ]
          },
          {
            "name": "Farxiga Franchise generic",
            "unit": "%",
            "values": [
              0.03,
              0.03,
              0.03,
              0.03,
              0.03,
              0.03,
              0.04,
              0.05,
              0.05,
              0.04,
              0.04,
              0.04,
              0.04,
              0.04,
              0.04,
              0.04,
              0.04,
              0.04
            ]
          },
          {
            "name": "Jardiance Franchise",
            "unit": "%",
            "values": [
              0.64,
              0.64,
              0.65,
              0.65,
              0.65,
              0.65,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.66,
              0.65
            ]
          },
          {
            "name": "Steglatro Franchise",
            "unit": "%",
            "values": [
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01,
              0.01
            ]
          }
        ],
        "figure_id": "3d30c9514ea07730",
        "provenance": {
          "page": 31
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 31,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -60,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Total SGLT-2",
            "unit": "%",
            "values": [
              20,
              23,
              20,
              19,
              19,
              26,
              18,
              20,
              15,
              18,
              15,
              14,
              13,
              12,
              12,
              11,
              11,
              11
            ]
          },
          {
            "name": "Invokana Franchise",
            "unit": "%",
            "values": [
              -30,
              -32,
              -33,
              -33,
              -30,
              -48,
              -38,
              -35,
              -45,
              -40,
              -45,
              -48,
              -48,
              -48,
              -48,
              -48,
              -40,
              -43
            ]
          },
          {
            "name": "Farxiga Franchise",
            "unit": "%",
            "values": [
              7,
              7,
              6,
              5,
              3,
              -10,
              -2,
              -5,
              10,
              15,
              10,
              8,
              7,
              6,
              5,
              6,
              8,
              9
            ]
          },
          {
            "name": "Jardiance Franchise",
            "unit": "%",
            "values": [
              25,
              25,
              23,
              22,
              20,
              42,
              25,
              28,
              20,
              22,
              18,
              17,
              16,
              15,
              14,
              13,
              12,
              10
            ]
          }
        ],
        "figure_id": "554a694fd71014c2",
        "provenance": {
          "page": 31
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 32,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 500000
            }
          }
        },
        "series": [
          {
            "name": "Invokana Franchise (JNJ)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 30000
              },
              {
                "x": 100,
                "y": 80000
              },
              {
                "x": 150,
                "y": 100000
              },
              {
                "x": 200,
                "y": 90000
              },
              {
                "x": 250,
                "y": 70000
              },
              {
                "x": 300,
                "y": 50000
              },
              {
                "x": 350,
                "y": 35000
              },
              {
                "x": 400,
                "y": 25000
              },
              {
                "x": 450,
                "y": 15000
              },
              {
                "x": 500,
                "y": 10000
              }
            ]
          },
          {
            "name": "Farxiga Franchise (AZN)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 10000
              },
              {
                "x": 100,
                "y": 30000
              },
              {
                "x": 150,
                "y": 45000
              },
              {
                "x": 200,
                "y": 60000
              },
              {
                "x": 250,
                "y": 70000
              },
              {
                "x": 300,
                "y": 80000
              },
              {
                "x": 350,
                "y": 100000
              },
              {
                "x": 400,
                "y": 130000
              },
              {
                "x": 450,
                "y": 160000
              },
              {
                "x": 500,
                "y": 200000
              },
              {
                "x": 520,
                "y": 210000
              }
            ]
          },
          {
            "name": "Jardiance Franchise (B.I/LLY)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 15000
              },
              {
                "x": 150,
                "y": 30000
              },
              {
                "x": 200,
                "y": 50000
              },
              {
                "x": 250,
                "y": 80000
              },
              {
                "x": 300,
                "y": 150000
              },
              {
                "x": 350,
                "y": 220000
              },
              {
                "x": 400,
                "y": 300000
              },
              {
                "x": 450,
                "y": 380000
              },
              {
                "x": 500,
                "y": 450000
              },
              {
                "x": 520,
                "y": 460000
              }
            ]
          },
          {
            "name": "Steglatro Franchise TRx",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 10000
              },
              {
                "x": 150,
                "y": 15000
              },
              {
                "x": 200,
                "y": 18000
              },
              {
                "x": 250,
                "y": 15000
              },
              {
                "x": 300,
                "y": 10000
              },
              {
                "x": 350,
                "y": 5000
              },
              {
                "x": 400,
                "y": 2000
              }
            ]
          }
        ],
        "figure_id": "b9cc8331531a1a77",
        "provenance": {
          "page": 32
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 32,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 700000
            }
          }
        },
        "series": [
          {
            "name": "Byetta (AZN)",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Trulicity (LLY)",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Victoza (NOVO)",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Mounjaro (LLY)",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Total Bydureon TRx",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Ozempic (NOVO)",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Tanzeum (GSK)",
            "unit": "TRx",
            "values": []
          },
          {
            "name": "Rybelsus (Novo)",
            "unit": "TRx",
            "values": []
          }
        ],
        "figure_id": "c21244746c1b97ab",
        "provenance": {
          "page": 32
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 33,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 350000
            }
          }
        },
        "series": [
          {
            "name": "Invokana Franchise (JNJ)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 30000
              },
              {
                "x": 100,
                "y": 80000
              },
              {
                "x": 125,
                "y": 100000
              },
              {
                "x": 150,
                "y": 95000
              },
              {
                "x": 200,
                "y": 90000
              },
              {
                "x": 250,
                "y": 70000
              },
              {
                "x": 300,
                "y": 45000
              },
              {
                "x": 350,
                "y": 40000
              },
              {
                "x": 400,
                "y": 30000
              },
              {
                "x": 440,
                "y": 25000
              }
            ]
          },
          {
            "name": "Jardiance Franchise (BULLY)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 10000
              },
              {
                "x": 100,
                "y": 25000
              },
              {
                "x": 150,
                "y": 45000
              },
              {
                "x": 200,
                "y": 90000
              },
              {
                "x": 250,
                "y": 120000
              },
              {
                "x": 300,
                "y": 160000
              },
              {
                "x": 350,
                "y": 200000
              },
              {
                "x": 400,
                "y": 250000
              },
              {
                "x": 440,
                "y": 310000
              }
            ]
          },
          {
            "name": "Rybelsus (Novo)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 20000
              },
              {
                "x": 150,
                "y": 35000
              },
              {
                "x": 200,
                "y": 50000
              },
              {
                "x": 250,
                "y": 60000
              },
              {
                "x": 300,
                "y": 50000
              },
              {
                "x": 350,
                "y": 40000
              },
              {
                "x": 400,
                "y": 35000
              },
              {
                "x": 440,
                "y": 30000
              }
            ]
          }
        ],
        "figure_id": "b578e51548a719cb",
        "provenance": {
          "page": 33
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 33,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 700000
            }
          }
        },
        "series": [
          {
            "name": "Trulicity (LLY)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 10000
              },
              {
                "x": 100,
                "y": 20000
              },
              {
                "x": 150,
                "y": 40000
              },
              {
                "x": 200,
                "y": 80000
              },
              {
                "x": 250,
                "y": 120000
              },
              {
                "x": 300,
                "y": 150000
              },
              {
                "x": 350,
                "y": 200000
              },
              {
                "x": 400,
                "y": 250000
              },
              {
                "x": 450,
                "y": 200000
              },
              {
                "x": 500,
                "y": 170000
              },
              {
                "x": 550,
                "y": 150000
              }
            ]
          },
          {
            "name": "Mounjaro (LLY)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 150000
              },
              {
                "x": 100,
                "y": 400000
              },
              {
                "x": 150,
                "y": 450000
              },
              {
                "x": 200,
                "y": 600000
              },
              {
                "x": 220,
                "y": 630000
              }
            ]
          },
          {
            "name": "Ozempic (NOVO)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 10000
              },
              {
                "x": 150,
                "y": 20000
              },
              {
                "x": 200,
                "y": 100000
              },
              {
                "x": 250,
                "y": 300000
              },
              {
                "x": 300,
                "y": 400000
              },
              {
                "x": 350,
                "y": 500000
              },
              {
                "x": 400,
                "y": 600000
              }
            ]
          },
          {
            "name": "Rybelsus (Novo)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 10000
              },
              {
                "x": 150,
                "y": 30000
              },
              {
                "x": 200,
                "y": 50000
              },
              {
                "x": 250,
                "y": 60000
              },
              {
                "x": 300,
                "y": 50000
              }
            ]
          },
          {
            "name": "Wegovy (NOVO)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 10000
              },
              {
                "x": 100,
                "y": 120000
              },
              {
                "x": 150,
                "y": 100000
              },
              {
                "x": 200,
                "y": 250000
              },
              {
                "x": 250,
                "y": 200000
              }
            ]
          },
          {
            "name": "Saxenda (NOVO)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 1000
              },
              {
                "x": 100,
                "y": 2000
              },
              {
                "x": 150,
                "y": 5000
              },
              {
                "x": 200,
                "y": 10000
              },
              {
                "x": 250,
                "y": 15000
              },
              {
                "x": 300,
                "y": 10000
              },
              {
                "x": 350,
                "y": 15000
              },
              {
                "x": 400,
                "y": 20000
              },
              {
                "x": 450,
                "y": 10000
              },
              {
                "x": 500,
                "y": 5000
              },
              {
                "x": 550,
                "y": 0
              }
            ]
          },
          {
            "name": "Zepbound (Eli Lilly)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              }
            ]
          }
        ],
        "figure_id": "76aade1e7cfeb502",
        "provenance": {
          "page": 33
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx YOY growth",
        "page": 34,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -40,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Total GLP-1",
            "unit": "%",
            "values": [
              16,
              22,
              20,
              28,
              15,
              25,
              10,
              30,
              20,
              25,
              27,
              25,
              22,
              19,
              18,
              18,
              17,
              13
            ]
          },
          {
            "name": "Xultophy",
            "unit": "%",
            "values": [
              -5,
              -10,
              -15,
              -5,
              5,
              -25,
              -15,
              -25,
              -20,
              -15,
              -18,
              -25,
              -30,
              -25,
              -30,
              -25,
              -35,
              -30
            ]
          },
          {
            "name": "Ozempic",
            "unit": "%",
            "values": [
              18,
              25,
              40,
              58,
              10,
              25,
              15,
              42,
              20,
              20,
              18,
              15,
              10,
              5,
              0,
              2,
              -1,
              -1
            ]
          },
          {
            "name": "Trulicity",
            "unit": "%",
            "values": [
              -30,
              -30,
              -30,
              -30,
              -35,
              -20,
              -10,
              -30,
              -10,
              -15,
              -10,
              -20,
              -25,
              -15,
              -20,
              -20,
              -15,
              -12
            ]
          }
        ],
        "figure_id": "77bafd79d7b94476",
        "provenance": {
          "page": 34
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 35,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 80000,
                "max": 200000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -40,
                "max": 10
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              180000,
              168000,
              184000,
              178000,
              178000,
              154000,
              146000,
              170000,
              160000,
              170000,
              168000,
              162000,
              160000,
              166000,
              150000,
              144000,
              160000,
              154000
            ]
          },
          {
            "name": "Trulicity",
            "unit": "%",
            "values": [
              -28,
              -27,
              -26,
              -27,
              -28,
              -10,
              -22,
              -10,
              -30,
              -12,
              -18,
              -10,
              -12,
              -2,
              -1,
              -10,
              -14,
              -12
            ]
          }
        ],
        "figure_id": "67e66a21fce3b8cb",
        "provenance": {
          "page": 35
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 35,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 400000,
                "max": 820000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": 0,
                "max": 70
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              580000,
              520000,
              585000,
              600000,
              610000,
              550000,
              640000,
              510000,
              600000,
              670000,
              680000,
              690000,
              720000,
              690000,
              740000,
              700000,
              790000,
              760000,
              770000,
              780000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              20,
              25,
              20,
              18,
              25,
              30,
              40,
              10,
              30,
              15,
              40,
              20,
              55,
              30,
              45,
              35,
              40,
              35,
              48,
              35
            ]
          }
        ],
        "figure_id": "77ddca9283bbc94f",
        "provenance": {
          "page": 35
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 36,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "LLY",
            "unit": "%",
            "values": [
              53,
              53.5,
              53,
              53.5,
              53.5,
              53.5,
              54.5,
              53.5,
              54,
              54.5,
              54.5,
              54,
              54.5,
              54,
              54.5,
              54.5,
              54.5,
              54
            ]
          },
          {
            "name": "NOVO",
            "unit": "%",
            "values": [
              34.5,
              34,
              34,
              33.5,
              33.5,
              33,
              33,
              34,
              34.5,
              34,
              34,
              34.5,
              34.5,
              34.5,
              34.5,
              34.5,
              34.5,
              35
            ]
          },
          {
            "name": "Admelog",
            "unit": "%",
            "values": [
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2
            ]
          },
          {
            "name": "Others",
            "unit": "%",
            "values": [
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              9,
              7,
              8.5,
              7.5,
              7.5,
              7,
              7,
              7,
              7,
              7,
              7,
              7,
              7
            ]
          }
        ],
        "figure_id": "797d0f702d16fc88",
        "provenance": {
          "page": 36
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx YOY growth",
        "page": 36,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -40,
              "max": 20
            }
          }
        },
        "series": [
          {
            "name": "LLY",
            "unit": "%",
            "values": [
              0.5,
              2.5,
              3.5,
              1.5,
              2.5,
              16.5,
              -2.5,
              -0.5,
              7.5,
              -0.5,
              1.5,
              -2.5,
              -5.5,
              -3.5,
              -4.5,
              -3.5,
              -5.5,
              -6
            ]
          },
          {
            "name": "NOVO",
            "unit": "%",
            "values": [
              -18.5,
              -15.5,
              -13.5,
              -16.5,
              -14.5,
              -34.5,
              -21.5,
              -25.5,
              -12.5,
              -18.5,
              -15.5,
              -17.5,
              -13.5,
              -12.5,
              -13.5,
              -12.5,
              -11.5,
              -11
            ]
          },
          {
            "name": "Admelog (SNY)",
            "unit": "%",
            "values": [
              -12.5,
              -8.5,
              -6.5,
              -4.5,
              -2.5,
              5.5,
              -15.5,
              -10.5,
              -1.5,
              -8.5,
              -12.5,
              -21.5,
              -17.5,
              -13.5,
              -18.5,
              -20.5,
              -22.5,
              -23
            ]
          }
        ],
        "figure_id": "5d2741944268c411",
        "provenance": {
          "page": 36
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx share",
        "page": 37,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 80
            }
          }
        },
        "series": [
          {
            "name": "Lantus + Lantus Solostar + Toujeo",
            "unit": "%",
            "values": [
              60,
              60.5,
              61.5,
              62.5,
              63,
              63.5,
              66,
              64.5,
              65.5,
              67,
              68,
              69,
              70,
              70.5,
              71,
              71.5,
              72,
              72
            ]
          },
          {
            "name": "Tresiba",
            "unit": "%",
            "values": [
              16.5,
              16.5,
              16.5,
              16.5,
              16.5,
              16.5,
              17,
              15.5,
              16,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15.5,
              15
            ]
          },
          {
            "name": "Basaglar",
            "unit": "%",
            "values": [
              13.5,
              13.5,
              13.5,
              13.5,
              13.5,
              13.5,
              12.5,
              12,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11
            ]
          },
          {
            "name": "Levemir",
            "unit": "%",
            "values": [
              5,
              4.5,
              4,
              3.5,
              3,
              2.5,
              2,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5
            ]
          },
          {
            "name": "Semglee",
            "unit": "%",
            "values": [
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              2,
              3,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5
            ]
          },
          {
            "name": "Soliqua",
            "unit": "%",
            "values": [
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1,
              1
            ]
          },
          {
            "name": "Xultophy",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0
            ]
          }
        ],
        "figure_id": "2d6ea4657ea81598",
        "provenance": {
          "page": 37
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx YOY growth",
        "page": 37,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -100,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Total Long-acting Insulin",
            "unit": "%",
            "values": [
              -68,
              -69,
              -70,
              -75,
              -80,
              -85,
              -88,
              -90,
              -92,
              -93,
              -94,
              -95,
              -96,
              -97,
              -98,
              -98,
              -99,
              -99
            ]
          },
          {
            "name": "Lantus",
            "unit": "%",
            "values": [
              10,
              12,
              14,
              15,
              28,
              -10,
              10,
              -5,
              0,
              -2,
              -1,
              -2,
              -3,
              -4,
              -5,
              -6,
              -50,
              -25
            ]
          },
          {
            "name": "Lantus Solostar",
            "unit": "%",
            "values": [
              22,
              28,
              29,
              30,
              55,
              38,
              25,
              10,
              20,
              22,
              25,
              20,
              18,
              20,
              25,
              30,
              32,
              20
            ]
          },
          {
            "name": "Levemir",
            "unit": "%",
            "values": [
              -5,
              -2,
              0,
              0,
              12,
              -18,
              -5,
              -2,
              -5,
              -8,
              -10,
              -12,
              -13,
              -14,
              -15,
              -16,
              -18,
              -18
            ]
          },
          {
            "name": "Toujeo Solostar",
            "unit": "%",
            "values": [
              5,
              8,
              10,
              12,
              15,
              18,
              15,
              10,
              5,
              2,
              0,
              -1,
              -2,
              -3,
              -4,
              -5,
              -6,
              -1
            ]
          },
          {
            "name": "Basaglar",
            "unit": "%",
            "values": [
              -1,
              -2,
              -3,
              -4,
              -5,
              -8,
              -10,
              -12,
              -15,
              -18,
              -20,
              -22,
              -23,
              -24,
              -25,
              -26,
              -27,
              -28
            ]
          },
          {
            "name": "Tresiba",
            "unit": "%",
            "values": [
              10,
              12,
              13,
              14,
              15,
              16,
              17,
              18,
              19,
              20,
              21,
              22,
              23,
              24,
              25,
              26,
              27,
              28
            ]
          }
        ],
        "figure_id": "3e0c2884d993c8f6",
        "provenance": {
          "page": 37
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 37,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 90
            }
          }
        },
        "series": [
          {
            "name": "Basaglar",
            "unit": "%",
            "values": [
              20,
              20,
              20,
              20,
              20,
              20,
              20,
              19,
              18,
              17,
              16,
              15,
              15,
              15,
              15,
              15,
              15,
              15
            ]
          },
          {
            "name": "Semglee",
            "unit": "%",
            "values": [
              5,
              5,
              5,
              5,
              4,
              4,
              4,
              5,
              4,
              4,
              3,
              3,
              3,
              2,
              2,
              2,
              2,
              2
            ]
          },
          {
            "name": "Lantus",
            "unit": "%",
            "values": [
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              6,
              8
            ]
          },
          {
            "name": "Lantus Solostar",
            "unit": "%",
            "values": [
              64,
              64,
              65,
              65,
              65,
              66,
              66,
              67,
              68,
              68,
              69,
              70,
              71,
              72,
              72,
              73,
              77,
              75
            ]
          }
        ],
        "figure_id": "0bacb0e3cbb9cd24",
        "provenance": {
          "page": 37
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 38,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 80
            }
          }
        },
        "series": [
          {
            "name": "Basaglar",
            "unit": "%",
            "values": [
              18.0,
              17.8,
              17.5,
              17.2,
              17.0,
              16.8,
              16.5,
              16.2,
              15.8,
              15.5,
              15.2,
              14.8,
              14.5,
              14.2,
              14.0,
              13.8,
              13.5,
              13.0
            ]
          },
          {
            "name": "Semglee",
            "unit": "%",
            "values": [
              4.5,
              4.8,
              5.0,
              5.2,
              5.5,
              5.8,
              6.0,
              5.8,
              5.5,
              6.0,
              6.5,
              6.0,
              5.5,
              5.0,
              4.5,
              4.0,
              3.5,
              2.0
            ]
          },
          {
            "name": "Lantus",
            "unit": "%",
            "values": [
              10.0,
              10.2,
              10.5,
              10.8,
              11.0,
              11.2,
              11.5,
              11.8,
              12.0,
              12.2,
              12.5,
              12.0,
              11.5,
              11.0,
              10.0,
              8.0,
              6.0,
              7.0
            ]
          },
          {
            "name": "Lantus Solostar",
            "unit": "%",
            "values": [
              56.0,
              56.5,
              57.0,
              57.5,
              58.0,
              58.5,
              59.0,
              59.5,
              60.0,
              60.5,
              61.0,
              62.0,
              62.5,
              63.0,
              63.5,
              64.0,
              65.0,
              66.0
            ]
          },
          {
            "name": "Toujeo",
            "unit": "%",
            "values": [
              12.0,
              12.2,
              12.5,
              12.8,
              13.0,
              13.2,
              13.5,
              13.8,
              14.0,
              13.5,
              13.0,
              12.5,
              12.0,
              11.5,
              11.0,
              10.5,
              10.0,
              11.0
            ]
          }
        ],
        "figure_id": "d3e202cd2fbca354",
        "provenance": {
          "page": 38
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 39,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 340000,
                "max": 460000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -8,
                "max": 0
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              420000,
              395000,
              425000,
              415000,
              420000,
              420000,
              425000,
              420000,
              450000,
              350000,
              430000,
              380000,
              430000,
              410000,
              425000,
              410000,
              420000,
              400000,
              415000,
              405000,
              420000,
              410000,
              400000,
              415000,
              380000,
              420000,
              370000,
              410000,
              400000,
              395000
            ]
          },
          {
            "name": "4-week rolling YOY growth",
            "unit": "%",
            "values": [
              -4.5,
              -4.2,
              -4.0,
              -3.8,
              -3.5,
              -3.0,
              -2.0,
              -1.0,
              -5.0,
              -3.0,
              -4.0,
              -3.5,
              -4.0,
              -3.0,
              -3.5,
              -4.0,
              -3.5,
              -4.0,
              -4.5,
              -4.8,
              -4.5,
              -4.0,
              -4.2,
              -4.5,
              -5.0,
              -4.8,
              -5.0,
              -5.2,
              -5.0,
              -5.2
            ]
          }
        ],
        "figure_id": "89f66ee75cc95550",
        "provenance": {
          "page": 39
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 40,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2Q17",
              "3Q17",
              "4Q17",
              "1Q18",
              "2Q18",
              "3Q18",
              "4Q18",
              "1Q19",
              "2Q19",
              "3Q19",
              "4Q19",
              "1Q20",
              "2Q20",
              "3Q20",
              "4Q20",
              "1Q21",
              "2Q21",
              "3Q21",
              "4Q21",
              "1Q22",
              "2Q22",
              "3Q22",
              "4Q22",
              "1Q23",
              "2Q23",
              "3Q23",
              "4Q23",
              "1Q24",
              "2Q24",
              "3Q24",
              "4Q24",
              "1Q25",
              "2Q25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 16000
            }
          },
          "y2": {
            "unit": "'000",
            "range": {
              "min": 0,
              "max": 200
            }
          }
        },
        "series": [
          {
            "name": "S/Rx",
            "unit": null,
            "values": [
              11500,
              13000,
              10000,
              12500,
              11000,
              13000,
              11000,
              13500,
              12000,
              13500,
              11000,
              10500,
              13500,
              11000,
              11500,
              12000,
              12500,
              11000,
              9000,
              10500,
              10000,
              9000,
              8500,
              11500,
              10500,
              8500,
              11000,
              10500,
              11000,
              10000,
              9500,
              6000,
              7500
            ]
          },
          {
            "name": "TRx ('000)",
            "unit": "'000",
            "values": [
              50,
              55,
              60,
              65,
              70,
              75,
              80,
              85,
              90,
              95,
              100,
              105,
              110,
              115,
              120,
              125,
              130,
              135,
              140,
              145,
              150,
              155,
              160,
              165,
              165,
              160,
              165,
              170,
              170,
              165,
              160,
              155,
              150
            ]
          }
        ],
        "figure_id": "adbc0537b5ff3a28",
        "provenance": {
          "page": 40
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 41,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2Q17",
              "3Q17",
              "4Q17",
              "1Q18",
              "2Q18",
              "3Q18",
              "4Q18",
              "1Q19",
              "2Q19",
              "3Q19",
              "4Q19",
              "1Q20",
              "2Q20",
              "3Q20",
              "4Q20",
              "1Q21",
              "2Q21",
              "3Q21",
              "4Q21",
              "1Q22",
              "2Q22",
              "3Q22",
              "4Q22",
              "1Q23",
              "2Q23",
              "3Q23",
              "4Q23",
              "1Q24",
              "2Q24",
              "3Q24",
              "4Q24",
              "1Q25",
              "2Q25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 25000
            }
          }
        },
        "series": [
          {
            "name": "S/Rx",
            "unit": null,
            "values": [
              23000,
              15000,
              12000,
              13000,
              11500,
              12000,
              10000,
              10500,
              9000,
              7000,
              6000,
              6500,
              5500,
              5000,
              7500,
              5500,
              6000,
              4500,
              5500,
              4000,
              6500,
              5000,
              5500,
              4500,
              5000,
              4000,
              3500,
              4000,
              5000,
              5500,
              5000,
              5500,
              6000
            ]
          },
          {
            "name": "TRx ('000)",
            "unit": "('000)",
            "values": [
              0,
              0,
              0,
              5,
              10,
              15,
              20,
              25,
              30,
              35,
              40,
              45,
              50,
              55,
              60,
              70,
              80,
              90,
              100,
              110,
              115,
              120,
              120,
              120,
              120,
              120,
              120,
              120,
              120,
              120,
              120,
              130,
              140
            ]
          }
        ],
        "figure_id": "d1475b8ec910afeb",
        "provenance": {
          "page": 41
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 41,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1Q16",
              "2Q16",
              "3Q16",
              "4Q16",
              "1Q17",
              "2Q17",
              "3Q17",
              "4Q17",
              "1Q18",
              "2Q18",
              "3Q18",
              "4Q18",
              "1Q19",
              "2Q19",
              "3Q19",
              "4Q19",
              "1Q20",
              "2Q20",
              "3Q20",
              "4Q20",
              "1Q21",
              "2Q21",
              "3Q21",
              "4Q21",
              "1Q22",
              "2Q22",
              "3Q22",
              "4Q22",
              "1Q23",
              "2Q23",
              "3Q23",
              "4Q23",
              "1Q24",
              "2Q24",
              "3Q24",
              "4Q24",
              "1Q25",
              "2Q25"
            ]
          },
          "y": {
            "left": {
              "unit": "$/Rx",
              "range": {
                "min": 0,
                "max": 7000
              }
            },
            "right": {
              "unit": "TRx ('000)",
              "range": {
                "min": 0,
                "max": 300
              }
            }
          }
        },
        "series": [
          {
            "name": "S/Rx",
            "unit": "$/Rx",
            "values": [
              5700,
              5800,
              5600,
              6300,
              6000,
              5000,
              4000,
              3500,
              3800,
              4100,
              3800,
              3600,
              3900,
              3800,
              3600,
              4000,
              4100,
              4400,
              3800,
              3900,
              4000,
              4400,
              3800,
              3900,
              4000,
              3500,
              3000,
              3800,
              3900,
              3800,
              4100,
              3500,
              3800,
              3500,
              4000,
              3500,
              3400,
              3600
            ]
          },
          {
            "name": "TRx ('000)",
            "unit": "TRx ('000)",
            "values": [
              40,
              60,
              80,
              90,
              100,
              120,
              140,
              160,
              180,
              200,
              210,
              220,
              230,
              240,
              250,
              260,
              270,
              280,
              290,
              295,
              298,
              299,
              298,
              295,
              290,
              280,
              270,
              260,
              250,
              240,
              230,
              220,
              230,
              240,
              250,
              260,
              270,
              280
            ]
          }
        ],
        "figure_id": "98b581cbbe34e2cb",
        "provenance": {
          "page": 41
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 41,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2Q17",
              "3Q17",
              "4Q17",
              "1Q18",
              "2Q18",
              "3Q18",
              "4Q18",
              "1Q19",
              "2Q19",
              "3Q19",
              "4Q19",
              "1Q20",
              "2Q20",
              "3Q20",
              "4Q20",
              "1Q21",
              "2Q21",
              "3Q21",
              "4Q21",
              "1Q22",
              "2Q22",
              "3Q22",
              "4Q22",
              "1Q23",
              "2Q23",
              "3Q23",
              "4Q23",
              "1Q24",
              "2Q24",
              "3Q24",
              "4Q24",
              "1Q25",
              "2Q25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 4000
            }
          }
        },
        "series": [
          {
            "name": "S/Rx",
            "unit": null,
            "values": [
              3000,
              3550,
              2450,
              2950,
              3050,
              2900,
              2950,
              3300,
              3150,
              2950,
              2850,
              2950,
              2800,
              2700,
              2850,
              2950,
              2700,
              3150,
              3050,
              2900,
              3150,
              2900,
              2850,
              3150,
              2900,
              2800,
              2950,
              2850,
              2600,
              2500,
              2700,
              2850,
              2900
            ]
          },
          {
            "name": "TRx ('000)",
            "unit": "000",
            "values": [
              0,
              50,
              100,
              150,
              200,
              250,
              300,
              350,
              400,
              450,
              500,
              550,
              600,
              650,
              700,
              750,
              800,
              850,
              900,
              950,
              1000,
              1050,
              1100,
              1150,
              1200,
              1250,
              1300,
              1350,
              1400,
              1450,
              1500,
              1550,
              1600
            ]
          }
        ],
        "figure_id": "8776526160cfeab5",
        "provenance": {
          "page": 41
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 42,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "4Q19",
              "1Q20",
              "2Q20",
              "3Q20",
              "4Q20",
              "1Q21",
              "2Q21",
              "3Q21",
              "4Q21",
              "1Q22",
              "2Q22",
              "3Q22",
              "4Q22",
              "1Q23",
              "2Q23",
              "3Q23",
              "4Q23",
              "1Q24",
              "2Q24",
              "3Q24",
              "4Q24",
              "1Q25",
              "2Q25"
            ]
          },
          "y": {
            "left": {
              "unit": "S/Rx",
              "range": {
                "min": 0,
                "max": 8000
              }
            },
            "right": {
              "unit": "TRx ('000)",
              "range": {
                "min": 0,
                "max": 350
              }
            }
          }
        },
        "series": [
          {
            "name": "S/Rx",
            "unit": "S/Rx",
            "values": [
              7000,
              5400,
              5200,
              5700,
              5200,
              5400,
              5700,
              6000,
              4900,
              5500,
              5800,
              5700,
              3600,
              4000,
              4500,
              4700,
              3500,
              4300,
              4500,
              4700,
              4000,
              4200,
              4300
            ]
          },
          {
            "name": "TRx ('000)",
            "unit": "TRx ('000)",
            "values": [
              0,
              20,
              40,
              60,
              80,
              100,
              120,
              140,
              150,
              160,
              180,
              200,
              220,
              250,
              270,
              290,
              300,
              310,
              320,
              330,
              340,
              345,
              350
            ]
          }
        ],
        "figure_id": "8b0b37591d82439a",
        "provenance": {
          "page": 42
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 42,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "3Q19",
              "4Q19",
              "1Q20",
              "2Q20",
              "3Q20",
              "4Q20",
              "1Q21",
              "2Q21",
              "3Q21",
              "4Q21",
              "1Q22",
              "2Q22",
              "3Q22",
              "4Q22",
              "1Q23",
              "2Q23",
              "3Q23",
              "4Q23",
              "1Q24",
              "2Q24",
              "3Q24",
              "4Q24",
              "1Q25",
              "2Q25"
            ]
          },
          "y": {
            "left": {
              "unit": "S/Rx",
              "range": {
                "min": 0,
                "max": 20000
              }
            },
            "right": {
              "unit": "TRx ('000)",
              "range": {
                "min": 0,
                "max": 300
              }
            }
          }
        },
        "series": [
          {
            "name": "S/Rx",
            "unit": "S/Rx",
            "values": [
              18900,
              16000,
              14200,
              14200,
              16000,
              16000,
              14800,
              14800,
              17000,
              17200,
              14800,
              16000,
              17000,
              18000,
              13000,
              13800,
              13500,
              10800,
              13000,
              16000,
              17000,
              12500,
              14200,
              21500
            ]
          },
          {
            "name": "TRx ('000)",
            "unit": "TRx ('000)",
            "values": [
              0,
              10,
              20,
              25,
              30,
              35,
              40,
              45,
              50,
              55,
              60,
              70,
              80,
              90,
              110,
              130,
              150,
              170,
              190,
              220,
              240,
              260,
              280,
              290
            ]
          }
        ],
        "figure_id": "d8ce92341fea147c",
        "provenance": {
          "page": 42
        }
      },
      {
        "type": "line",
        "title": "Weekly YOY growth",
        "page": 43,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -40,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "IL-17A",
            "unit": "%",
            "values": [
              20,
              25,
              20,
              25,
              20,
              82,
              35,
              15,
              58,
              10,
              25,
              15,
              28,
              20,
              15,
              18,
              12,
              20,
              18,
              17
            ]
          },
          {
            "name": "IL-23",
            "unit": "%",
            "values": [
              18,
              15,
              20,
              18,
              15,
              68,
              -22,
              20,
              58,
              10,
              20,
              15,
              20,
              15,
              15,
              15,
              10,
              18,
              15,
              14
            ]
          },
          {
            "name": "JAK",
            "unit": "%",
            "values": [
              25,
              20,
              25,
              20,
              22,
              60,
              -10,
              20,
              55,
              15,
              30,
              20,
              28,
              25,
              20,
              25,
              18,
              25,
              20,
              24
            ]
          }
        ],
        "figure_id": "7de904713be9f530",
        "provenance": {
          "page": 43
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 43,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 2500
            }
          }
        },
        "series": [
          {
            "name": "Dupixent (SNY/REGN)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              100,
              300,
              500,
              700,
              800,
              950,
              900,
              1100,
              1200,
              1150,
              1550,
              1100,
              1500,
              1500,
              1650,
              1800,
              1900,
              2100,
              1900
            ]
          },
          {
            "name": "Adbry (Leo)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              0,
              50,
              100,
              150,
              200,
              250,
              200,
              250,
              300,
              300,
              300,
              350,
              350,
              350,
              350,
              400,
              400,
              450,
              300
            ]
          },
          {
            "name": "Ebglyss (LLY)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              0,
              50,
              100,
              200,
              250,
              400,
              450,
              400,
              500,
              600,
              650,
              500,
              650,
              700,
              750,
              800,
              600,
              950,
              900
            ]
          }
        ],
        "figure_id": "9737802859850fbe",
        "provenance": {
          "page": 43
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 44,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "Adbry (Leo)",
            "unit": "%",
            "values": [
              100,
              100,
              95,
              90,
              85,
              83,
              78,
              75,
              72,
              68,
              65,
              62,
              59,
              56,
              54,
              52,
              50,
              48
            ]
          },
          {
            "name": "Ebglyss (LLY)",
            "unit": "%",
            "values": [
              0,
              0,
              5,
              10,
              15,
              17,
              22,
              25,
              28,
              32,
              35,
              38,
              41,
              44,
              46,
              48,
              50,
              52
            ]
          }
        ],
        "figure_id": "60f79e2603ab3f26",
        "provenance": {
          "page": 44
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 45,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Taltz",
            "unit": "%",
            "values": [
              42.5,
              42.0,
              41.5,
              41.0,
              40.5,
              42.0,
              39.0,
              35.0,
              34.5,
              35.0,
              35.5,
              36.5,
              35.5,
              35.0,
              35.5,
              34.5,
              34.0,
              34.0
            ]
          },
          {
            "name": "Bimzelx",
            "unit": "%",
            "values": [
              3.0,
              3.5,
              4.0,
              4.5,
              5.0,
              6.0,
              7.5,
              8.0,
              9.0,
              10.0,
              11.0,
              12.0,
              12.5,
              13.0,
              13.5,
              14.0,
              14.0,
              14.0
            ]
          },
          {
            "name": "Siliq",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          },
          {
            "name": "Cosentyx",
            "unit": "%",
            "values": [
              53.0,
              53.5,
              53.0,
              53.5,
              52.5,
              51.5,
              55.0,
              57.0,
              55.0,
              54.0,
              53.0,
              52.0,
              51.5,
              51.0,
              50.5,
              51.5,
              52.0,
              52.0
            ]
          }
        ],
        "figure_id": "f21c6077933e8511",
        "provenance": {
          "page": 45
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 45,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": [
            {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 20000
              },
              "label": "Weekly TRx"
            },
            {
              "unit": "%",
              "range": {
                "min": -60,
                "max": 80
              },
              "label": "Weekly YOY"
            }
          ]
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              15500,
              13000,
              15000,
              14000,
              15000,
              17800,
              10500,
              12500,
              10000,
              13500,
              12500,
              13500,
              13000,
              13500,
              12000,
              11000,
              14000,
              14000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              10,
              5,
              10,
              8,
              15,
              -50,
              15,
              -10,
              -10,
              0,
              -5,
              0,
              -5,
              -5,
              -5,
              5,
              -5,
              -10
            ]
          }
        ],
        "figure_id": "db6f832bc113cb1d",
        "provenance": {
          "page": 45
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 45,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 25000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -40,
                "max": 100
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              16000,
              19000,
              17000,
              19500,
              19000,
              14500,
              15500,
              19500,
              19000,
              20500,
              18000,
              20500,
              19500,
              20000,
              17000,
              22000,
              21000,
              21500
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              30,
              20,
              25,
              30,
              35,
              -10,
              45,
              10,
              30,
              20,
              25,
              10,
              15,
              18,
              10,
              25,
              15,
              10
            ]
          }
        ],
        "figure_id": "1d4b076cf2264f6e",
        "provenance": {
          "page": 45
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 46,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 25000
            }
          }
        },
        "series": [
          {
            "name": "Omvoh (LLY)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 100,
                "y": 500
              },
              {
                "x": 200,
                "y": 1000
              },
              {
                "x": 300,
                "y": 1500
              },
              {
                "x": 400,
                "y": 2000
              }
            ]
          },
          {
            "name": "Tremfya (JnJ)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 500
              },
              {
                "x": 100,
                "y": 1500
              },
              {
                "x": 150,
                "y": 2500
              },
              {
                "x": 200,
                "y": 4000
              },
              {
                "x": 250,
                "y": 5500
              },
              {
                "x": 300,
                "y": 7000
              },
              {
                "x": 350,
                "y": 8500
              },
              {
                "x": 400,
                "y": 10000
              },
              {
                "x": 420,
                "y": 12000
              }
            ]
          },
          {
            "name": "Skyrizi (ABBV)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 1000
              },
              {
                "x": 100,
                "y": 3000
              },
              {
                "x": 150,
                "y": 5000
              },
              {
                "x": 200,
                "y": 8000
              },
              {
                "x": 250,
                "y": 12000
              },
              {
                "x": 300,
                "y": 18000
              },
              {
                "x": 320,
                "y": 22000
              }
            ]
          },
          {
            "name": "Bumya (Sun Pharma)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 100,
                "y": 100
              },
              {
                "x": 200,
                "y": 200
              },
              {
                "x": 300,
                "y": 300
              },
              {
                "x": 400,
                "y": 400
              }
            ]
          }
        ],
        "figure_id": "b00f3ee754b20395",
        "provenance": {
          "page": 46
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 47,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 60
            }
          }
        },
        "series": [
          {
            "name": "Tremfya",
            "unit": "%",
            "values": [
              22.5,
              22.0,
              22.0,
              21.5,
              24.0,
              22.5,
              22.0,
              22.0,
              22.5,
              22.0,
              22.5,
              22.5,
              23.0,
              23.5,
              24.0,
              25.0,
              26.0,
              27.0
            ]
          },
          {
            "name": "Stelara",
            "unit": "%",
            "values": [
              35.0,
              34.0,
              34.5,
              33.5,
              34.0,
              32.5,
              33.5,
              32.0,
              31.0,
              30.5,
              30.0,
              29.0,
              28.0,
              27.0,
              25.0,
              23.5,
              22.0,
              21.0
            ]
          },
          {
            "name": "Omvoh",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          },
          {
            "name": "Skyrizi",
            "unit": "%",
            "values": [
              41.0,
              42.0,
              41.5,
              42.0,
              43.0,
              42.0,
              43.0,
              44.0,
              45.0,
              45.5,
              46.0,
              47.0,
              47.5,
              48.0,
              49.0,
              50.0,
              50.5,
              51.0
            ]
          },
          {
            "name": "Ilumya",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          }
        ],
        "figure_id": "443c7b3a72d89eec",
        "provenance": {
          "page": 47
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 47,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 7000,
              "max": 25000
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": null,
            "values": [
              15500,
              13500,
              16000,
              16500,
              17000,
              13500,
              18500,
              17000,
              19500,
              18000,
              20500,
              19000,
              20500,
              17500,
              22000,
              16500,
              22000,
              21500
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              50,
              40,
              50,
              45,
              40,
              -10,
              55,
              25,
              50,
              40,
              55,
              45,
              45,
              40,
              45,
              55,
              45,
              50
            ]
          }
        ],
        "figure_id": "287c1af1d345220b",
        "provenance": {
          "page": 47
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 47,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 2000,
                "max": 14000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -40,
                "max": 80
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              8500,
              9200,
              8200,
              8800,
              9800,
              7000,
              10400,
              7200,
              9500,
              8800,
              9600,
              9200,
              9800,
              8200,
              11000,
              8500,
              11500,
              12000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              15,
              18,
              12,
              25,
              10,
              -20,
              30,
              -10,
              20,
              15,
              25,
              20,
              30,
              20,
              35,
              25,
              30,
              40
            ]
          }
        ],
        "figure_id": "c65f72a4f5242db6",
        "provenance": {
          "page": 47
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 48,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": [
            {
              "unit": "TRx",
              "range": {
                "min": 6000,
                "max": 16000
              },
              "label": "Weekly TRx"
            },
            {
              "unit": "%",
              "range": {
                "min": -40,
                "max": 50
              },
              "label": "Weekly YOY growth"
            }
          ]
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              11700,
              13400,
              12800,
              13200,
              12800,
              13500,
              15000,
              10500,
              13700,
              12000,
              13400,
              12500,
              13000,
              12000,
              12500,
              10000,
              11500,
              10500,
              10000,
              9500,
              9200
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              3,
              5,
              6,
              4,
              6,
              8,
              -28,
              8,
              -1,
              -2,
              3,
              -1,
              -5,
              -1,
              -5,
              -10,
              -18,
              -25,
              -28,
              -27,
              -28
            ]
          }
        ],
        "figure_id": "205de568560ee01c",
        "provenance": {
          "page": 48
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 49,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 30000
            }
          }
        },
        "series": [
          {
            "name": "Xeljanz (PFE)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 1000
              },
              {
                "x": 100,
                "y": 2000
              },
              {
                "x": 150,
                "y": 3000
              },
              {
                "x": 200,
                "y": 4000
              },
              {
                "x": 250,
                "y": 5000
              },
              {
                "x": 300,
                "y": 6000
              },
              {
                "x": 350,
                "y": 9000
              },
              {
                "x": 400,
                "y": 11000
              },
              {
                "x": 450,
                "y": 10000
              },
              {
                "x": 500,
                "y": 9500
              },
              {
                "x": 550,
                "y": 9000
              },
              {
                "x": 600,
                "y": 8000
              },
              {
                "x": 650,
                "y": 8500
              },
              {
                "x": 670,
                "y": 8000
              }
            ]
          },
          {
            "name": "Cibinqo (PFE)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 100
              },
              {
                "x": 100,
                "y": 200
              },
              {
                "x": 150,
                "y": 300
              },
              {
                "x": 200,
                "y": 400
              },
              {
                "x": 250,
                "y": 500
              },
              {
                "x": 300,
                "y": 600
              },
              {
                "x": 350,
                "y": 700
              },
              {
                "x": 370,
                "y": 750
              }
            ]
          },
          {
            "name": "Olumiant (LLY)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 200
              },
              {
                "x": 100,
                "y": 500
              },
              {
                "x": 150,
                "y": 800
              },
              {
                "x": 200,
                "y": 1200
              },
              {
                "x": 250,
                "y": 1500
              },
              {
                "x": 300,
                "y": 1800
              },
              {
                "x": 350,
                "y": 2000
              },
              {
                "x": 370,
                "y": 2000
              }
            ]
          },
          {
            "name": "Rinvoq (ABBV)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 1000
              },
              {
                "x": 100,
                "y": 2000
              },
              {
                "x": 150,
                "y": 4000
              },
              {
                "x": 200,
                "y": 6000
              },
              {
                "x": 250,
                "y": 8000
              },
              {
                "x": 300,
                "y": 12000
              },
              {
                "x": 350,
                "y": 20000
              },
              {
                "x": 370,
                "y": 27000
              }
            ]
          }
        ],
        "figure_id": "b7fd6b5dd65d7a5e",
        "provenance": {
          "page": 49
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx share",
        "page": 49,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 80
            }
          }
        },
        "series": [
          {
            "name": "Rinvoq",
            "unit": "%",
            "values": [
              64.5,
              65.0,
              65.5,
              66.0,
              66.5,
              67.0,
              67.5,
              68.0,
              68.5,
              69.0,
              69.5,
              70.0,
              70.0,
              70.5,
              70.5,
              70.5,
              71.0,
              71.0
            ]
          },
          {
            "name": "Xeljanz total",
            "unit": "%",
            "values": [
              27.0,
              26.5,
              26.0,
              25.5,
              25.0,
              24.5,
              24.0,
              23.5,
              23.5,
              23.5,
              23.5,
              23.5,
              23.5,
              23.0,
              22.5,
              22.5,
              22.0,
              22.0
            ]
          },
          {
            "name": "Olumiant",
            "unit": "%",
            "values": [
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              6.0,
              5.5,
              5.5,
              5.5,
              5.5,
              5.5,
              5.0,
              5.0
            ]
          },
          {
            "name": "Cibinqo",
            "unit": "%",
            "values": [
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          }
        ],
        "figure_id": "17c880b0f5553c36",
        "provenance": {
          "page": 49
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 50,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 42000
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": null,
            "values": [
              30500,
              28500,
              32000,
              32500,
              31000,
              34500,
              28000,
              34500,
              31000,
              33500,
              34500,
              35000,
              36000,
              37000,
              32000,
              34500,
              38000,
              39000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              27,
              29,
              25,
              32,
              17,
              37,
              5,
              45,
              25,
              30,
              28,
              25,
              24,
              23,
              28,
              20,
              25,
              27
            ]
          }
        ],
        "figure_id": "15e866d7dfdb721d",
        "provenance": {
          "page": 50
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 51,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 6000,
                "max": 10000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -30,
                "max": 30
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              8600,
              8000,
              8800,
              8500,
              8800,
              7200,
              8800,
              7500,
              8000,
              8500,
              8200,
              8500,
              8600,
              9000,
              7600,
              8400,
              8700,
              8200,
              8700
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              -2,
              -5,
              -3,
              -1,
              -2,
              -22,
              -5,
              10,
              -5,
              0,
              2,
              -1,
              -2,
              5,
              -5,
              -2,
              5,
              -2,
              -1
            ]
          }
        ],
        "figure_id": "20ee4183ea5c7c41",
        "provenance": {
          "page": 51
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 52,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 0,
              "max": 32000
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": null,
            "values": [
              19000,
              21000,
              20500,
              21500,
              22500,
              22000,
              23500,
              19000,
              22500,
              23000,
              24500,
              25000,
              25500,
              26000,
              22000,
              26500,
              27000,
              27500
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              48,
              40,
              50,
              35,
              45,
              78,
              48,
              68,
              30,
              50,
              45,
              48,
              40,
              35,
              45,
              30,
              35,
              38
            ]
          }
        ],
        "figure_id": "fd6371a3ff3d2bfe",
        "provenance": {
          "page": 52
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 52,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 3000
            }
          }
        },
        "series": [
          {
            "name": "Nemluvio (Galderma)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 1,
                "y": 10
              },
              {
                "x": 2,
                "y": 20
              },
              {
                "x": 3,
                "y": 40
              },
              {
                "x": 4,
                "y": 60
              },
              {
                "x": 5,
                "y": 90
              },
              {
                "x": 6,
                "y": 120
              },
              {
                "x": 7,
                "y": 160
              },
              {
                "x": 8,
                "y": 200
              },
              {
                "x": 9,
                "y": 250
              },
              {
                "x": 10,
                "y": 300
              },
              {
                "x": 11,
                "y": 280
              },
              {
                "x": 12,
                "y": 350
              },
              {
                "x": 13,
                "y": 290
              },
              {
                "x": 14,
                "y": 400
              },
              {
                "x": 15,
                "y": 450
              },
              {
                "x": 16,
                "y": 380
              },
              {
                "x": 17,
                "y": 420
              },
              {
                "x": 18,
                "y": 480
              },
              {
                "x": 19,
                "y": 500
              },
              {
                "x": 20,
                "y": 550
              },
              {
                "x": 21,
                "y": 520
              },
              {
                "x": 22,
                "y": 600
              },
              {
                "x": 23,
                "y": 680
              },
              {
                "x": 24,
                "y": 750
              },
              {
                "x": 25,
                "y": 820
              },
              {
                "x": 26,
                "y": 900
              },
              {
                "x": 27,
                "y": 980
              },
              {
                "x": 28,
                "y": 1050
              },
              {
                "x": 29,
                "y": 1120
              },
              {
                "x": 30,
                "y": 1200
              },
              {
                "x": 31,
                "y": 1280
              },
              {
                "x": 32,
                "y": 1350
              },
              {
                "x": 33,
                "y": 1420
              },
              {
                "x": 34,
                "y": 1500
              },
              {
                "x": 35,
                "y": 1580
              },
              {
                "x": 36,
                "y": 1650
              },
              {
                "x": 37,
                "y": 1720
              },
              {
                "x": 38,
                "y": 1800
              },
              {
                "x": 39,
                "y": 1950
              },
              {
                "x": 40,
                "y": 1650
              },
              {
                "x": 41,
                "y": 1800
              },
              {
                "x": 42,
                "y": 1900
              },
              {
                "x": 43,
                "y": 2000
              },
              {
                "x": 44,
                "y": 2200
              },
              {
                "x": 45,
                "y": 1700
              },
              {
                "x": 46,
                "y": 2000
              },
              {
                "x": 47,
                "y": 2400
              },
              {
                "x": 48,
                "y": 2350
              },
              {
                "x": 49,
                "y": 2450
              }
            ]
          }
        ],
        "figure_id": "237af4067e54e240",
        "provenance": {
          "page": 52
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 54,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": -20,
              "max": 30
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": null,
            "values": [
              17800,
              15800,
              17500,
              16200,
              18000,
              15500,
              18200,
              14800,
              16800,
              17200,
              16500,
              17500,
              17800,
              17500,
              15800,
              18800,
              16800,
              17500,
              18200
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              12,
              8,
              10,
              8,
              11,
              8,
              11,
              18,
              -15,
              12,
              8,
              15,
              10,
              12,
              8,
              13,
              10,
              12,
              8,
              10,
              5,
              8,
              12,
              8,
              10,
              5,
              8,
              12,
              8
            ]
          }
        ],
        "figure_id": "f429c8e7480934a2",
        "provenance": {
          "page": 54
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 55,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 90000
            }
          }
        },
        "series": [
          {
            "name": "Eucrisa (Pfizer)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 2000
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 75,
                "y": 8000
              },
              {
                "x": 100,
                "y": 10000
              },
              {
                "x": 125,
                "y": 11000
              },
              {
                "x": 150,
                "y": 10000
              },
              {
                "x": 175,
                "y": 8000
              },
              {
                "x": 200,
                "y": 7000
              },
              {
                "x": 225,
                "y": 7000
              },
              {
                "x": 250,
                "y": 6000
              },
              {
                "x": 275,
                "y": 6000
              },
              {
                "x": 300,
                "y": 6000
              },
              {
                "x": 325,
                "y": 5500
              },
              {
                "x": 350,
                "y": 5000
              },
              {
                "x": 375,
                "y": 5000
              }
            ]
          },
          {
            "name": "Dupixent (SNY/REGN)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 1000
              },
              {
                "x": 50,
                "y": 3000
              },
              {
                "x": 75,
                "y": 6000
              },
              {
                "x": 100,
                "y": 9000
              },
              {
                "x": 125,
                "y": 15000
              },
              {
                "x": 150,
                "y": 20000
              },
              {
                "x": 175,
                "y": 25000
              },
              {
                "x": 200,
                "y": 30000
              },
              {
                "x": 225,
                "y": 35000
              },
              {
                "x": 250,
                "y": 40000
              },
              {
                "x": 275,
                "y": 50000
              },
              {
                "x": 300,
                "y": 55000
              },
              {
                "x": 325,
                "y": 60000
              },
              {
                "x": 350,
                "y": 70000
              },
              {
                "x": 375,
                "y": 75000
              },
              {
                "x": 390,
                "y": 77000
              }
            ]
          },
          {
            "name": "Opzelura (Incyte)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 1000
              },
              {
                "x": 50,
                "y": 4000
              },
              {
                "x": 75,
                "y": 7000
              },
              {
                "x": 100,
                "y": 10000
              },
              {
                "x": 125,
                "y": 12000
              },
              {
                "x": 150,
                "y": 13000
              },
              {
                "x": 175,
                "y": 14000
              },
              {
                "x": 200,
                "y": 15000
              }
            ]
          }
        ],
        "figure_id": "da90dbd976ded7ca",
        "provenance": {
          "page": 55
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 55,
        "axes": {
          "x": {
            "type": "time",
            "labels": [
              "2/3/17",
              "4/25/18",
              "7/15/19",
              "10/3/20",
              "12/23/21",
              "3/14/23",
              "6/2/24",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "Weekly TRx",
            "range": {
              "min": 0,
              "max": 120000
            }
          }
        },
        "series": [
          {
            "name": "Eucrisa",
            "unit": "Weekly TRx",
            "values": [
              1000,
              5000,
              10000,
              8000,
              5000,
              4000,
              3000,
              2000
            ]
          },
          {
            "name": "Dupixent",
            "unit": "Weekly TRx",
            "values": [
              0,
              2000,
              10000,
              20000,
              40000,
              60000,
              80000,
              95000
            ]
          },
          {
            "name": "Opzelura",
            "unit": "Weekly TRx",
            "values": [
              0,
              0,
              0,
              0,
              5000,
              10000,
              12000,
              15000
            ]
          }
        ],
        "figure_id": "16e1d132382c9448",
        "provenance": {
          "page": 55
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 56,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 120000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -40,
                "max": 100
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              74000,
              64000,
              72000,
              76000,
              78000,
              60000,
              88000,
              64000,
              84000,
              76000,
              84000,
              86000,
              84000,
              88000,
              78000,
              72000,
              92000,
              94000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              30,
              28,
              32,
              30,
              34,
              -10,
              38,
              20,
              34,
              28,
              38,
              32,
              36,
              32,
              30,
              40,
              30,
              28
            ]
          }
        ],
        "figure_id": "6455ccd411bd7bbc",
        "provenance": {
          "page": 56
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 57,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 70
            }
          }
        },
        "series": [
          {
            "name": "Harvoni",
            "unit": "%",
            "values": [
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              1
            ]
          },
          {
            "name": "Epclusa",
            "unit": "%",
            "values": [
              41,
              42,
              41,
              44,
              42,
              43,
              45,
              42,
              38,
              34,
              33,
              36,
              31,
              35,
              33,
              35,
              34,
              35
            ]
          },
          {
            "name": "Vosevi",
            "unit": "%",
            "values": [
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              3
            ]
          },
          {
            "name": "Mavyret",
            "unit": "%",
            "values": [
              54,
              55,
              52,
              50,
              53,
              54,
              50,
              57,
              60,
              62,
              60,
              63,
              59,
              62,
              61,
              62,
              61,
              61
            ]
          }
        ],
        "figure_id": "23976b57bfd6f9b2",
        "provenance": {
          "page": 57
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 57,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 70
            }
          }
        },
        "series": [
          {
            "name": "Isentress",
            "unit": "%",
            "values": [
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5,
              8.5
            ]
          },
          {
            "name": "Stribild",
            "unit": "%",
            "values": [
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5,
              1.5
            ]
          },
          {
            "name": "Genvoya",
            "unit": "%",
            "values": [
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5,
              7.5
            ]
          },
          {
            "name": "Biktarvy",
            "unit": "%",
            "values": [
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5,
              58.5
            ]
          },
          {
            "name": "Tivicay",
            "unit": "%",
            "values": [
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5,
              6.5
            ]
          },
          {
            "name": "Triumeq",
            "unit": "%",
            "values": [
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5,
              4.5
            ]
          },
          {
            "name": "Dovato",
            "unit": "%",
            "values": [
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5,
              11.5
            ]
          },
          {
            "name": "Cabenuva",
            "unit": "%",
            "values": [
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5,
              2.5
            ]
          }
        ],
        "figure_id": "754faf69b983d3c7",
        "provenance": {
          "page": 57
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 58,
        "axes": {
          "x": {
            "type": "numeric",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 70000
            }
          }
        },
        "series": [
          {
            "name": "Biktarvy (GILD)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 10000
              },
              {
                "x": 50,
                "y": 20000
              },
              {
                "x": 75,
                "y": 27000
              },
              {
                "x": 100,
                "y": 35000
              },
              {
                "x": 125,
                "y": 40000
              },
              {
                "x": 150,
                "y": 43000
              },
              {
                "x": 175,
                "y": 46000
              },
              {
                "x": 200,
                "y": 50000
              },
              {
                "x": 225,
                "y": 52000
              },
              {
                "x": 250,
                "y": 54000
              },
              {
                "x": 275,
                "y": 55000
              },
              {
                "x": 300,
                "y": 57000
              },
              {
                "x": 325,
                "y": 60000
              },
              {
                "x": 350,
                "y": 64000
              },
              {
                "x": 360,
                "y": 50000
              }
            ]
          },
          {
            "name": "Dovato (ViiV)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 500
              },
              {
                "x": 50,
                "y": 1000
              },
              {
                "x": 75,
                "y": 2000
              },
              {
                "x": 100,
                "y": 3000
              },
              {
                "x": 125,
                "y": 4000
              },
              {
                "x": 150,
                "y": 5000
              },
              {
                "x": 175,
                "y": 6000
              },
              {
                "x": 200,
                "y": 7000
              },
              {
                "x": 225,
                "y": 8000
              },
              {
                "x": 250,
                "y": 9000
              },
              {
                "x": 275,
                "y": 10000
              },
              {
                "x": 300,
                "y": 11000
              },
              {
                "x": 325,
                "y": 12000
              },
              {
                "x": 335,
                "y": 13000
              }
            ]
          },
          {
            "name": "Cabenuva (ViiV)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 100
              },
              {
                "x": 50,
                "y": 200
              },
              {
                "x": 75,
                "y": 500
              },
              {
                "x": 100,
                "y": 1000
              },
              {
                "x": 125,
                "y": 1500
              },
              {
                "x": 150,
                "y": 2000
              },
              {
                "x": 175,
                "y": 2500
              },
              {
                "x": 200,
                "y": 3000
              },
              {
                "x": 225,
                "y": 3500
              },
              {
                "x": 250,
                "y": 4000
              },
              {
                "x": 260,
                "y": 4200
              }
            ]
          }
        ],
        "figure_id": "db84097a24a9aa43",
        "provenance": {
          "page": 58
        }
      },
      {
        "type": "line",
        "title": "Weekly TRx share",
        "page": 59,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 90
            }
          }
        },
        "series": [
          {
            "name": "Truvada (brand+Gx)",
            "unit": "%",
            "values": [
              20,
              19.5,
              19.5,
              19,
              19.5,
              20,
              19,
              17.5,
              16,
              16,
              15.5,
              15.5,
              15.5,
              15,
              14.5,
              14.5,
              15,
              15
            ]
          },
          {
            "name": "Descovy",
            "unit": "%",
            "values": [
              77,
              77,
              77,
              77,
              77.5,
              77.5,
              78.5,
              79.5,
              80,
              79.5,
              80,
              80.5,
              80.5,
              80.5,
              81,
              80.5,
              79.5,
              79.5
            ]
          },
          {
            "name": "Apretude",
            "unit": "%",
            "values": [
              3,
              3.5,
              3.5,
              3.5,
              4,
              4,
              4.5,
              4,
              4,
              4,
              4,
              4.5,
              4.5,
              4.5,
              5,
              5,
              5.5,
              5.5
            ]
          },
          {
            "name": "Yeztugo",
            "unit": "%",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.5,
              0.5,
              0.5,
              1,
              1,
              1
            ]
          }
        ],
        "figure_id": "fb81ea686d65252a",
        "provenance": {
          "page": 59
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 59,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 4000
            }
          }
        },
        "series": [
          {
            "name": "Apretude (ViiV)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Descovy (Gilead)",
            "unit": "TRx",
            "values": [
              0,
              10,
              50,
              150,
              300,
              500,
              700,
              900,
              980,
              1000,
              1200,
              1500,
              1900,
              2000,
              2500,
              2600,
              2500,
              2900,
              3000,
              3400,
              3500,
              3700,
              3800,
              3750,
              3700
            ]
          },
          {
            "name": "Yeztugo oral (Gilead)",
            "unit": "TRx",
            "values": [
              0,
              0,
              10,
              50,
              150,
              180,
              100,
              80,
              50,
              40,
              30,
              20,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10,
              10
            ]
          },
          {
            "name": "Yeztugo Inj (Gilead)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              10,
              50,
              100,
              150,
              200,
              220,
              200,
              180,
              150,
              120,
              150,
              180,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200,
              200
            ]
          }
        ],
        "figure_id": "a00931059244cfaf",
        "provenance": {
          "page": 59
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 60,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 40000
            }
          }
        },
        "series": [
          {
            "name": "Apretude (ViiV)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 200
              },
              {
                "x": 50,
                "y": 500
              },
              {
                "x": 75,
                "y": 1000
              },
              {
                "x": 100,
                "y": 1500
              },
              {
                "x": 125,
                "y": 2000
              },
              {
                "x": 150,
                "y": 2500
              },
              {
                "x": 175,
                "y": 3000
              },
              {
                "x": 185,
                "y": 3200
              }
            ]
          },
          {
            "name": "Descovy (Gilead)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 5000
              },
              {
                "x": 50,
                "y": 10000
              },
              {
                "x": 75,
                "y": 14000
              },
              {
                "x": 100,
                "y": 16000
              },
              {
                "x": 125,
                "y": 15000
              },
              {
                "x": 150,
                "y": 14000
              },
              {
                "x": 175,
                "y": 14500
              },
              {
                "x": 200,
                "y": 27000
              },
              {
                "x": 225,
                "y": 26000
              },
              {
                "x": 250,
                "y": 28000
              },
              {
                "x": 275,
                "y": 29000
              },
              {
                "x": 300,
                "y": 31000
              },
              {
                "x": 325,
                "y": 30000
              },
              {
                "x": 350,
                "y": 32000
              },
              {
                "x": 360,
                "y": 33000
              }
            ]
          },
          {
            "name": "Yeztugo (Gilead)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 25,
                "y": 0
              },
              {
                "x": 50,
                "y": 0
              },
              {
                "x": 75,
                "y": 0
              },
              {
                "x": 100,
                "y": 0
              },
              {
                "x": 125,
                "y": 0
              },
              {
                "x": 150,
                "y": 0
              },
              {
                "x": 175,
                "y": 0
              },
              {
                "x": 200,
                "y": 0
              },
              {
                "x": 225,
                "y": 0
              },
              {
                "x": 250,
                "y": 0
              },
              {
                "x": 275,
                "y": 0
              },
              {
                "x": 300,
                "y": 0
              },
              {
                "x": 325,
                "y": 0
              },
              {
                "x": 350,
                "y": 0
              },
              {
                "x": 360,
                "y": 0
              }
            ]
          }
        ],
        "figure_id": "4acaaf614aa84485",
        "provenance": {
          "page": 60
        }
      },
      {
        "type": "area",
        "title": null,
        "page": 62,
        "axes": {
          "x": {
            "type": "time",
            "labels": [
              "5/25/18",
              "6/7/19",
              "6/19/20",
              "7/2/21",
              "7/15/22",
              "7/28/23",
              "8/9/24",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "Weekly TRx",
            "range": {
              "min": 0,
              "max": 250000
            }
          }
        },
        "series": [
          {
            "name": "Inj. CGRP",
            "unit": "Weekly TRx",
            "values": [
              0,
              15000,
              30000,
              50000,
              70000,
              75000,
              80000,
              85000
            ]
          },
          {
            "name": "Oral CGRP",
            "unit": "Weekly TRx",
            "values": [
              0,
              5000,
              15000,
              30000,
              50000,
              75000,
              100000,
              150000
            ]
          }
        ],
        "figure_id": "d839a7ec5550f8ea",
        "provenance": {
          "page": 62
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 63,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 50
            }
          }
        },
        "series": [
          {
            "name": "Aimovig",
            "unit": "%",
            "values": [
              29.5,
              29.8,
              29.5,
              29.0,
              28.8,
              28.5,
              28.8,
              28.5,
              28.0,
              28.0,
              27.8,
              27.5,
              27.2,
              27.0,
              26.8,
              26.8,
              27.0,
              27.0
            ]
          },
          {
            "name": "Ajovy",
            "unit": "%",
            "values": [
              24.0,
              24.5,
              24.8,
              24.8,
              25.0,
              24.8,
              24.8,
              25.0,
              25.2,
              25.5,
              25.5,
              25.8,
              26.0,
              26.2,
              26.5,
              26.8,
              27.0,
              27.0
            ]
          },
          {
            "name": "Emgality",
            "unit": "%",
            "values": [
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0,
              46.0
            ]
          },
          {
            "name": "Vyepti",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        ],
        "figure_id": "7a3637d7dfad3ee4",
        "provenance": {
          "page": 63
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 63,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 50
            }
          }
        },
        "series": [
          {
            "name": "Ubrelvy",
            "unit": "%",
            "values": [
              32.5,
              33,
              32.5,
              32,
              32.5,
              33,
              32.5,
              33,
              32.5,
              33,
              33,
              33,
              33,
              33,
              33.5,
              33.5,
              33.5,
              33
            ]
          },
          {
            "name": "Qulipta",
            "unit": "%",
            "values": [
              22.5,
              22.5,
              23,
              23,
              22.5,
              22.5,
              24,
              24,
              23.5,
              23.5,
              23.5,
              24,
              24,
              23.5,
              23.5,
              24,
              24.5,
              24
            ]
          },
          {
            "name": "Nurtec",
            "unit": "%",
            "values": [
              45,
              44.5,
              45,
              44.5,
              44,
              44.5,
              44,
              43.5,
              43.5,
              43.5,
              43.5,
              43.5,
              43.5,
              43.5,
              43.5,
              43,
              43,
              43
            ]
          }
        ],
        "figure_id": "c6a1bcc0b7060ae5",
        "provenance": {
          "page": 63
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 64,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "5/25/18",
              "6/7/19",
              "6/19/20",
              "7/2/21",
              "7/15/22",
              "7/28/23",
              "8/9/24",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "Weekly TRx",
            "range": {
              "min": 0,
              "max": 300000
            }
          }
        },
        "series": [
          {
            "name": "Total CGRP",
            "unit": "Weekly TRx",
            "values": [
              1000,
              20000,
              60000,
              100000,
              150000,
              200000,
              230000,
              240000
            ]
          },
          {
            "name": "Nurtec (Biohaven)",
            "unit": "Weekly TRx",
            "values": [
              0,
              0,
              1000,
              10000,
              30000,
              50000,
              65000,
              70000
            ]
          },
          {
            "name": "Ubrelvy (ABBV)",
            "unit": "Weekly TRx",
            "values": [
              0,
              0,
              5000,
              20000,
              35000,
              45000,
              50000,
              55000
            ]
          },
          {
            "name": "Quipfa (ABBV)",
            "unit": "Weekly TRx",
            "values": [
              0,
              0,
              0,
              0,
              5000,
              15000,
              25000,
              30000
            ]
          },
          {
            "name": "Ajovy (TEVA/AGN)",
            "unit": "Weekly TRx",
            "values": [
              0,
              10000,
              20000,
              25000,
              20000,
              20000,
              20000,
              20000
            ]
          },
          {
            "name": "Emgality (LLY)",
            "unit": "Weekly TRx",
            "values": [
              0,
              15000,
              25000,
              30000,
              25000,
              25000,
              25000,
              25000
            ]
          },
          {
            "name": "Aimovig (AMGN/Novartis)",
            "unit": "Weekly TRx",
            "values": [
              0,
              20000,
              30000,
              35000,
              30000,
              30000,
              30000,
              30000
            ]
          },
          {
            "name": "Vyepti (Lundbeck)",
            "unit": "Weekly TRx",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          }
        ],
        "figure_id": "9893e64d999982d1",
        "provenance": {
          "page": 64
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 64,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -40,
              "max": 50
            }
          }
        },
        "series": [
          {
            "name": "Aimoviq",
            "unit": "%",
            "values": [
              -12,
              -10,
              -12,
              -15,
              -13,
              -32,
              -22,
              -10,
              -15,
              -5,
              -12,
              -8,
              -9,
              -8,
              -9,
              -8,
              -8,
              -8
            ]
          },
          {
            "name": "Ajovy",
            "unit": "%",
            "values": [
              18,
              22,
              18,
              20,
              19,
              39,
              10,
              22,
              15,
              22,
              11,
              12,
              10,
              11,
              13,
              15,
              15,
              15
            ]
          },
          {
            "name": "Emgality",
            "unit": "%",
            "values": [
              8,
              12,
              5,
              10,
              33,
              22,
              10,
              12,
              5,
              15,
              5,
              3,
              5,
              6,
              7,
              5,
              6,
              5
            ]
          },
          {
            "name": "Total Inj. CGRP",
            "unit": "%",
            "values": [
              3,
              5,
              2,
              3,
              12,
              10,
              -2,
              8,
              -2,
              14,
              -2,
              0,
              0,
              2,
              3,
              5,
              5,
              3
            ]
          }
        ],
        "figure_id": "d50e673f04c60d72",
        "provenance": {
          "page": 64
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 65,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -10,
              "max": 70
            }
          }
        },
        "series": [
          {
            "name": "Ubrelvy",
            "unit": "%",
            "values": [
              17,
              20,
              24,
              20,
              19,
              23,
              18,
              10,
              18,
              26,
              20,
              18,
              15,
              18,
              19,
              17,
              15,
              11
            ]
          },
          {
            "name": "Qulipta",
            "unit": "%",
            "values": [
              45,
              42,
              47,
              41,
              39,
              65,
              42,
              39,
              47,
              30,
              29,
              32,
              30,
              33,
              31,
              33,
              29,
              27
            ]
          },
          {
            "name": "Nurtec",
            "unit": "%",
            "values": [
              22,
              25,
              22,
              20,
              16,
              -1,
              20,
              8,
              20,
              27,
              7,
              10,
              8,
              14,
              9,
              15,
              10,
              11
            ]
          },
          {
            "name": "Total Oral CGRP",
            "unit": "%",
            "values": [
              25,
              28,
              26,
              25,
              22,
              35,
              23,
              15,
              27,
              28,
              22,
              22,
              19,
              22,
              20,
              20,
              18,
              17
            ]
          }
        ],
        "figure_id": "5642c2567f2b9139",
        "provenance": {
          "page": 65
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 68,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 80
            }
          }
        },
        "series": [
          {
            "name": "Zeposia",
            "unit": "%",
            "values": [
              63,
              60,
              65,
              62,
              67,
              60,
              68,
              65,
              69,
              66,
              68,
              69,
              71,
              69,
              70,
              71,
              69,
              67
            ]
          },
          {
            "name": "Gilenya generic",
            "unit": "%",
            "values": [
              49,
              48,
              49,
              48,
              51,
              47,
              50,
              49,
              50,
              49,
              49,
              50,
              50,
              51,
              50,
              51,
              50,
              49
            ]
          },
          {
            "name": "Mayzent",
            "unit": "%",
            "values": [
              20,
              19,
              18,
              19,
              23,
              19,
              18,
              19,
              18,
              19,
              19,
              18,
              19,
              19,
              19,
              19,
              18,
              17
            ]
          },
          {
            "name": "Gilenya",
            "unit": "%",
            "values": [
              9,
              8,
              7,
              8,
              6,
              8,
              7,
              7,
              6,
              7,
              6,
              6,
              6,
              6,
              6,
              7,
              8,
              7
            ]
          }
        ],
        "figure_id": "812b43a88d24ecd4",
        "provenance": {
          "page": 68
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 68,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 70
            }
          }
        },
        "series": [
          {
            "name": "Tecfidera",
            "unit": "%",
            "values": [
              9.5,
              9.5,
              9.5,
              9.5,
              9.5,
              8.5,
              8.5,
              7.5,
              7.0,
              6.0,
              6.0,
              6.5,
              6.0,
              6.5,
              6.0,
              5.5,
              6.0,
              6.0
            ]
          },
          {
            "name": "Tecfidera generics",
            "unit": "%",
            "values": [
              55.0,
              54.0,
              56.0,
              53.0,
              54.0,
              52.0,
              53.0,
              54.0,
              53.0,
              52.0,
              56.0,
              53.0,
              53.0,
              54.0,
              52.0,
              54.0,
              54.0,
              53.0
            ]
          },
          {
            "name": "Vumerity",
            "unit": "%",
            "values": [
              35.0,
              36.0,
              34.0,
              35.0,
              33.0,
              36.0,
              37.0,
              38.0,
              39.0,
              37.0,
              42.0,
              39.0,
              41.0,
              38.0,
              40.0,
              42.0,
              40.0,
              41.0
            ]
          },
          {
            "name": "Tecfidera+Vumerity",
            "unit": "%",
            "values": [
              45.0,
              45.0,
              43.0,
              44.0,
              43.0,
              44.0,
              45.0,
              46.0,
              47.0,
              43.0,
              48.0,
              45.0,
              47.0,
              45.0,
              46.0,
              47.0,
              46.0,
              47.0
            ]
          }
        ],
        "figure_id": "6a24818beb42c154",
        "provenance": {
          "page": 68
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 68,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Apr-16",
              "Jul-16",
              "Oct-16",
              "Jan-17",
              "Apr-17",
              "Jul-17",
              "Oct-17",
              "Jan-18",
              "Apr-18",
              "Jul-18",
              "Oct-18",
              "Jan-19",
              "Apr-19",
              "Jul-19",
              "Oct-19",
              "Jan-20",
              "Apr-20",
              "Jul-20",
              "Oct-20",
              "Jan-21",
              "Apr-21",
              "Jul-21",
              "Oct-21",
              "Jan-22",
              "Apr-22",
              "Jul-22",
              "Oct-22",
              "Jan-23",
              "Apr-23",
              "Jul-23",
              "Oct-23",
              "Jan-24",
              "Apr-24",
              "Jul-24",
              "Oct-24",
              "Jan-25",
              "Apr-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "$M",
            "range": {
              "min": 0,
              "max": 180
            }
          }
        },
        "series": [
          {
            "name": "Tysabri (BIIB)",
            "unit": "$M",
            "values": [
              132,
              140,
              148,
              158,
              145,
              155,
              140,
              130,
              145,
              135,
              140,
              125,
              135,
              120,
              118,
              115,
              118,
              115,
              110,
              105,
              110,
              100,
              105,
              100,
              105,
              98,
              100,
              110,
              80,
              90,
              85,
              90,
              90,
              88,
              85,
              90,
              115
            ]
          },
          {
            "name": "Total Avonex (BIIB)",
            "unit": "$M",
            "values": [
              145,
              148,
              140,
              145,
              150,
              140,
              130,
              125,
              120,
              115,
              110,
              105,
              100,
              95,
              90,
              85,
              80,
              75,
              70,
              65,
              60,
              58,
              55,
              50,
              60,
              55,
              50,
              60,
              50,
              55,
              50,
              55,
              55,
              58,
              55,
              58,
              60
            ]
          }
        ],
        "figure_id": "ae9989870cef6715",
        "provenance": {
          "page": 68
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 69,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 80000
            }
          }
        },
        "series": [
          {
            "name": "Latuda (Sunovion)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 5000
              },
              {
                "x": 100,
                "y": 12000
              },
              {
                "x": 150,
                "y": 25000
              },
              {
                "x": 200,
                "y": 35000
              },
              {
                "x": 250,
                "y": 45000
              },
              {
                "x": 300,
                "y": 48000
              },
              {
                "x": 350,
                "y": 49000
              },
              {
                "x": 400,
                "y": 50000
              },
              {
                "x": 450,
                "y": 52000
              },
              {
                "x": 500,
                "y": 54000
              },
              {
                "x": 550,
                "y": 55000
              },
              {
                "x": 600,
                "y": 55000
              },
              {
                "x": 650,
                "y": 10000
              },
              {
                "x": 680,
                "y": 0
              }
            ]
          },
          {
            "name": "Vraylar (ABBV)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 2000
              },
              {
                "x": 100,
                "y": 5000
              },
              {
                "x": 150,
                "y": 10000
              },
              {
                "x": 200,
                "y": 18000
              },
              {
                "x": 250,
                "y": 25000
              },
              {
                "x": 300,
                "y": 30000
              },
              {
                "x": 350,
                "y": 40000
              },
              {
                "x": 400,
                "y": 50000
              },
              {
                "x": 450,
                "y": 60000
              },
              {
                "x": 500,
                "y": 68000
              }
            ]
          },
          {
            "name": "Caplyta (Intra-Cellular)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 500
              },
              {
                "x": 100,
                "y": 1500
              },
              {
                "x": 150,
                "y": 3000
              },
              {
                "x": 200,
                "y": 6000
              },
              {
                "x": 250,
                "y": 9000
              },
              {
                "x": 300,
                "y": 12000
              },
              {
                "x": 350,
                "y": 14000
              }
            ]
          },
          {
            "name": "Lybalvi (Alkermes)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 200
              },
              {
                "x": 100,
                "y": 1000
              },
              {
                "x": 150,
                "y": 2000
              },
              {
                "x": 200,
                "y": 4000
              },
              {
                "x": 250,
                "y": 5000
              }
            ]
          },
          {
            "name": "Cobenfy (Bristol Myers)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 100
              },
              {
                "x": 100,
                "y": 500
              },
              {
                "x": 150,
                "y": 1000
              },
              {
                "x": 200,
                "y": 1500
              },
              {
                "x": 250,
                "y": 2000
              }
            ]
          },
          {
            "name": "Rexulti (Otsuka)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 50,
                "y": 3000
              },
              {
                "x": 100,
                "y": 8000
              },
              {
                "x": 150,
                "y": 15000
              },
              {
                "x": 200,
                "y": 18000
              },
              {
                "x": 250,
                "y": 19000
              },
              {
                "x": 300,
                "y": 20000
              },
              {
                "x": 350,
                "y": 22000
              },
              {
                "x": 400,
                "y": 25000
              },
              {
                "x": 450,
                "y": 30000
              },
              {
                "x": 500,
                "y": 37000
              }
            ]
          }
        ],
        "figure_id": "1bfbf4e8a411a90d",
        "provenance": {
          "page": 69
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 70,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "Weekly TRx",
            "range": {
              "min": 0,
              "max": 80000
            }
          }
        },
        "series": [
          {
            "name": "Vraylar (ABBV)",
            "unit": "Weekly TRx",
            "values": [
              57000,
              64000,
              62000,
              64000,
              65000,
              67000,
              60000,
              68000,
              64000,
              65000,
              66000,
              65000,
              66000,
              67000,
              68000,
              60000,
              67000,
              68000
            ]
          },
          {
            "name": "Rexulti (Otsuka)",
            "unit": "Weekly TRx",
            "values": [
              62000,
              66000,
              64000,
              65000,
              66000,
              68000,
              67000,
              69000,
              65000,
              66000,
              67000,
              66000,
              67000,
              68000,
              69000,
              62000,
              68000,
              69000
            ]
          },
          {
            "name": "Caplyta (Intra-Cellular)",
            "unit": "Weekly TRx",
            "values": [
              29000,
              31000,
              30000,
              31000,
              32000,
              33000,
              27000,
              32000,
              33000,
              33000,
              34000,
              35000,
              36000,
              34000,
              36000,
              38000,
              37000,
              37000
            ]
          },
          {
            "name": "Latuda (Sunovion)",
            "unit": "Weekly TRx",
            "values": [
              10000,
              11000,
              11000,
              11000,
              11000,
              12000,
              10000,
              12000,
              12000,
              12000,
              12000,
              13000,
              13000,
              12000,
              13000,
              14000,
              14000,
              14000
            ]
          },
          {
            "name": "Lybalvi (Alkermes)",
            "unit": "Weekly TRx",
            "values": [
              4000,
              4500,
              4500,
              4500,
              5000,
              5000,
              4500,
              5000,
              5000,
              5000,
              5000,
              5500,
              5500,
              5500,
              5500,
              5500,
              5500,
              5500
            ]
          },
          {
            "name": "Latuda Generics",
            "unit": "Weekly TRx",
            "values": [
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000,
              1000
            ]
          },
          {
            "name": "Cobenfy (BMY)",
            "unit": "Weekly TRx",
            "values": [
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500,
              1500
            ]
          }
        ],
        "figure_id": "5f5a2350fc7f8068",
        "provenance": {
          "page": 70
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 70,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": -10,
              "max": 75000
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": null,
            "values": [
              60000,
              57000,
              63000,
              64000,
              64500,
              66000,
              53000,
              67000,
              60000,
              64000,
              65000,
              63000,
              66000,
              67000,
              63000,
              67000,
              62000,
              67000,
              68000
            ]
          },
          {
            "name": "Weekly TRx YOY growth",
            "unit": "%",
            "values": [
              17,
              17,
              16,
              15,
              15,
              35,
              -5,
              23,
              10,
              15,
              16,
              14,
              12,
              13,
              12,
              10,
              10,
              9,
              9
            ]
          }
        ],
        "figure_id": "a4c26b8c56f9fff7",
        "provenance": {
          "page": 70
        }
      },
      {
        "type": "line",
        "title": "Monthly IQVIA sales",
        "page": 70,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jan-23",
              "Feb-23",
              "Mar-23",
              "Apr-23",
              "May-23",
              "Jun-23",
              "Jul-23",
              "Aug-23",
              "Sep-23",
              "Oct-23",
              "Nov-23",
              "Dec-23",
              "Jan-24",
              "Feb-24",
              "Mar-24",
              "Apr-24",
              "May-24",
              "Jun-24",
              "Jul-24",
              "Aug-24",
              "Sep-24",
              "Oct-24",
              "Nov-24",
              "Dec-24",
              "Jan-25",
              "Feb-25",
              "Mar-25",
              "Apr-25",
              "May-25",
              "Jun-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "$M",
            "range": {
              "min": 0,
              "max": 25
            }
          }
        },
        "series": [
          {
            "name": "Legembi (BIIB/Eisai)",
            "unit": "$M",
            "values": [
              0.1,
              0.1,
              0.1,
              0.1,
              0.2,
              0.3,
              0.5,
              0.8,
              1.5,
              2.5,
              3.5,
              4.5,
              6.0,
              7.5,
              9.0,
              10.5,
              12.0,
              13.5,
              15.0,
              16.5,
              18.0,
              19.0,
              20.0,
              20.5,
              21.0,
              21.5,
              21.5,
              21.5,
              21.5,
              21.5
            ]
          },
          {
            "name": "Kisunla (LLY)",
            "unit": "$M",
            "values": [
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              0.1,
              0.5,
              1.5,
              3.0,
              5.0,
              7.0,
              9.0,
              11.0,
              12.5,
              13.5,
              14.5
            ]
          }
        ],
        "figure_id": "27ed83b432f3a0e5",
        "provenance": {
          "page": 70
        }
      },
      {
        "type": "bar",
        "title": null,
        "page": 71,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1",
              "2",
              "3",
              "4",
              "5",
              "6",
              "7",
              "8",
              "9",
              "10",
              "11",
              "12",
              "13",
              "14",
              "15",
              "16",
              "17",
              "18",
              "19",
              "20",
              "21",
              "22",
              "23",
              "24",
              "25",
              "26",
              "27",
              "28",
              "29",
              "30"
            ]
          },
          "y": {
            "unit": "$000s",
            "range": {
              "min": 0,
              "max": 25
            }
          }
        },
        "series": [
          {
            "name": "Kisunla (LLY)",
            "unit": "$000s",
            "values": [
              0.1,
              0.2,
              0.5,
              1.2,
              2.5,
              3.5,
              4.5,
              7.5,
              9.5,
              11.5,
              12.5,
              14.0,
              12.0,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null
            ]
          },
          {
            "name": "Leqembi (BIIB/Eisai)",
            "unit": "$000s",
            "values": [
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              null,
              1.0,
              1.5,
              2.5,
              3.0,
              4.0,
              5.5,
              7.0,
              8.5,
              9.5,
              10.5,
              11.5,
              12.5,
              13.5,
              14.5,
              15.5,
              16.5,
              17.5,
              18.5,
              19.5,
              20.5,
              21.5
            ]
          }
        ],
        "figure_id": "483e81c66b5b8494",
        "provenance": {
          "page": 71
        }
      },
      {
        "type": "bar",
        "title": null,
        "page": 71,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jan-23",
              "Feb-23",
              "Mar-23",
              "Apr-23",
              "May-23",
              "Jun-23",
              "Jul-23",
              "Aug-23",
              "Sep-23",
              "Oct-23",
              "Nov-23",
              "Dec-23",
              "Jan-24",
              "Feb-24",
              "Mar-24",
              "Apr-24",
              "May-24",
              "Jun-24",
              "Jul-24",
              "Aug-24",
              "Sep-24",
              "Oct-24",
              "Nov-24",
              "Dec-24",
              "Jan-25",
              "Feb-25",
              "Mar-25",
              "Apr-25",
              "May-25",
              "Jun-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "$000s",
            "range": {
              "min": 0,
              "max": 40
            }
          }
        },
        "series": [
          {
            "name": "Leqembi (BIIB/Eisai)",
            "unit": "$000s",
            "values": [
              0.5,
              0.8,
              1.2,
              1.6,
              2.0,
              2.5,
              3.0,
              3.5,
              4.0,
              4.5,
              5.0,
              5.5,
              6.0,
              6.5,
              7.0,
              7.5,
              8.0,
              8.5,
              9.0,
              9.5,
              10.0,
              10.5,
              11.0,
              11.5,
              12.0,
              12.5,
              13.0,
              13.5,
              14.0,
              14.5,
              15.0,
              15.5,
              16.0,
              16.5,
              17.0,
              17.5,
              18.0,
              18.5,
              19.0,
              19.5,
              20.0,
              20.5,
              21.0
            ]
          },
          {
            "name": "Kisunla (LLY)",
            "unit": "$000s",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0.5,
              1.0,
              1.5,
              2.0,
              2.5,
              3.0,
              3.5,
              4.0,
              4.5,
              5.0,
              5.5,
              6.0,
              6.5,
              7.0,
              7.5,
              8.0,
              8.5,
              9.0
            ]
          }
        ],
        "figure_id": "0bc5987ac5a5e069",
        "provenance": {
          "page": 71
        }
      },
      {
        "type": "bar",
        "title": null,
        "page": 72,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1Q:23",
              "2Q:23",
              "3Q:23",
              "4Q:23",
              "1Q:24",
              "2Q:24",
              "3Q:24",
              "4Q:24",
              "1Q:25",
              "2Q:25"
            ]
          },
          "y": {
            "unit": "$M",
            "range": {
              "min": 0,
              "max": 120
            }
          }
        },
        "series": [
          {
            "name": "Legembi (BIIB/Eisai)",
            "unit": "$M",
            "values": [
              0.5,
              1.5,
              3.5,
              8.0,
              19.0,
              30.0,
              39.0,
              50.0,
              52.0,
              63.0
            ]
          },
          {
            "name": "Kisunla (LLY)",
            "unit": "$M",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              7.0,
              18.0,
              40.0
            ]
          }
        ],
        "figure_id": "4b9d851b5eae79b3",
        "provenance": {
          "page": 72
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 74,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 50
            }
          }
        },
        "series": [
          {
            "name": "Restasis",
            "unit": "%",
            "values": [
              48,
              49,
              47,
              45,
              42,
              47,
              46,
              45,
              44,
              43,
              41,
              39,
              38,
              37,
              35,
              36,
              37,
              36,
              37,
              36,
              37,
              36,
              37,
              38,
              37,
              38,
              39,
              38,
              36
            ]
          },
          {
            "name": "Xiidra",
            "unit": "%",
            "values": [
              24,
              25,
              24,
              24,
              23,
              24,
              23,
              25,
              23,
              22,
              23,
              25,
              24,
              25,
              24,
              23,
              23,
              24,
              23,
              23,
              23,
              23,
              24,
              24,
              23,
              23,
              22,
              21,
              21
            ]
          },
          {
            "name": "Tyrvaya",
            "unit": "%",
            "values": [
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              4,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3,
              3
            ]
          },
          {
            "name": "Xdemvy",
            "unit": "%",
            "values": [
              4,
              4,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              6,
              6,
              7,
              7,
              7,
              8,
              8,
              8,
              8,
              7,
              7,
              7,
              7,
              8,
              8,
              8,
              8,
              8,
              8,
              8
            ]
          },
          {
            "name": "Miebo",
            "unit": "%",
            "values": [
              13,
              15,
              14,
              16,
              19,
              12,
              14,
              15,
              16,
              15,
              18,
              16,
              15,
              16,
              18,
              19,
              20,
              21,
              22,
              23,
              24,
              25,
              26,
              27,
              26,
              25,
              24,
              27,
              27
            ]
          },
          {
            "name": "Vevye",
            "unit": "%",
            "values": [
              4,
              4,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              5,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6,
              6
            ]
          }
        ],
        "figure_id": "ae92dc4bb2c5c8ce",
        "provenance": {
          "page": 74
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 74,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "Weekly TRx",
            "range": {
              "min": 0,
              "max": 50000
            }
          }
        },
        "series": [
          {
            "name": "Restasis",
            "unit": "Weekly TRx",
            "values": [
              42000,
              39000,
              43500,
              43000,
              44000,
              46000,
              39000,
              34000,
              32000,
              34000,
              33500,
              34000,
              35500,
              36500,
              33500,
              37000,
              36500,
              37500
            ]
          },
          {
            "name": "Xiidra",
            "unit": "Weekly TRx",
            "values": [
              21000,
              19500,
              22000,
              23000,
              24500,
              22000,
              20000,
              21500,
              21000,
              22000,
              22500,
              22500,
              22500,
              22500,
              23500,
              22500,
              22000,
              22500
            ]
          },
          {
            "name": "Tyrvaya",
            "unit": "Weekly TRx",
            "values": [
              3500,
              3800,
              4000,
              4200,
              4500,
              4000,
              3000,
              3000,
              3500,
              3800,
              4000,
              4000,
              4000,
              4000,
              4000,
              4000,
              4000,
              4000
            ]
          },
          {
            "name": "Xdemvy",
            "unit": "Weekly TRx",
            "values": [
              3800,
              4000,
              4200,
              4500,
              4800,
              5000,
              4000,
              4500,
              5000,
              6000,
              7000,
              7000,
              7000,
              7000,
              7000,
              7500,
              7500,
              8000
            ]
          },
          {
            "name": "Miebo",
            "unit": "Weekly TRx",
            "values": [
              11500,
              13000,
              15000,
              18000,
              11000,
              19000,
              13000,
              16000,
              18000,
              20000,
              22000,
              23000,
              25000,
              27000,
              25000,
              22000,
              25000,
              28500
            ]
          },
          {
            "name": "Vevye",
            "unit": "Weekly TRx",
            "values": [
              3500,
              3800,
              4000,
              4200,
              4500,
              5000,
              3500,
              4000,
              4500,
              5000,
              5000,
              5000,
              5000,
              5000,
              5000,
              5000,
              5000,
              5500
            ]
          }
        ],
        "figure_id": "e55920bca86b31f5",
        "provenance": {
          "page": 74
        }
      },
      {
        "type": "line",
        "title": "Monthly IQVIA sales ($M)",
        "page": 75,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Jan-22",
              "Feb-22",
              "Mar-22",
              "Apr-22",
              "May-22",
              "Jun-22",
              "Jul-22",
              "Aug-22",
              "Sep-22",
              "Oct-22",
              "Nov-22",
              "Dec-22",
              "Jan-23",
              "Feb-23",
              "Mar-23",
              "Apr-23",
              "May-23",
              "Jun-23",
              "Jul-23",
              "Aug-23",
              "Sep-23",
              "Oct-23",
              "Nov-23",
              "Dec-23",
              "Jan-24",
              "Feb-24",
              "Mar-24",
              "Apr-24",
              "May-24",
              "Jun-24",
              "Jul-24",
              "Aug-24",
              "Sep-24",
              "Oct-24",
              "Nov-24",
              "Dec-24",
              "Jan-25",
              "Feb-25",
              "Mar-25",
              "Apr-25",
              "May-25",
              "Jun-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "$M",
            "range": {
              "min": 0,
              "max": 45
            }
          }
        },
        "series": [
          {
            "name": "Vyvgart (ARGX)",
            "unit": "$M",
            "values": [
              0,
              2,
              5,
              8,
              12,
              16,
              18,
              20.5,
              16,
              12,
              8,
              9,
              10,
              10.5,
              11,
              12,
              13,
              14,
              13,
              15,
              13,
              16,
              12,
              10,
              30,
              41,
              32,
              39,
              32,
              38,
              32,
              42,
              34,
              35,
              34,
              35,
              36,
              35,
              36,
              36,
              36,
              36,
              36
            ]
          }
        ],
        "figure_id": "7b905003aab7b382",
        "provenance": {
          "page": 75
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 76,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 41
            }
          }
        },
        "series": [
          {
            "name": "Advair+Breo franchise (including A.G.)",
            "unit": "%",
            "values": [
              35.0,
              34.5,
              33.5,
              32.5,
              32.0,
              33.0,
              33.5,
              33.0,
              32.5,
              32.0,
              31.5,
              31.0,
              30.5,
              30.5,
              30.5,
              30.0,
              30.0,
              30.0
            ]
          },
          {
            "name": "Wixela",
            "unit": "%",
            "values": [
              10.5,
              11.0,
              10.0,
              10.5,
              10.0,
              10.5,
              10.5,
              10.5,
              10.0,
              9.5,
              9.0,
              9.0,
              9.0,
              9.5,
              9.5,
              10.0,
              10.0,
              10.0
            ]
          },
          {
            "name": "Airuduo (brand+Gx)",
            "unit": "%",
            "values": [
              4.5,
              4.0,
              4.5,
              4.5,
              4.5,
              4.5,
              4.0,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5,
              3.5
            ]
          },
          {
            "name": "Dulera",
            "unit": "%",
            "values": [
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0,
              5.0
            ]
          },
          {
            "name": "Symbicort",
            "unit": "%",
            "values": [
              32.0,
              32.5,
              33.0,
              33.5,
              34.0,
              33.5,
              34.0,
              34.5,
              35.0,
              35.0,
              35.5,
              35.5,
              36.0,
              36.0,
              36.0,
              36.0,
              36.0,
              36.0
            ]
          }
        ],
        "figure_id": "0ca01df56a7597d7",
        "provenance": {
          "page": 76
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 76,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": -40,
              "max": 0
            }
          }
        },
        "series": [
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              -21.5,
              -21.0,
              -22.0,
              -22.5,
              -23.5,
              -35.5,
              -20.0,
              -18.0,
              -20.0,
              -12.0,
              -10.0,
              -12.0,
              -10.0,
              -11.0,
              -12.0,
              -13.0,
              -14.0,
              -15.0
            ]
          }
        ],
        "figure_id": "74cce2256ec956dc",
        "provenance": {
          "page": 76
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 77,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 35
            }
          }
        },
        "series": [
          {
            "name": "GSK",
            "unit": "%",
            "values": [
              24.0,
              24.5,
              23.5,
              23.0,
              23.0,
              23.5,
              22.0,
              21.0,
              21.5,
              21.0,
              20.5,
              21.0,
              21.5,
              21.5,
              21.5,
              21.0,
              21.5,
              21.0
            ]
          },
          {
            "name": "Viatris",
            "unit": "%",
            "values": [
              28.5,
              28.5,
              27.5,
              28.5,
              28.0,
              28.5,
              28.0,
              27.5,
              26.0,
              24.0,
              24.5,
              25.5,
              26.5,
              27.5,
              28.0,
              28.5,
              28.5,
              29.0
            ]
          },
          {
            "name": "Prasco (A.G.)",
            "unit": "%",
            "values": [
              22.5,
              22.0,
              22.5,
              22.5,
              22.5,
              22.5,
              22.5,
              22.5,
              22.0,
              21.5,
              21.0,
              21.0,
              21.0,
              21.0,
              21.0,
              20.5,
              20.5,
              21.0
            ]
          },
          {
            "name": "Hikma",
            "unit": "%",
            "values": [
              23.0,
              23.5,
              25.0,
              25.5,
              26.0,
              26.5,
              27.5,
              28.0,
              28.5,
              30.0,
              30.5,
              29.5,
              29.5,
              28.5,
              28.0,
              28.5,
              29.0,
              29.0
            ]
          }
        ],
        "figure_id": "e2acafb2b2f881ae",
        "provenance": {
          "page": 77
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 77,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "unit": "%",
            "range": {
              "min": 0,
              "max": 50
            }
          }
        },
        "series": [
          {
            "name": "Spiriva",
            "unit": "%",
            "values": [
              44.0,
              44.0,
              44.5,
              45.0,
              45.0,
              45.0,
              45.5,
              45.5,
              45.5,
              46.0,
              46.0,
              46.5,
              45.0,
              44.0,
              43.5,
              43.0,
              43.5,
              43.0
            ]
          },
          {
            "name": "Spiriva generic",
            "unit": "%",
            "values": [
              22.0,
              22.0,
              21.5,
              21.0,
              20.5,
              20.0,
              19.5,
              19.5,
              20.0,
              20.0,
              20.0,
              20.0,
              20.5,
              20.0,
              20.0,
              20.0,
              20.0,
              20.0
            ]
          },
          {
            "name": "Tudorza",
            "unit": "%",
            "values": [
              9.0,
              9.0,
              8.5,
              8.5,
              8.5,
              8.5,
              9.0,
              9.5,
              10.0,
              9.5,
              9.5,
              9.0,
              9.0,
              9.5,
              9.5,
              9.0,
              9.0,
              9.0
            ]
          },
          {
            "name": "Incruse Ellipta",
            "unit": "%",
            "values": [
              24.5,
              24.5,
              25.0,
              25.0,
              24.5,
              24.5,
              25.0,
              25.5,
              26.0,
              25.5,
              25.0,
              25.5,
              26.0,
              27.0,
              27.5,
              28.0,
              28.0,
              28.0
            ]
          },
          {
            "name": "Anoro Ellipta",
            "unit": "%",
            "values": [
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0,
              0.0
            ]
          }
        ],
        "figure_id": "9fc9b56cd51722a2",
        "provenance": {
          "page": 77
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 78,
        "axes": {
          "x": {
            "type": "value",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 7000
            }
          }
        },
        "series": [
          {
            "name": "Daliresp (ABBV)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              100,
              200,
              500,
              1000,
              1200,
              1500,
              1800,
              2000,
              2200,
              2500,
              2600,
              2800,
              3000,
              3500,
              3000,
              4000,
              4100,
              3800,
              4500,
              4800,
              5000,
              5100,
              5500,
              5600,
              5800,
              6000,
              6100
            ]
          },
          {
            "name": "Ohtuvayre (Verona)",
            "unit": "TRx",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              100,
              200,
              300,
              400,
              500,
              600,
              700,
              800,
              900,
              800,
              900,
              1000,
              1200,
              1500,
              2000,
              1000,
              900,
              800,
              400,
              500,
              400,
              300,
              200,
              300,
              200,
              200
            ]
          }
        ],
        "figure_id": "ddc7b7462f9c1196",
        "provenance": {
          "page": 78
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 79,
        "axes": {
          "x": {
            "type": "linear",
            "labels": "Weeks since launch"
          },
          "y": {
            "unit": "TRx",
            "range": {
              "min": 0,
              "max": 12000
            }
          }
        },
        "series": [
          {
            "name": "Evenity (AMGN)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 20,
                "y": 100
              },
              {
                "x": 40,
                "y": 200
              },
              {
                "x": 60,
                "y": 300
              },
              {
                "x": 80,
                "y": 400
              },
              {
                "x": 100,
                "y": 500
              },
              {
                "x": 120,
                "y": 600
              },
              {
                "x": 140,
                "y": 700
              },
              {
                "x": 160,
                "y": 800
              },
              {
                "x": 180,
                "y": 900
              },
              {
                "x": 200,
                "y": 1000
              },
              {
                "x": 220,
                "y": 1100
              },
              {
                "x": 240,
                "y": 1200
              },
              {
                "x": 260,
                "y": 1300
              },
              {
                "x": 280,
                "y": 1400
              },
              {
                "x": 300,
                "y": 1500
              },
              {
                "x": 320,
                "y": 1300
              }
            ]
          },
          {
            "name": "Prolia (AMGN)",
            "unit": "TRx",
            "values": [
              {
                "x": 0,
                "y": 0
              },
              {
                "x": 20,
                "y": 100
              },
              {
                "x": 40,
                "y": 200
              },
              {
                "x": 60,
                "y": 300
              },
              {
                "x": 80,
                "y": 400
              },
              {
                "x": 100,
                "y": 500
              },
              {
                "x": 120,
                "y": 700
              },
              {
                "x": 140,
                "y": 900
              },
              {
                "x": 160,
                "y": 1200
              },
              {
                "x": 180,
                "y": 1500
              },
              {
                "x": 200,
                "y": 2000
              },
              {
                "x": 220,
                "y": 2500
              },
              {
                "x": 240,
                "y": 3000
              },
              {
                "x": 260,
                "y": 3500
              },
              {
                "x": 280,
                "y": 4000
              },
              {
                "x": 300,
                "y": 4500
              },
              {
                "x": 320,
                "y": 5000
              },
              {
                "x": 340,
                "y": 5500
              },
              {
                "x": 360,
                "y": 6000
              },
              {
                "x": 380,
                "y": 6500
              },
              {
                "x": 400,
                "y": 7000
              },
              {
                "x": 420,
                "y": 7500
              },
              {
                "x": 440,
                "y": 8000
              },
              {
                "x": 460,
                "y": 8200
              },
              {
                "x": 480,
                "y": 8500
              },
              {
                "x": 500,
                "y": 8700
              },
              {
                "x": 520,
                "y": 9000
              },
              {
                "x": 540,
                "y": 9500
              },
              {
                "x": 560,
                "y": 9000
              },
              {
                "x": 580,
                "y": 9200
              },
              {
                "x": 600,
                "y": 9500
              },
              {
                "x": 620,
                "y": 9700
              },
              {
                "x": 640,
                "y": 9800
              },
              {
                "x": 660,
                "y": 9900
              },
              {
                "x": 680,
                "y": 10000
              },
              {
                "x": 700,
                "y": 9800
              }
            ]
          }
        ],
        "figure_id": "6509964fdb875f07",
        "provenance": {
          "page": 79
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 81,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 140000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -40,
                "max": 120
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              58000,
              90000,
              108000,
              112000,
              114000,
              68000,
              36000,
              60000,
              50000,
              56000,
              48000,
              40000,
              30000,
              26000,
              22000,
              26000,
              24000,
              38000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              -5,
              -10,
              -2,
              10,
              80,
              -20,
              -5,
              60,
              20,
              85,
              60,
              30,
              0,
              -15,
              -25,
              -30,
              -25,
              -20
            ]
          }
        ],
        "figure_id": "5b9bef5391ee3aa4",
        "provenance": {
          "page": 81
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 81,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 5000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -70,
                "max": 0
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              2750,
              4000,
              4500,
              3800,
              3100,
              2200,
              1250,
              2000,
              1750,
              2000,
              1750,
              1500,
              1300,
              1000,
              1000,
              1100,
              1200,
              1400
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              -25,
              -20,
              -30,
              -45,
              -20,
              -60,
              -30,
              -20,
              -30,
              -20,
              -30,
              -35,
              -40,
              -45,
              -40,
              -25,
              -35,
              -45
            ]
          }
        ],
        "figure_id": "acfdf4913e0216ed",
        "provenance": {
          "page": 81
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 81,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 16000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": 0,
                "max": 90
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              10800,
              10200,
              12000,
              13000,
              12500,
              11800,
              9000,
              6500,
              8500,
              9800,
              11000,
              12200,
              11500,
              11800,
              11000,
              10000,
              11200,
              13800
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              90,
              80,
              70,
              60,
              50,
              40,
              30,
              20,
              10,
              0,
              10,
              20,
              30,
              40,
              50,
              60,
              70,
              80
            ]
          }
        ],
        "figure_id": "ee6b8e65a8e58616",
        "provenance": {
          "page": 81
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 82,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": [
            {
              "unit": "count",
              "range": {
                "min": 0,
                "max": 1600000
              },
              "label": "Weekly TRx"
            },
            {
              "unit": "%",
              "range": {
                "min": -500,
                "max": 2500
              },
              "label": "Weekly YOY growth"
            }
          ]
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "count",
            "values": [
              400000,
              1400000,
              1480000,
              1300000,
              900000,
              600000,
              150000,
              100000,
              80000,
              120000,
              100000,
              80000,
              100000,
              80000,
              60000,
              50000,
              60000,
              50000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              1800,
              2200,
              1000,
              250,
              250,
              200,
              100,
              150,
              200,
              200,
              250,
              250,
              280,
              250,
              200,
              250,
              300,
              450
            ]
          }
        ],
        "figure_id": "a6d2bf95ada5ff4f",
        "provenance": {
          "page": 82
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 82,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "8/30/24",
              "9/20/24",
              "10/11/24",
              "11/1/24",
              "11/22/24",
              "12/13/24",
              "1/3/25",
              "1/24/25",
              "2/14/25",
              "3/7/25",
              "3/28/25",
              "4/18/25",
              "5/9/25",
              "5/30/25",
              "6/20/25",
              "7/11/25",
              "8/1/25",
              "8/22/25"
            ]
          },
          "y": {
            "left": {
              "unit": "TRx",
              "range": {
                "min": 0,
                "max": 1200000
              }
            },
            "right": {
              "unit": "%",
              "range": {
                "min": -500,
                "max": 5000
              }
            }
          }
        },
        "series": [
          {
            "name": "Weekly TRx",
            "unit": "TRx",
            "values": [
              250000,
              950000,
              1050000,
              900000,
              600000,
              250000,
              100000,
              70000,
              50000,
              70000,
              80000,
              60000,
              70000,
              50000,
              70000,
              50000,
              60000,
              50000
            ]
          },
          {
            "name": "Weekly YOY growth",
            "unit": "%",
            "values": [
              2000,
              4500,
              1000,
              200,
              100,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              50,
              100
            ]
          }
        ],
        "figure_id": "e7c37a8ecdcbce29",
        "provenance": {
          "page": 82
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 83,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Dec-20",
              "Jan-21",
              "Feb-21",
              "Mar-21",
              "Apr-21",
              "May-21",
              "Jun-21",
              "Jul-21",
              "Aug-21",
              "Sep-21",
              "Oct-21",
              "Nov-21",
              "Dec-21",
              "Jan-22",
              "Feb-22",
              "Mar-22",
              "Apr-22",
              "May-22",
              "Jun-22",
              "Jul-22",
              "Aug-22",
              "Sep-22",
              "Oct-22",
              "Nov-22",
              "Dec-22",
              "Jan-23",
              "Feb-23",
              "Mar-23",
              "Apr-23",
              "May-23",
              "Jun-23",
              "Jul-23",
              "Aug-23",
              "Sep-23",
              "Oct-23",
              "Nov-23",
              "Dec-23",
              "Jan-24",
              "Feb-24",
              "Mar-24",
              "Apr-24",
              "May-24",
              "Jun-24",
              "Jul-24",
              "Aug-24",
              "Sep-24",
              "Oct-24",
              "Nov-24",
              "Dec-24",
              "Jan-25",
              "Feb-25",
              "Mar-25",
              "Apr-25",
              "May-25",
              "Jun-25",
              "Jul-25"
            ]
          },
          "y": {
            "unit": "Mn",
            "range": {
              "min": 0,
              "max": 18
            }
          }
        },
        "series": [
          {
            "name": "Comirnaty",
            "unit": "Mn",
            "values": [
              0.5,
              3.5,
              8.5,
              12,
              15,
              13,
              10,
              8,
              12,
              13,
              16,
              14,
              10,
              5.5,
              4,
              5.5,
              5,
              4,
              3,
              2.5,
              3,
              4,
              8,
              6,
              4,
              1,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              5.5,
              3.5,
              1.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              5.5,
              3.5,
              1.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          },
          {
            "name": "Novavax",
            "unit": "Mn",
            "values": [
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0,
              0
            ]
          },
          {
            "name": "Spikevax",
            "unit": "Mn",
            "values": [
              0.5,
              2,
              6,
              10,
              12,
              10,
              7,
              4,
              3,
              6,
              11.5,
              9,
              6,
              3,
              2,
              3.5,
              3,
              2.5,
              2,
              1.5,
              1.5,
              2,
              5,
              3.5,
              2,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              7,
              4.5,
              2.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              4.5,
              2.5,
              1,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5,
              0.5
            ]
          }
        ],
        "figure_id": "1408d4dbd6784ade",
        "provenance": {
          "page": 83
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "031e9bb1104d1b3b",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>Rolling 12-Wk</td></tr><tr><td>ABBV</td><td>Botox</td><td>NA</td><td>NA</td><td>NA</td><td>8%</td><td>10%</td><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "7bccc96ca50d6788",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lling 12-Wk</td></tr><tr><td>ABBV</td><td>Botox</td><td>NA</td><td>NA</td><td>NA</td><td>8%</td><td>10%</td><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</t",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "1871bdbefa20b3a8",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td></tr><tr><td>ABBV</td><td>Botox</td><td>NA</td><td>NA</td><td>NA</td><td>8%</td><td>10%</td><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "a38e3bea9402cc70",
        "value": 0.605,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>NA</td><td>NA</td><td>8%</td><td>10%</td><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira<",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "dc9bfc5b52729b15",
        "value": 0.614,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "NA</td><td>8%</td><td>10%</td><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%<",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "665a34e8ec0cdde9",
        "value": 0.613,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>10%</td><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%<",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "8004e7bc9331eb07",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>10%</td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%<",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "a76afa6fe98e9145",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></tr><tr><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "4d6dd14394e6cd76",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td>HCV franchise</td><td>60.5%</td><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "87d265210442f2d3",
        "value": 0.136,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>61.4%</td><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>I",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "3ca0c67dd55dbf62",
        "value": 0.13699999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>61.3%</td><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "7c26a9c9b10568ea",
        "value": 0.146,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>6%</td><td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "1dde8f53ef09ba18",
        "value": -0.41,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>4%</td><td>4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "793f342a9be3df45",
        "value": -0.4,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">4%</td></tr><tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td>",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "69cd2cba78fbd589",
        "value": -0.39,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<tr><td></td><td>Humira</td><td>13.6%</td><td>13.7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><t",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "ceaafbbd356913b2",
        "value": 0.321,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7%</td><td>14.6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzes",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "5ccd4ee081b73057",
        "value": 0.305,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "6%</td><td>-41%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "31be3001f8fbdee5",
        "value": 0.304,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>-40%</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td>",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "db4f9c2e108041d7",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-39%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td><td>NA</td><td",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "cec81ecbbcd8b6d5",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9%</td></tr><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td><td>NA</td><td>10%</td><t",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "f9c6fdf554065061",
        "value": -0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td></td><td>Imbruvica</td><td>32.1%</td><td>30.5%</td><td>30.4%</td><td>8%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td><td>NA</td><td>10%</td><td>11%</td><",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "aaab3c948b55d2ad",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>0%</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td><td>NA</td><td>10%</td><td>11%</td><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</t",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "974831405ad345f2",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-9%</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td><td>NA</td><td>10%</td><td>11%</td><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "2cbbfcc4fb1496d7",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td></td><td>Linzess</td><td>NA</td><td>NA</td><td>NA</td><td>10%</td><td>11%</td><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "c9ead5b462e35f8a",
        "value": 0.049,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>NA</td><td>10%</td><td>11%</td><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpt",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "ff959137f9e6de24",
        "value": 0.049,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>10%</td><td>11%</td><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "7d78c2bb21793c60",
        "value": 0.049,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>11%</td><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "5646de161ca55691",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>11%</td></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>2",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "097bcfff44e21d7b",
        "value": -0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></tr><tr><td></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "6463d9de92ab6a6b",
        "value": -0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td><td>Lumigan+Lumigan X</td><td>4.9%</td><td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "1bb6910d62d242c6",
        "value": 0.24,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>4.9%</td><td>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinv",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "88702f26ac4fa571",
        "value": 0.24100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>4.9%</td><td>-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "18e5745aa947cbff",
        "value": 0.23800000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-8%</td><td>-9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "c3c67894218e4d79",
        "value": 0.27,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9%</td><td>-10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "466c19697811817c",
        "value": 0.28,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "10%</td></tr><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>3",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "5107b57126898b2a",
        "value": 0.29,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td></td><td>Quilpta</td><td>24.0%</td><td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>3",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "a7738983de22a294",
        "value": 0.11800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>24.1%</td><td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyr",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "19445b8aea0b7b91",
        "value": 0.11599999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>23.8%</td><td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "ca3c6458768d4f03",
        "value": 0.115,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>27%</td><td>28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "626770eeb0e018a7",
        "value": 0.39,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">28%</td><td>29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "6103e48d719401e2",
        "value": 0.36,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">29%</td></tr><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "0ba027cad29e4f45",
        "value": 0.37,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><tr><td></td><td>Rinvoq</td><td>11.8%</td><td>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "db943a44d1ee2811",
        "value": 0.094,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>11.6%</td><td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "a5559326c050031e",
        "value": 0.096,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>11.5%</td><td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "5f76a2d9eb14169e",
        "value": 0.094,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>39%</td><td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4%</td><td>33.",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "8f2efd6768d5c201",
        "value": 0.42,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>36%</td><td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4%</td><td>33.4%</td><td>33",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "c32791f9c225f460",
        "value": 0.45,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>37%</td></tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4%</td><td>33.4%</td><td>33.3%</td><td>",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "a0949ed6dbed50d2",
        "value": 0.44,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td></td><td>Skyrizi</td><td>9.4%</td><td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4%</td><td>33.4%</td><td>33.3%</td><td>18%</td><td>",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "4a5c843882d720f1",
        "value": 0.33399999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>9.6%</td><td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4%</td><td>33.4%</td><td>33.3%</td><td>18%</td><td>17%</td><td>17%</td></tr><tr><td></td><td>Venc",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "69df167b5a137952",
        "value": 0.33399999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>9.4%</td><td>42%</td><td>45%</td><td>44%</td></tr><tr><td></td><td>Ubrelvy</td><td>33.4%</td><td>33.4%</td><td>33.3%</td><td>18%</td><td>17%</td><td>17%</td></tr><tr><td></td><td>Venclexta</td><td>",
        "provenance": {
          "page": 10
        }
      },
      {
        "num_id": "61fd87c61875724c",
        "value": 0.266,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "g 12-Wk</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>AMGN</td><td>Alimovig</td><td>26.6%</td><td>26.9%</td><td>27.0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "cfe57ebf554f606e",
        "value": 0.26899999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td><td></td><td></td><td></td><td></td></tr><tr><td>AMGN</td><td>Alimovig</td><td>26.6%</td><td>26.9%</td><td>27.0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "99f8889d37b9c4d6",
        "value": 0.27,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td><td></td><td></td></tr><tr><td>AMGN</td><td>Alimovig</td><td>26.6%</td><td>26.9%</td><td>27.0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "b1818e352a64bf70",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td><td></td></tr><tr><td>AMGN</td><td>Alimovig</td><td>26.6%</td><td>26.9%</td><td>27.0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "54a8e39108ee58a3",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></tr><tr><td>AMGN</td><td>Alimovig</td><td>26.6%</td><td>26.9%</td><td>27.0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "6cb02e53dc50df7a",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>AMGN</td><td>Alimovig</td><td>26.6%</td><td>26.9%</td><td>27.0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "10d905852bab6e3d",
        "value": 0.207,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".0%</td><td>-8%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "182cdd977bc9b820",
        "value": 0.195,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "1d12572963a74979",
        "value": 0.188,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "cc8c824dff2e4b15",
        "value": -0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td><td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "aea18f9065101aca",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td></tr><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "6e5e5e595f5425bc",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td></td><td>Aranesp</td><td>20.7%</td><td>19.5%</td><td>18.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "186fe2baa48de676",
        "value": 0.11800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "8.8%</td><td>-2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "db901eeb4721d1e3",
        "value": 0.11800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "2%</td><td>-7%</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epo",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "79010d82d3d4d3ae",
        "value": 0.11800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-7%</td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "45d96a979c200413",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "9c045deef577bb63",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td></tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "578b1717015a86ed",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td></td><td>Enbrel</td><td>11.8%</td><td>11.8%</td><td>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "d202c9205fce5eeb",
        "value": 0.39799999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>11.8%</td><td>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td><td>-12%</td><td>-16%</td><td>-3%</td><td></td><td></td></tr><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "3b29e90f71e50e39",
        "value": 0.39,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>7%</td><td>7%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td><td>-12%</td><td>-16%</td><td>-3%</td><td></td><td></td></tr><tr><td></td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "79aa57fd557e1989",
        "value": 0.409,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>6%</td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td><td>-12%</td><td>-16%</td><td>-3%</td><td></td><td></td></tr><tr><td></td><td>Evenity</td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "abb771a879903be5",
        "value": -0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td><td>-12%</td><td>-16%</td><td>-3%</td><td></td><td></td></tr><tr><td></td><td>Evenity</td><td>NM</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "5b67a2435eeb331a",
        "value": -0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td></tr><tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td><td>-12%</td><td>-16%</td><td>-3%</td><td></td><td></td></tr><tr><td></td><td>Evenity</td><td>NM</td><td>NM</td><td>N",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "22555ffec44bc712",
        "value": -0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<tr><td></td><td>Epogen</td><td>39.8%</td><td>39.0%</td><td>40.9%</td><td>-12%</td><td>-16%</td><td>-3%</td><td></td><td></td></tr><tr><td></td><td>Evenity</td><td>NM</td><td>NM</td><td>NM</td><td>47%",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "662f2d3a3b58b252",
        "value": 0.47,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>-3%</td><td></td><td></td></tr><tr><td></td><td>Evenity</td><td>NM</td><td>NM</td><td>NM</td><td>47%</td><td>38%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "cf31633b35b33ce8",
        "value": 0.38,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td></td></tr><tr><td></td><td>Evenity</td><td>NM</td><td>NM</td><td>NM</td><td>47%</td><td>38%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "7809a855bcebaa28",
        "value": 0.35,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td></td><td>Evenity</td><td>NM</td><td>NM</td><td>NM</td><td>47%</td><td>38%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "9dd470c90e1c69db",
        "value": 0.079,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>NM</td><td>47%</td><td>38%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><td>8%</td><td>6%</td><td>4%</td><td></td><td></td></tr><tr><td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "1a6fb4a59ab65e02",
        "value": 0.078,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "47%</td><td>38%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><td>8%</td><td>6%</td><td>4%</td><td></td><td></td></tr><tr><td></td><td>Proli",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "7b31d6dcdeeddad6",
        "value": 0.078,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "8%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><td>8%</td><td>6%</td><td>4%</td><td></td><td></td></tr><tr><td></td><td>Prolia</td><td>NM<",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "3178f00d5282283d",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td></td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><td>8%</td><td>6%</td><td>4%</td><td></td><td></td></tr><tr><td></td><td>Prolia</td><td>NM</td><td>NM</t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "5a67dac18f27d4eb",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><td>8%</td><td>6%</td><td>4%</td><td></td><td></td></tr><tr><td></td><td>Prolia</td><td>NM</td><td>NM</td><td>NM</t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "752785a94042d36d",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></tr><tr><td></td><td>Otezla</td><td>7.9%</td><td>7.8%</td><td>7.8%</td><td>8%</td><td>6%</td><td>4%</td><td></td><td></td></tr><tr><td></td><td>Prolia</td><td>NM</td><td>NM</td><td>NM</td><td>1%</t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "b8bbb8ca1338648b",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>4%</td><td></td><td></td></tr><tr><td></td><td>Prolia</td><td>NM</td><td>NM</td><td>NM</td><td>1%</td><td>-6%</td><td>-6%</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "64450ac37b284b2c",
        "value": -0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td></td></tr><tr><td></td><td>Prolia</td><td>NM</td><td>NM</td><td>NM</td><td>1%</td><td>-6%</td><td>-6%</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "026f10dcf1735874",
        "value": -0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></td></tr><tr><td></td><td>Prolia</td><td>NM</td><td>NM</td><td>NM</td><td>1%</td><td>-6%</td><td>-6%</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "7ea6d473b35e5c08",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>NM</td><td>1%</td><td>-6%</td><td>-6%</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><td>29%</td><td>33%</td><td>33%</td><td></td><td></td></tr><tr><t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "d4e1dbfc7d732e63",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "1%</td><td>-6%</td><td>-6%</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><td>29%</td><td>33%</td><td>33%</td><td></td><td></td></tr><tr><td></td><td>Ta",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "0cbc1890c82eb401",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>-6%</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><td>29%</td><td>33%</td><td>33%</td><td></td><td></td></tr><tr><td></td><td>Taveos</td><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "08d27767aa9aae91",
        "value": 0.29,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><td>29%</td><td>33%</td><td>33%</td><td></td><td></td></tr><tr><td></td><td>Taveos</td><td>NM</td><td>NM",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "53e0983c238a4bf7",
        "value": 0.33,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td></tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><td>29%</td><td>33%</td><td>33%</td><td></td><td></td></tr><tr><td></td><td>Taveos</td><td>NM</td><td>NM</td><td>NM<",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "db43da583cdaccbd",
        "value": 0.33,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td></td><td>Repatha</td><td>1.9%</td><td>2.0%</td><td>2.0%</td><td>29%</td><td>33%</td><td>33%</td><td></td><td></td></tr><tr><td></td><td>Taveos</td><td>NM</td><td>NM</td><td>NM</td><td>34%<",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "ac3b1987d0fccaa1",
        "value": 0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>33%</td><td></td><td></td></tr><tr><td></td><td>Taveos</td><td>NM</td><td>NM</td><td>NM</td><td>34%</td><td>46%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Tazespire</td><td>NM</td><td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "62cb2c4f9a240c6a",
        "value": 0.46,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td></td></tr><tr><td></td><td>Taveos</td><td>NM</td><td>NM</td><td>NM</td><td>34%</td><td>46%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Tazespire</td><td>NM</td><td>NM</td><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "1bbf22a8afe53fcf",
        "value": 0.35,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td></tr><tr><td></td><td>Taveos</td><td>NM</td><td>NM</td><td>NM</td><td>34%</td><td>46%</td><td>35%</td><td></td><td></td></tr><tr><td></td><td>Tazespire</td><td>NM</td><td>NM</td><td>NM</td><td>4",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "22f9970f692ba4d1",
        "value": 0.48,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">35%</td><td></td><td></td></tr><tr><td></td><td>Tazespire</td><td>NM</td><td>NM</td><td>NM</td><td>48%</td><td>57%</td><td>59%</td><td></td><td></td></tr><tr><td>BIIB</td><td>Avonex</td><td>6.0%</td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "685c3b5938399dd0",
        "value": 0.57,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td><td></td></tr><tr><td></td><td>Tazespire</td><td>NM</td><td>NM</td><td>NM</td><td>48%</td><td>57%</td><td>59%</td><td></td><td></td></tr><tr><td>BIIB</td><td>Avonex</td><td>6.0%</td><td>6.2%</td",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "f5de8f546efb9d89",
        "value": 0.59,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></tr><tr><td></td><td>Tazespire</td><td>NM</td><td>NM</td><td>NM</td><td>48%</td><td>57%</td><td>59%</td><td></td><td></td></tr><tr><td>BIIB</td><td>Avonex</td><td>6.0%</td><td>6.2%</td><td>6.4%</t",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "63c5e09b6ad8edea",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>48%</td><td>57%</td><td>59%</td><td></td><td></td></tr><tr><td>BIIB</td><td>Avonex</td><td>6.0%</td><td>6.2%</td><td>6.4%</td><td>-1%</td><td>1%</td><td>1%</td><td></td><td></td></tr><tr><td>",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "715b889bf8774d2d",
        "value": 0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>57%</td><td>59%</td><td></td><td></td></tr><tr><td>BIIB</td><td>Avonex</td><td>6.0%</td><td>6.2%</td><td>6.4%</td><td>-1%</td><td>1%</td><td>1%</td><td></td><td></td></tr><tr><td></td><td>Pleg",
        "provenance": {
          "page": 11
        }
      },
      {
        "num_id": "a24d7419ebcc3777",
        "value": 0.19,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Rolling</td><td>4-Wk Rolling</td><td>12-Wk</td></tr><tr><td rowspan=\"6\">AZN</td><td>Breztri</td><td>19.0%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "1c56ef365f5ea465",
        "value": 0.18899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>4-Wk Rolling</td><td>12-Wk</td></tr><tr><td rowspan=\"6\">AZN</td><td>Breztri</td><td>19.0%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d9182e45707732d6",
        "value": 0.18100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>12-Wk</td></tr><tr><td rowspan=\"6\">AZN</td><td>Breztri</td><td>19.0%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "22c9c8289e3efe6c",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td rowspan=\"6\">AZN</td><td>Breztri</td><td>19.0%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "b16384f20a481f91",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td rowspan=\"6\">AZN</td><td>Breztri</td><td>19.0%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d148bbdfe0dc5f87",
        "value": 0.21,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "n=\"6\">AZN</td><td>Breztri</td><td>19.0%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "1da9204062266583",
        "value": 0.039,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>18.9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydure",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "4f1844de6f70baae",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9%</td><td>18.1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "8491a25ce658d682",
        "value": 0.044000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".1%</td><td>20%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "abc67a1227a241ed",
        "value": -0.59,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0%</td><td>20%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "b0dd7d26636008f1",
        "value": -0.57,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>21%</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "e7b7fd9021021161",
        "value": -0.53,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>Brilinta</td><td>3.9%</td><td>4.0%</td><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "11a56c9e037acc47",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>4.4%</td><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "7f9c41829bc281b1",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-59%</td><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d6de5584d02739bf",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-57%</td><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "dbaf3b833ed2e2bd",
        "value": -0.99,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-53%</td></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "21e62fc3567fda04",
        "value": -0.99,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></tr><tr><td>Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "6ea19d4d452f5d10",
        "value": -0.98,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">Byetta/Bydureon Franchise</td><td>0.0%</td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "b928bcff322930a5",
        "value": 0.303,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>0.0%</td><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "c4cda1afb0b55e67",
        "value": 0.32299999999999995,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>0.0%</td><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "eb8771351ac7070a",
        "value": 0.32899999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-99%</td><td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "225c23ebc6dbc43b",
        "value": 0.26,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>-99%</td><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "2a992d1303171892",
        "value": 0.29,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>-98%</td></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "49a92659d8c45558",
        "value": 0.18,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></tr><tr><td>Calquence*</td><td>30.3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "3aea85bb11c85553",
        "value": 0.281,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "3%</td><td>32.3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "626b561bff227f9e",
        "value": 0.27899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "3%</td><td>32.9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "29ab7c86b46507de",
        "value": 0.27899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9%</td><td>26%</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "40fb9ec75cdb688a",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>29%</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "3f4032c823f35e2c",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>18%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "f8b1031655f866f9",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td></tr><tr><td>Farxiga</td><td>28.1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "12b4feb7c260f680",
        "value": 0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "1%</td><td>27.9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "fe211fe96644ab45",
        "value": 0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".9%</td><td>27.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga ",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "2002f915ac13a745",
        "value": 0.015,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7.9%</td><td>10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "ebc0d9a6abac45af",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "10%</td><td>9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "4e5c1750080004b3",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9%</td><td>9%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%<",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "1ed8aba462b82eb7",
        "value": -0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td></tr><tr><td>Xigduo XR</td><td>1.4%</td><td>1.4%</td><td>1.5%</td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "9b9c3a5d5aae7ba8",
        "value": 0.295,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>-8%</td><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "2018d277f15af46c",
        "value": 0.293,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>-8%</td><td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "e2ba489485a9b101",
        "value": 0.293,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>-9%</td></tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "fbf51ada0596feef",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><t",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "53c674ff62a2b15f",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rowspan=\"2\"></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "2e38deb25b23f762",
        "value": 0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></td><td>Farxiga franchise</td><td>29.5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td>",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "d7a2ee8716dc5084",
        "value": 0.36,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".5%</td><td>29.3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">G",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "29a66dd273c7be8c",
        "value": 0.358,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".3%</td><td>29.3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Adv",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "85eb820aa49e93cd",
        "value": 0.35600000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".3%</td><td>9%</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Advair</td><td>7.",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "6f2eaae89a19b4d3",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>8%</td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Advair</td><td>7.6%</td><td>7.6",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "57a4dc22f4f5cb66",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>8%</td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Advair</td><td>7.6%</td><td>7.6%</td><td>7.",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "ec6b8fe8ac5f8fec",
        "value": 0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></tr><tr><td>Symbicort</td><td>36.0%</td><td>35.8%</td><td>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Advair</td><td>7.6%</td><td>7.6%</td><td>7.6%</td><td>-",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "251144e3c44199bc",
        "value": 0.076,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>35.6%</td><td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Advair</td><td>7.6%</td><td>7.6%</td><td>7.6%</td><td>-19%</td><td>-18%</td><td>-16%</td></tr><tr><td>Advair+Breo+A",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "4d66f21c73c8db71",
        "value": 0.076,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>15%</td><td>15%</td><td>16%</td></tr><tr><td rowspan=\"6\">GSK</td><td>Advair</td><td>7.6%</td><td>7.6%</td><td>7.6%</td><td>-19%</td><td>-18%</td><td>-16%</td></tr><tr><td>Advair+Breo+A.G. franchise",
        "provenance": {
          "page": 12
        }
      },
      {
        "num_id": "6f5f8a1074cc2024",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Regulatory Disclosures on Subject Companies As of July 31, 2025, Morgan Stanley beneficially owned 1% or more of a class of common equity securities of the following companies covered in Morgan Stanle",
        "provenance": {
          "page": 86
        }
      },
      {
        "num_id": "93d245130599065d",
        "value": 0.4,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ry</td><td>Count</td><td>% of Total Other MISC</td></tr><tr><td>Overweight/Buy</td><td>1495</td><td>40%</td><td>378</td><td>45%</td><td>25%</td><td>701</td><td>41%</td></tr><tr><td>Equal-weight/Hold</",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "19b60037e502386b",
        "value": 0.45,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">% of Total Other MISC</td></tr><tr><td>Overweight/Buy</td><td>1495</td><td>40%</td><td>378</td><td>45%</td><td>25%</td><td>701</td><td>41%</td></tr><tr><td>Equal-weight/Hold</td><td>1607</td><td>43%<",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "4963b928e62a7019",
        "value": 0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Other MISC</td></tr><tr><td>Overweight/Buy</td><td>1495</td><td>40%</td><td>378</td><td>45%</td><td>25%</td><td>701</td><td>41%</td></tr><tr><td>Equal-weight/Hold</td><td>1607</td><td>43%</td><td>374<",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "9e4d73bf68fbd54a",
        "value": 0.41,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>Overweight/Buy</td><td>1495</td><td>40%</td><td>378</td><td>45%</td><td>25%</td><td>701</td><td>41%</td></tr><tr><td>Equal-weight/Hold</td><td>1607</td><td>43%</td><td>374</td><td>45%</td><td>23%<",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "a1f373f78fe650d7",
        "value": 0.43,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>45%</td><td>25%</td><td>701</td><td>41%</td></tr><tr><td>Equal-weight/Hold</td><td>1607</td><td>43%</td><td>374</td><td>45%</td><td>23%</td><td>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td>",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "6e4f38959fec8b45",
        "value": 0.45,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>701</td><td>41%</td></tr><tr><td>Equal-weight/Hold</td><td>1607</td><td>43%</td><td>374</td><td>45%</td><td>23%</td><td>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "c8f6019ee61065b8",
        "value": 0.23,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>41%</td></tr><tr><td>Equal-weight/Hold</td><td>1607</td><td>43%</td><td>374</td><td>45%</td><td>23%</td><td>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td>0</td><td>0",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "e98c5fcc3d940894",
        "value": 0.45,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">Equal-weight/Hold</td><td>1607</td><td>43%</td><td>374</td><td>45%</td><td>23%</td><td>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td>0</td><td>0%</td><td>0%</td><td>2</",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "960d4499793a4cf8",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "4</td><td>45%</td><td>23%</td><td>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td>0</td><td>0%</td><td>0%</td><td>2</td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>58",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "dd369be670fcdb9f",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">23%</td><td>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td>0</td><td>0%</td><td>0%</td><td>2</td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>588</td><td>16%</td><td",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "7870f30c9f5a26ad",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>766</td><td>45%</td></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td>0</td><td>0%</td><td>0%</td><td>2</td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>588</td><td>16%</td><td>83</td><td",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "c2e8574847dec571",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></tr><tr><td>Not-Rated/Hold</td><td>5</td><td>0%</td><td>0</td><td>0%</td><td>0%</td><td>2</td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>588</td><td>16%</td><td>83</td><td>10%</td><td>14%</td>",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "ce998c027b7d8ca5",
        "value": 0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">0</td><td>0%</td><td>0%</td><td>2</td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>588</td><td>16%</td><td>83</td><td>10%</td><td>14%</td><td>236</td><td>14%</td></tr><tr><td>Total</td><td>3,695<",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "47c76965b2142d6d",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>2</td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>588</td><td>16%</td><td>83</td><td>10%</td><td>14%</td><td>236</td><td>14%</td></tr><tr><td>Total</td><td>3,695</td><td></td><td>835</t",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "22ee3dc00d777d43",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>0%</td></tr><tr><td>Underweight/Sell</td><td>588</td><td>16%</td><td>83</td><td>10%</td><td>14%</td><td>236</td><td>14%</td></tr><tr><td>Total</td><td>3,695</td><td></td><td>835</td><td></td><",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "761ec4451ee40742",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>Underweight/Sell</td><td>588</td><td>16%</td><td>83</td><td>10%</td><td>14%</td><td>236</td><td>14%</td></tr><tr><td>Total</td><td>3,695</td><td></td><td>835</td><td></td><td></td><td>1705</td><td",
        "provenance": {
          "page": 87
        }
      },
      {
        "num_id": "75768098093b0767",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "mpanies' section in Morgan Stanley Research lists all companies mentioned where Morgan Stanley owns 1% or more of a class of common equity securities of the companies. For all other companies mentione",
        "provenance": {
          "page": 88
        }
      },
      {
        "num_id": "e3d67ee473036d76",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "companies mentioned in Morgan Stanley Research, Morgan Stanley may have an investment of less than 1% in securities/instruments or derivatives of securities/instruments of companies and may trade them",
        "provenance": {
          "page": 88
        }
      },
      {
        "num_id": "eb534359a87c0ed4",
        "value": 13.75,
        "unit": "$",
        "metric_type": "currency",
        "context": "<table><tr><td>Dyne Therapeutics Inc (DYN.O)</td><td>O (04/30/2024)</td><td>$13.75</td></tr><tr><td>Fractyl Health Inc (GUTS.O)</td><td>O (02/27/2024)</td><td>$0.99</td></tr><tr><td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "947f1d2e9670fa79",
        "value": 0.99,
        "unit": "$",
        "metric_type": "currency",
        "context": "30/2024)</td><td>$13.75</td></tr><tr><td>Fractyl Health Inc (GUTS.O)</td><td>O (02/27/2024)</td><td>$0.99</td></tr><tr><td>IO Biotech (IOBT.O)</td><td>O (11/30/2021)</td><td>$1.58</td></tr><tr><td>Ion",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "960d2ab5aa2d2fb6",
        "value": 1.58,
        "unit": "$",
        "metric_type": "currency",
        "context": "td>O (02/27/2024)</td><td>$0.99</td></tr><tr><td>IO Biotech (IOBT.O)</td><td>O (11/30/2021)</td><td>$1.58</td></tr><tr><td>Ionis Pharmaceuticals Inc (IONS.O)</td><td>O (07/30/2025)</td><td>$42.62</td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "161f09ab8899657e",
        "value": 42.62,
        "unit": "$",
        "metric_type": "currency",
        "context": "1)</td><td>$1.58</td></tr><tr><td>Ionis Pharmaceuticals Inc (IONS.O)</td><td>O (07/30/2025)</td><td>$42.62</td></tr><tr><td>Kyverna Therapeutics (KYTX.O)</td><td>O (03/04/2024)</td><td>$3.70</td></tr>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "23452112949a454e",
        "value": 3.7,
        "unit": "$",
        "metric_type": "currency",
        "context": "/2025)</td><td>$42.62</td></tr><tr><td>Kyverna Therapeutics (KYTX.O)</td><td>O (03/04/2024)</td><td>$3.70</td></tr><tr><td>Mirum Pharmaceuticals (MIRM.O)</td><td>O (11/13/2023)</td><td>$75.53</td></tr",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "da338fdef46ccddb",
        "value": 75.53,
        "unit": "$",
        "metric_type": "currency",
        "context": "/2024)</td><td>$3.70</td></tr><tr><td>Mirum Pharmaceuticals (MIRM.O)</td><td>O (11/13/2023)</td><td>$75.53</td></tr><tr><td>Rhythm Pharmaceuticals Inc (RYTM.O)</td><td>O (12/19/2023)</td><td>$104.23</",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "594982be3fabf76e",
        "value": 104.23,
        "unit": "$",
        "metric_type": "currency",
        "context": "</td><td>$75.53</td></tr><tr><td>Rhythm Pharmaceuticals Inc (RYTM.O)</td><td>O (12/19/2023)</td><td>$104.23</td></tr><tr><td>Rocket Pharmaceuticals Inc (RCKT.O)</td><td>E (05/27/2025)</td><td>$3.35</t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "fc38386197dabbe2",
        "value": 3.35,
        "unit": "$",
        "metric_type": "currency",
        "context": "/td><td>$104.23</td></tr><tr><td>Rocket Pharmaceuticals Inc (RCKT.O)</td><td>E (05/27/2025)</td><td>$3.35</td></tr><tr><td>Sarepta Therapeutics Inc (SRPT.O)</td><td>E (06/16/2025)</td><td>$18.34</td><",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "d67da204f87059fd",
        "value": 18.34,
        "unit": "$",
        "metric_type": "currency",
        "context": "25)</td><td>$3.35</td></tr><tr><td>Sarepta Therapeutics Inc (SRPT.O)</td><td>E (06/16/2025)</td><td>$18.34</td></tr><tr><td>Silence Therapeutics Plc (SLN.O)</td><td>O (05/08/2023)</td><td>$5.10</td></",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "0bbde3548e79cb99",
        "value": 5.1,
        "unit": "$",
        "metric_type": "currency",
        "context": "25)</td><td>$18.34</td></tr><tr><td>Silence Therapeutics Plc (SLN.O)</td><td>O (05/08/2023)</td><td>$5.10</td></tr><tr><td>Tenaya Therapeutics Inc (TNYA.O)</td><td>O (08/24/2021)</td><td>$1.13</td></t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "307e7b9f92a047da",
        "value": 1.13,
        "unit": "$",
        "metric_type": "currency",
        "context": "023)</td><td>$5.10</td></tr><tr><td>Tenaya Therapeutics Inc (TNYA.O)</td><td>O (08/24/2021)</td><td>$1.13</td></tr><tr><td>Viking Therapeutics Inc (VKTX.O)</td><td>O (06/27/2024)</td><td>$27.58</td></",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "91c68e49b9520262",
        "value": 27.58,
        "unit": "$",
        "metric_type": "currency",
        "context": "021)</td><td>$1.13</td></tr><tr><td>Viking Therapeutics Inc (VKTX.O)</td><td>O (06/27/2024)</td><td>$27.58</td></tr><tr><td>Vir Biotechnology Inc (VIR.O)</td><td>O (01/08/2025)</td><td>$5.04</td></tr>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "a6efd90ac509cfe5",
        "value": 5.04,
        "unit": "$",
        "metric_type": "currency",
        "context": "/2024)</td><td>$27.58</td></tr><tr><td>Vir Biotechnology Inc (VIR.O)</td><td>O (01/08/2025)</td><td>$5.04</td></tr><tr><td>Y-mABs Therapeutics Inc. (YMAB.O)</td><td>E (08/05/2025)</td><td>$8.54</td></",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "493d1576d11938a0",
        "value": 8.54,
        "unit": "$",
        "metric_type": "currency",
        "context": "25)</td><td>$5.04</td></tr><tr><td>Y-mABs Therapeutics Inc. (YMAB.O)</td><td>E (08/05/2025)</td><td>$8.54</td></tr><tr><td>Zentalis Pharmaceuticals Inc (ZNTL.O)</td><td>E (06/18/2024)</td><td>$1.76</t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "4e54a38f25ae37c7",
        "value": 1.76,
        "unit": "$",
        "metric_type": "currency",
        "context": "/td><td>$8.54</td></tr><tr><td>Zentalis Pharmaceuticals Inc (ZNTL.O)</td><td>E (06/18/2024)</td><td>$1.76</td></tr></table> # Sean Laaman, Ph.D. <table><tr><td>ABSCI CORP (ABSI.O)</td><td>O (07/03/202",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "c38cf5293861ea21",
        "value": 2.47,
        "unit": "$",
        "metric_type": "currency",
        "context": "r></table> # Sean Laaman, Ph.D. <table><tr><td>ABSCI CORP (ABSI.O)</td><td>O (07/03/2024)</td><td>$2.47</td></tr><tr><td>Acadia Pharmaceuticals Inc (ACAD.O)</td><td>E (08/06/2024)</td><td>$26.23</td><",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "0f71ad56bf15181d",
        "value": 26.23,
        "unit": "$",
        "metric_type": "currency",
        "context": ")</td><td>$2.47</td></tr><tr><td>Acadia Pharmaceuticals Inc (ACAD.O)</td><td>E (08/06/2024)</td><td>$26.23</td></tr><tr><td>Alector Inc (ALEC.O)</td><td>U (11/26/2024)</td><td>$2.39</td></tr><tr><td>a",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "3d39f687a4e9d0d5",
        "value": 2.39,
        "unit": "$",
        "metric_type": "currency",
        "context": ">E (08/06/2024)</td><td>$26.23</td></tr><tr><td>Alector Inc (ALEC.O)</td><td>U (11/26/2024)</td><td>$2.39</td></tr><tr><td>argenx SE (ARGX.O)</td><td>O (07/02/2025)</td><td>$704.07</td></tr><tr><td>Ax",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "c44d0999dd31a9e7",
        "value": 704.07,
        "unit": "$",
        "metric_type": "currency",
        "context": "<td>U (11/26/2024)</td><td>$2.39</td></tr><tr><td>argenx SE (ARGX.O)</td><td>O (07/02/2025)</td><td>$704.07</td></tr><tr><td>Axsome Therapeutics (AXSM.O)</td><td>O (04/29/2024)</td><td>$121.75</td></t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "eece44ef4b9b58b4",
        "value": 121.75,
        "unit": "$",
        "metric_type": "currency",
        "context": "/2025)</td><td>$704.07</td></tr><tr><td>Axsome Therapeutics (AXSM.O)</td><td>O (04/29/2024)</td><td>$121.75</td></tr><tr><td>BeOne Medicines (ONC.O)</td><td>O (12/02/2024)</td><td>$297.96</td></tr><tr",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "6264cfaacce7cb7d",
        "value": 297.96,
        "unit": "$",
        "metric_type": "currency",
        "context": "04/29/2024)</td><td>$121.75</td></tr><tr><td>BeOne Medicines (ONC.O)</td><td>O (12/02/2024)</td><td>$297.96</td></tr><tr><td>Biomarin Pharmaceutical Inc (BMRN.O)</td><td>O (07/02/2025)</td><td>$57.68<",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "3381cb4f334e3331",
        "value": 57.68,
        "unit": "$",
        "metric_type": "currency",
        "context": "td><td>$297.96</td></tr><tr><td>Biomarin Pharmaceutical Inc (BMRN.O)</td><td>O (07/02/2025)</td><td>$57.68</td></tr><tr><td>Centessa Pharmaceuticals, Inc (CNTA.O)</td><td>O (09/19/2024)</td><td>$16.56",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "12911e06c816ee10",
        "value": 16.56,
        "unit": "$",
        "metric_type": "currency",
        "context": "d><td>$57.68</td></tr><tr><td>Centessa Pharmaceuticals, Inc (CNTA.O)</td><td>O (09/19/2024)</td><td>$16.56</td></tr><tr><td>Certara Inc (CERT.O)</td><td>E (01/05/2021)</td><td>$10.87</td></tr><tr><td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "b38f2421298d7d0a",
        "value": 10.87,
        "unit": "$",
        "metric_type": "currency",
        "context": ">O (09/19/2024)</td><td>$16.56</td></tr><tr><td>Certara Inc (CERT.O)</td><td>E (01/05/2021)</td><td>$10.87</td></tr><tr><td>CG Oncology (CGON.O)</td><td>O (02/19/2024)</td><td>$26.72</td></tr><tr><td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "870c2ee87bd88e53",
        "value": 26.72,
        "unit": "$",
        "metric_type": "currency",
        "context": ">E (01/05/2021)</td><td>$10.87</td></tr><tr><td>CG Oncology (CGON.O)</td><td>O (02/19/2024)</td><td>$26.72</td></tr><tr><td>Contineum Therapeutics (CTNM.O)</td><td>O (04/30/2024)</td><td>$10.05</td></",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "23602382a3f86d95",
        "value": 10.05,
        "unit": "$",
        "metric_type": "currency",
        "context": "024)</td><td>$26.72</td></tr><tr><td>Contineum Therapeutics (CTNM.O)</td><td>O (04/30/2024)</td><td>$10.05</td></tr><tr><td>Cullinan Therapeutics (CGEM.O)</td><td>O (03/06/2025)</td><td>$7.61</td></tr",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "aa410b9bd282dbb8",
        "value": 7.61,
        "unit": "$",
        "metric_type": "currency",
        "context": "2024)</td><td>$10.05</td></tr><tr><td>Cullinan Therapeutics (CGEM.O)</td><td>O (03/06/2025)</td><td>$7.61</td></tr><tr><td>Denali Therapeutics Inc (DNLI.O)</td><td>O (03/06/2025)</td><td>$15.65</td></",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "249b1c30845088d1",
        "value": 15.65,
        "unit": "$",
        "metric_type": "currency",
        "context": "025)</td><td>$7.61</td></tr><tr><td>Denali Therapeutics Inc (DNLI.O)</td><td>O (03/06/2025)</td><td>$15.65</td></tr><tr><td>Disc Medicine Inc (IRON.O)</td><td>O (11/04/2024)</td><td>$59.66</td></tr><t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "d9e23e686c0e1400",
        "value": 59.66,
        "unit": "$",
        "metric_type": "currency",
        "context": "/06/2025)</td><td>$15.65</td></tr><tr><td>Disc Medicine Inc (IRON.O)</td><td>O (11/04/2024)</td><td>$59.66</td></tr><tr><td>Erasca, Inc. (ERAS.O)</td><td>E (08/17/2025)</td><td>$1.57</td></tr><tr><td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "f72127d0ad14312d",
        "value": 1.57,
        "unit": "$",
        "metric_type": "currency",
        "context": "O (11/04/2024)</td><td>$59.66</td></tr><tr><td>Erasca, Inc. (ERAS.O)</td><td>E (08/17/2025)</td><td>$1.57</td></tr><tr><td>Exelixis Inc. (EXEL.O)</td><td>O (01/26/2025)</td><td>$37.90</td></tr><tr><td",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "41d7d0c122ea583b",
        "value": 37.9,
        "unit": "$",
        "metric_type": "currency",
        "context": "E (08/17/2025)</td><td>$1.57</td></tr><tr><td>Exelixis Inc. (EXEL.O)</td><td>O (01/26/2025)</td><td>$37.90</td></tr><tr><td>Halozyme Therapeutics, Inc (HALO.O)</td><td>O (08/05/2025)</td><td>$72.81</t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "677a09daa6735ee6",
        "value": 72.81,
        "unit": "$",
        "metric_type": "currency",
        "context": "</td><td>$37.90</td></tr><tr><td>Halozyme Therapeutics, Inc (HALO.O)</td><td>O (08/05/2025)</td><td>$72.81</td></tr><tr><td>Immunocore Holdings Ltd (IMCR.O)</td><td>E (12/12/2024)</td><td>$32.24</td><",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "efd8a2a3e0640083",
        "value": 32.24,
        "unit": "$",
        "metric_type": "currency",
        "context": "25)</td><td>$72.81</td></tr><tr><td>Immunocore Holdings Ltd (IMCR.O)</td><td>E (12/12/2024)</td><td>$32.24</td></tr><tr><td>Neurocrine Biosciences Inc (NBIX.O)</td><td>O (03/06/2025)</td><td>$138.94</",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "5c79242298571eac",
        "value": 138.94,
        "unit": "$",
        "metric_type": "currency",
        "context": "</td><td>$32.24</td></tr><tr><td>Neurocrine Biosciences Inc (NBIX.O)</td><td>O (03/06/2025)</td><td>$138.94</td></tr><tr><td>Recursion Pharmaceuticals Inc (RXRX.O)</td><td>E (05/22/2023)</td><td>$4.87",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "81d9551a04b89251",
        "value": 4.87,
        "unit": "$",
        "metric_type": "currency",
        "context": "><td>$138.94</td></tr><tr><td>Recursion Pharmaceuticals Inc (RXRX.O)</td><td>E (05/22/2023)</td><td>$4.87</td></tr><tr><td>Schrodinger Inc. (SDGR.O)</td><td>E (11/19/2021)</td><td>$19.76</td></tr></ta",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "78d35d22a89f8359",
        "value": 19.76,
        "unit": "$",
        "metric_type": "currency",
        "context": "05/22/2023)</td><td>$4.87</td></tr><tr><td>Schrodinger Inc. (SDGR.O)</td><td>E (11/19/2021)</td><td>$19.76</td></tr></table> # Terence C Flynn, Ph.D. <table><tr><td>Alumis Inc. (ALMS.O)</td><td>O (05/",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "12227e7b5470772e",
        "value": 4.7,
        "unit": "$",
        "metric_type": "currency",
        "context": "able> # Terence C Flynn, Ph.D. <table><tr><td>Alumis Inc. (ALMS.O)</td><td>O (05/30/2025)</td><td>$4.70</td></tr><tr><td>Amgen Inc. (AMGN.O)</td><td>E (10/16/2023)</td><td>$285.61</td></tr><tr><td>Arc",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "96906d201116d899",
        "value": 285.61,
        "unit": "$",
        "metric_type": "currency",
        "context": "td>O (05/30/2025)</td><td>$4.70</td></tr><tr><td>Amgen Inc. (AMGN.O)</td><td>E (10/16/2023)</td><td>$285.61</td></tr><tr><td>Arcus Biosciences Inc. (RCUS.N)</td><td>O (10/11/2022)</td><td>$10.61</td><",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "74bc0b307fd330b7",
        "value": 10.61,
        "unit": "$",
        "metric_type": "currency",
        "context": "23)</td><td>$285.61</td></tr><tr><td>Arcus Biosciences Inc. (RCUS.N)</td><td>O (10/11/2022)</td><td>$10.61</td></tr><tr><td>Arvinas Inc (ARVN.O)</td><td>E (04/06/2022)</td><td>$7.76</td></tr><tr><td>B",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "321ddef2f3521199",
        "value": 7.76,
        "unit": "$",
        "metric_type": "currency",
        "context": ">O (10/11/2022)</td><td>$10.61</td></tr><tr><td>Arvinas Inc (ARVN.O)</td><td>E (04/06/2022)</td><td>$7.76</td></tr><tr><td>Biogen Inc (BIIB.O)</td><td>E (10/31/2024)</td><td>$132.65</td></tr><tr><td>B",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "3622eddea85e3fc8",
        "value": 132.65,
        "unit": "$",
        "metric_type": "currency",
        "context": "td>E (04/06/2022)</td><td>$7.76</td></tr><tr><td>Biogen Inc (BIIB.O)</td><td>E (10/31/2024)</td><td>$132.65</td></tr><tr><td>Biohaven Ltd (BHVN.N)</td><td>O (07/24/2024)</td><td>$15.52</td></tr><tr><t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "b136a1bdb4890e41",
        "value": 15.52,
        "unit": "$",
        "metric_type": "currency",
        "context": "(10/31/2024)</td><td>$132.65</td></tr><tr><td>Biohaven Ltd (BHVN.N)</td><td>O (07/24/2024)</td><td>$15.52</td></tr><tr><td>BioNTech SE (BNTX.O)</td><td>O (09/23/2024)</td><td>$101.93</td></tr><tr><td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "7feae86565d4284e",
        "value": 101.93,
        "unit": "$",
        "metric_type": "currency",
        "context": ">O (07/24/2024)</td><td>$15.52</td></tr><tr><td>BioNTech SE (BNTX.O)</td><td>O (09/23/2024)</td><td>$101.93</td></tr><tr><td>C4 Therapeutics (CCCC.O)</td><td>E (11/06/2023)</td><td>$2.55</td></tr><tr>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "b5752b0a39cd3cf0",
        "value": 2.55,
        "unit": "$",
        "metric_type": "currency",
        "context": "9/23/2024)</td><td>$101.93</td></tr><tr><td>C4 Therapeutics (CCCC.O)</td><td>E (11/06/2023)</td><td>$2.55</td></tr><tr><td>CRISPR Therapeutics AG (CRSP.O)</td><td>U (10/11/2022)</td><td>$53.05</td></t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "34d1bc0bcddc1cda",
        "value": 53.05,
        "unit": "$",
        "metric_type": "currency",
        "context": "2023)</td><td>$2.55</td></tr><tr><td>CRISPR Therapeutics AG (CRSP.O)</td><td>U (10/11/2022)</td><td>$53.05</td></tr><tr><td>Gilead Sciences Inc. (GILD.O)</td><td>O (01/10/2025)</td><td>$112.56</td></t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "561cbd54195c5bb7",
        "value": 112.56,
        "unit": "$",
        "metric_type": "currency",
        "context": "/2022)</td><td>$53.05</td></tr><tr><td>Gilead Sciences Inc. (GILD.O)</td><td>O (01/10/2025)</td><td>$112.56</td></tr><tr><td>Intellia Therapeutics Inc (NTLA.O)</td><td>E (01/26/2025)</td><td>$11.60</t",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "2d5e62f14a7dd954",
        "value": 11.6,
        "unit": "$",
        "metric_type": "currency",
        "context": "</td><td>$112.56</td></tr><tr><td>Intellia Therapeutics Inc (NTLA.O)</td><td>E (01/26/2025)</td><td>$11.60</td></tr><tr><td>Legend Biotech Corp (LEGN.O)</td><td>O (01/31/2022)</td><td>$34.37</td></tr>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "ee57355f601fbbe8",
        "value": 34.37,
        "unit": "$",
        "metric_type": "currency",
        "context": "6/2025)</td><td>$11.60</td></tr><tr><td>Legend Biotech Corp (LEGN.O)</td><td>O (01/31/2022)</td><td>$34.37</td></tr><tr><td>Moderna Inc (MRNA.O)</td><td>E (12/16/2020)</td><td>$24.47</td></tr><tr><td>",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "a40ccf4188b3c4b9",
        "value": 24.47,
        "unit": "$",
        "metric_type": "currency",
        "context": ">O (01/31/2022)</td><td>$34.37</td></tr><tr><td>Moderna Inc (MRNA.O)</td><td>E (12/16/2020)</td><td>$24.47</td></tr><tr><td>Nurix Therapeutics Inc. (NRIX.O)</td><td>E (10/11/2022)</td><td>$9.41</td></",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "f24b658006f996d8",
        "value": 9.41,
        "unit": "$",
        "metric_type": "currency",
        "context": "20)</td><td>$24.47</td></tr><tr><td>Nurix Therapeutics Inc. (NRIX.O)</td><td>E (10/11/2022)</td><td>$9.41</td></tr><tr><td>Prime Medicine Inc (PRME.O)</td><td>E (11/14/2022)</td><td>$3.44</td></tr><tr",
        "provenance": {
          "page": 91
        }
      },
      {
        "num_id": "3346dd944e3426eb",
        "value": 307.24,
        "unit": "$",
        "metric_type": "currency",
        "context": "United Therapeutics Corp (UTHR.O) E (07/11/2024) \\$307.24 Vertex Pharmaceuticals (VRTX.O) E (05/03/2022) \\$392.05 Stock Ratings are subject to change. Please",
        "provenance": {
          "page": 92
        }
      },
      {
        "num_id": "504f6ecadd589469",
        "value": 392.05,
        "unit": "$",
        "metric_type": "currency",
        "context": "Therapeutics Corp (UTHR.O) E (07/11/2024) \\$307.24 Vertex Pharmaceuticals (VRTX.O) E (05/03/2022) \\$392.05 Stock Ratings are subject to change. Please see latest research for each company. * Historica",
        "provenance": {
          "page": 92
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 120,
      "tables_count": 0,
      "numerical_data_count": 221,
      "passages_count": 323,
      "entities_count": 20
    }
  }
}